Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast Jr, … , R B Colvin, R C Knapp
R C Bast Jr, … , R B Colvin, R C Knapp
Published November 1, 1981
Citation Information: J Clin Invest. 1981;68(5):1331-1337. https://doi.org/10.1172/JCI110380.
View: Text | PDF
Research Article Article has an altmetric score of 24

Reactivity of a monoclonal antibody with human ovarian carcinoma.

  • Text
  • PDF
Abstract

A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.

Authors

R C Bast Jr, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1969 Total
Citations: 8 15 19 21 29 23 29 28 24 31 31 36 45 29 65 35 24 27 31 22 20 13 17 16 13 19 14 21 23 22 21 38 43 49 42 54 59 47 48 25 21 11 6 5 1 1220
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (1221)

Title and authors Publication Year
Plasma proteomes and metabolism with genome-wide association data for causal effect identification in ovarian cancer
Qi L, Zhang C, Liu Y, Li W, Ren J, Zhao M
Discover Oncology 2025
Cancer Antigen 125 Levels at Time of Ovarian Cancer Diagnosis by Race and Ethnicity
Smith AJ, Gleason E, Kadiyala S, Wang X, Howell EA, McCarthy AM
JAMA Network Open 2025
Modern Emerging Biosensing Methodologies for the Early Diagnosis and Screening of Ovarian Cancer
Abul Rub F, Moursy N, Alhedeithy N, Mohamed J, Ifthikar Z, Elahi MA, Mir TA, Rehman MU, Tariq S, Alabudahash M, Chinnappan R, Yaqinuddin A
Biosensors 2025
miR-203 Alleviates Myocardial Damage Caused by Acute Coronary Syndrome by Inhibiting CA125.
Guo Y, Li J, Zhang L
Biochemical genetics 2025
Mapping the Binding Sites of CA125-Specific Antibodies on a Revised Molecular Model of MUC16
Wang CW, Srivastava A, Hanson EK, McEntee CR, Nair T, March JC, Whelan RJ
Cancers 2025
FLOT1 Is a Novel Serum Biomarker of Ovarian Cancer Targeted by N6‐methyladenosine Modification Inhibition
Guan B, Lu Q, Chen J, Fang J, Liu Z, Li W, Zhang L, Xu G
Cell Biology International 2025
Comparative Analysis of Salivary Tumor Marker CA-125 Among Oral Squamous Cell Carcinoma Patients and Healthy Individuals
Mohammed R, El Sheikh M, Hashim NT, Chaitanya NC, Suleiman A
Dentistry Journal 2025
A Dual Immunosensor Based on Optical Weak Value Amplification for Simultaneous Detection of CA125 and HE4
Wang B, Liang G, Meng L, Li H, Song Z, Xu Y, He Y, Duan D, Shi Q, Guan T, Gong Y
Sensors (Basel, Switzerland) 2025
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC Jr
British Journal of Cancer 2024
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
Wang CW, Weaver SD, Boonpattrawong N, Schuster-Little N, Patankar M, Whelan RJ
2024
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S
Therapeutic advances in medical oncology 2024
Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool
Bhadra M, Sachan M, Nara S
Frontiers in Molecular Biosciences 2024
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y
Signal Transduction and Targeted Therapy 2024
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis
Zheng K, Gao Y, Xu C, Kang Y
Journal of Gynecologic Oncology 2024
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy.
Malik S, Sikander M, Bell N, Zubieta D, Bell MC, Yallapu MM, Chauhan SC
Journal of Ovarian Research 2024
Identification of a novel histone acetylation-related long non-coding RNA model combined with qRT-PCR experiments for prognosis and therapy in gastric cancer.
Wu Z, Yang X, Yuan Z, Guo Y, Wang X, Qu L
Heliyon 2024
Preclinical evaluation and pilot clinical study of [(68)Ga]Ga-NOTA-H006 for non-invasive PET imaging of 5T4 oncofetal antigen.
He Y, Tian R, Xu D, Wu Y, Rina S, Chen T, Guan Y, Xie T, Ying T, Xie F, Han J
European journal of nuclear medicine and molecular imaging 2024
Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer
Wang X, Xing Y, Zhou X, Wang C, Han S, Zhao S
Cancer Reports 2024
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation
Su L, Wang Z, Cai M, Wang Q, Wang M, Yang W, Gong Y, Fang F, Xu L
Frontiers in Immunology 2024
Glycosylation editing: an innovative therapeutic opportunity in precision oncology.
Dai XF, Yang YX, Yang BZ
Molecular and cellular biochemistry 2024
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6
Aguilar EN, Sagar S, Murray BR, Rajesh C, Lei EK, Michaud SA, Goodlett DR, Caffrey TC, Grandgenett PM, Swanson B, Brooks TM, Black AR, van Faassen H, Hussack G, Henry KA, Hollingsworth MA, Brooks CL, Radhakrishnan P
Molecular cancer therapeutics 2024
Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer
Tian Y, Li X, Zhang H, Wang Y, Li H, Qin Q
Frontiers in Oncology 2024
Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer
Bhowmik AD, Shaw P, Pillai MS, Rao G, Dwivedi SK
Cancer letters 2024
MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma
Chirravuri-Venkata R, Dam V, Nimmakayala RK, Alsafwani ZW, Bhyravbhatla N, Lakshmanan I, Ponnusamy MP, Kumar S, Jain M, Ghersi D, Batra SK
Frontiers in Oncology 2023
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
Varier L, Sundaram SM, Gamit N, Warrier S
Cancers 2023
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
Chakraborty S, Shenoy PS, Mehrotra M, Phadte P, Singh P, Rekhi B, Ray P
Diagnostics 2023
Stearoyl-CoA desaturase 1 expression in early ovarian cancer alters free fatty acid level in serum
Kanoko Katoh, Yuki Katoh, Akiko Kubo, Miho Iida, Yuji Ikeda, Takashi Iwata, Hiroshi Nishio, Masaki Sugawara, Daiki Kato, Makoto Suematsu, Shuichi Hirai, Kei Kawana
Cancer Research Communications 2023
High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
Han GH, Yun H, Chung JY, Kim JH, Cho H
Oncology reports 2023
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Chien W, Tyner JW, Gery S, Zheng Y, Li LY, Gopinatha Pillai MS, Nam C, Bhowmick NA, Lin DC, Koeffler HP
Journal of Ovarian Research 2023
Successful treatment of breast metastasis from primary transverse colon cancer: A case report
Jiao X, Xing FZ, Zhai MM, Sun P
World journal of clinical cases 2023
Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer.
Englisz A, Smycz-Kubańska M, Mielczarek-Palacz A
2023
Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours among patients in Lagos, Nigeria
Shittu KA, Rabiu KA, Akinola OI, Ahmed SB, Adewunmi AA
ecancermedicalscience 2023
Serum leucine‐rich α2‐glycoprotein as a possible marker for inflammatory status in endometriosis
Kobayashi M, Nakamura O, Kitahara Y, Inoue N, Tsukui Y, Hasegawa Y, Hiraishi H, Yabuki A, Muraoka A, Osuka S, Iwase A
Reproductive Medicine and Biology 2023
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer.
Luo X, Lin X, Lin R, Yang Y, Wang C, Fang H, Huang H, Lu F
BMC Cancer 2023
Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses.
Song L, Qi J, Zhao J, Bai S, Wu Q, Xu R
Medicine 2023
Development and Validation of Tumor Marker Indices in Advanced Gastric Cancer Patients
Zhang J, Yin X, Wang H, Fang T, Gao J, Zhu Z, Li C, Wang Y, Wang X, Lu Z, Wu J, Wang Y, Zhang Y, Xue Y
Cancer control : journal of the Moffitt Cancer Center 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ
2023
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P
Cancers 2023
Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment.
Singla M, Smriti, Gupta S, Behal P, Singh SK, Preetam S, Rustagi S, Bora J, Mittal P, Malik S, Slama P
Frontiers in Nutrition 2023
Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D, Yang L, Jin Y, Qi H, Liu Y, Ren L
BMC medical informatics and decision making 2023
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
Tu SM, Chen JZ, Singh SR, Aydin AM, Gokden N, Tam NN, Leung YK, Langford T, Ho SM
Cancers 2023
Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study
Filiz AA, Kahyaoglu S, Atalay CR
Obstetrics & Gynecology Science 2023
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
L Ge, Y Sun, Y Shi, G Liu, F Teng, Z Geng, X Chen, H Xu, J Xu, X Jia
Journal of Ovarian Research 2022
Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer
K Lakatos, G González, J Hoballah, J Brooker, S Jeong, C Evans, P Krauledat, W Hansen, K Elias, M Patankar, V Fülöp, P Konstantinopoulos, D Cramer
Journal of Ovarian Research 2022
Circulating tumor cells in the early detection of human cancers
Feng Z, Wu J, Lu Y, Chan YT, Zhang C, Wang D, Luo D, Huang Y, Feng Y, Wang N
International journal of biological sciences 2022
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
Ghose A, Gullapalli SV, Chohan N, Bolina A, Moschetta M, Rassy E, Boussios S
Proteomes 2022
Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
White B, Patterson M, Karnwal S, Brooks CL
Proteins 2022
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.
de Campos Vieira Abib S, Chui CH, Cox S, Abdelhafeez AH, Fernandez-Pineda I, Elgendy A, Karpelowsky J, Lobos P, Wijnen M, Fuchs J, Hayes A, Gerstle JT
ecancermedicalscience 2022
Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women.
Huang Z, Tan L, Ling Y, Huang F, Ma W
BioMed Research International 2022
Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study.
Huang JH, Liu HS, Hu T, Zhang ZJ, He XW, Mo TW, Wen XF, Lan P, Lian L, Wu XR
Gastroenterology Report 2022
Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL, Pisanic TR 2nd
Cancers 2022
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series.
Folsom SM, Mumford B, Lemon L, Taylor S
Gynecologic Oncology Reports 2022
Oncofetal reprogramming in tumour development and progression.
Sharma A, Blériot C, Currenti J, Ginhoux F
Nature reviews. Cancer 2022
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer.
Jeon H, Seo SM, Kim TW, Ryu J, Kong H, Jang SH, Jang YS, Kim KS, Kim JH, Ryu S, Jeon S
Current issues in molecular biology 2022
[MUC16: The Novel Target for Tumor Therapy].
Gao R, Lou N, Han X, Shi Y
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2022
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
Hiepp L, Mayr D, Gärtner K, Schmoeckel E, Klauschen F, Burges A, Mahner S, Zeidler R, Czogalla B
PloS one 2022
Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers.
Farinella F, Merone M, Bacco L, Capirchio A, Ciccozzi M, Caligiore D
Scientific Reports 2022
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.
Chianca M, Panichella G, Fabiani I, Giannoni A, L'Abbate S, Aimo A, Del Franco A, Vergaro G, Grigoratos C, Castiglione V, Cipolla CM, Fedele A, Passino C, Emdin M, Cardinale DM
Frontiers in Cardiovascular Medicine 2022
Molecular Management of High-Grade Serous Ovarian Carcinoma
Punzón-Jiménez P, Lago V, Domingo S, Simón C, Mas A
International journal of molecular sciences 2022
Diagnostics of Ovarian Tumors in Postmenopausal Patients.
Mustafin C, Vesnin S, Turnbull A, Dixon M, Goltsov A, Goryanin I
2022
ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery
Wang J, Xu P, Zou G, Yin M, Mao X, Zhang X
Disease Markers 2022
A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer
Wang AJ, Gao Y, Shi YY, Dai MY, Cai HB
Frontiers in pharmacology 2022
Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer.
Utkarsh K, Kumar A, Aditi, Khan A, Nayyar A, Haque S, Iqbal S
Genes & Diseases 2022
A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus
P Pal, KN Starkweather, KH Hales, DB Hales
Comparative medicine 2021
Characterization of Cell-Bound CA125 on Immune Cell Subtypes of Ovarian Cancer Patients Using a Novel Imaging Platform
G González, K Lakatos, J Hoballah, R Fritz-Klaus, L Al-Johani, J Brooker, S Jeong, CL Evans, P Krauledat, DW Cramer, RA Hoffman, WP Hansen, MS Patankar
Cancers 2021
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
D Thomas, AK Rathinavel, P Radhakrishnan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021
Aptamers for Medical Applications: From Diagnosis to Therapeutics
Y Dong
2021
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
J Ryu, SN Thomas
Molecules (Basel, Switzerland) 2021
MAPK Signaling Is Required for Generation of Tunneling Nanotube-Like Structures in Ovarian Cancer Cells
JM Cole, R Dahl, KD Dahl
Cancers 2021
Design Strategies for Electrochemical Aptasensors for Cancer Diagnostic Devices
K Malecka, E Mikuła, EE Ferapontova
Sensors (Basel, Switzerland) 2021
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
E Yue, G Yang, Y Yao, G Wang, A Mohanty, F Fan, L Zhao, Y Zhang, T Mirzapoiazova, TC Walser, L Rodriguez-Rodriguez, Y Fong, R Salgia, EW Wang
Cancers 2021
Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer
M Zhang, S Cheng, Y Jin, Y Zhao, Y Wang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021
Toward improvement of screening through mass spectrometry-based proteomics: Ovarian cancer as a case study
GT Luu, LM Sanchez
International Journal of Mass Spectrometry 2021
The Search for Biomarkers in Endometriosis: a Long and Windy Road
M Králíčková, V Vetvicka, L Fiala, AS Laganà, S Garzon
Reproductive sciences (Thousand Oaks, Calif.) 2021
Next Generation Sequencing Technology in the Clinic and Its Challenges
LK Vestergaard, DN Oliveira, CK Høgdall, EV Høgdall
Cancers 2021
Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
S Mukherjee, K Sundfeldt, CA Borrebaeck, ME Jakobsson
Proteomes 2021
Dynamic light scattering and fluorescence dual-signal sensing of cancer antigen-125 via recognition of the polymerase chain reaction product with gold nanoparticle probe
R Shen, J Zhang, W Huang, S Wu, G Li, S Zou, L Ling
Analytica Chimica Acta 2021
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
C Walker, TM Nguyen, S Jessel, AB Alvero, DA Silasi, T Rutherford, S Draghici, G Mor
Cancers 2021
Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer
KE Bairi, OA Jarroudi, S Afqir
Seminars in Cancer Biology 2021
Clinical Molecular Diagnostics
S Pan, J Tang
2021
Contemporary Obstetrics and Gynecology for Developing Countries
F Okonofua, JA Balogun, K Odunsi, VN Chilaka
2021
Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion
H Lin, L Ni
Medicina Clínica 2021
An aptamer biosensor for CA125 quantification in human serum based on upconversion luminescence resonance energy transfer
X Zhang, Y Wang, H Deng, X Xiong, H Zhang, T Liang, C Li
Microchemical Journal 2021
Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer
WE Omer, MF Abdelbar, NM El-Kemary, N Fukata, MA El-Kemary
RSC Advances 2021
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer
J Liu, H Burris, JS Wang, L Barroilhet, M Gutierrez, Y Wang, A Vaze, R Commerford, S Royer-Joo, V Choeurng, E Humke, K Moore
Gynecologic Oncology 2021
State of the problem of early diagnosis and treatment of benign ovarian tumors in postmenopausal patients (literature review)
NM Podzolkova, RE Kuznetsov, OL Glazkova, LG Sozaeva, LB Tumgoeva
Gynecology 2021
Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
MÁ Elorriaga, JL Neyro, J Mieza, I Cristóbal, A Llueca
Journal of Personalized Medicine 2021
WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer
C Zhang, H Hu, X Wang, Y Zhu, M Jiang
Journal of Cancer 2021
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
S Liu, M Wu, F Wang
Journal of Cancer 2021
Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma
C Qin, Y Gao, J Li, C Huang, S He
Oncology Letters 2021
One-stop clinic for patients with suspected ovarian cancer: results from a retrospective outcome study of the referral pathway.
Ashmore AA, Gnanachandran C, Luqman I, Horrocks K
BMC Women's Health 2021
Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer.
Omer WE, Abdelbar MF, El-Kemary NM, Fukata N, El-Kemary MA
RSC Advances 2021
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
AM Macpherson, SC Barry, C Ricciardelli, MK Oehler
Journal of Clinical Medicine 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
D Zamarin, RA Burger, MW Sill, DJ Powell, HA Lankes, MD Feldman, O Zivanovic, C Gunderson, E Ko, C Mathews, S Sharma, AR Hagemann, S Khleif, C Aghajanian
Journal of Clinical Oncology 2020
ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells
P Dausinas, K Pulakanti, S Rao, JM Cole, R Dahl, KD Dahl
Gene 2020
Laboratory predictors of survival in ovarian cancer
MP Jammal, AM Filho, GH Bandeira, BM Murta, EF Murta, RS Nomelini
Revista da Associação Médica Brasileira 2020
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
YJ Lee, YM Kim, JS Kang, SH Nam, DY Kim, YT Kim
Oncology Letters 2020
Genetically predicted circulating protein biomarkers and ovarian cancer risk
DP Considine, G Jia, X Shu, JM Schildkraut, PD Pharoah, W Zheng, SP Kar
Gynecologic Oncology 2020
'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine
N Masood, SS Malik
2020
Raised CA125 – what we actually know…
T Howe, N Sokolovsky, A Sayasneh, K Omar, F Tahmasebi
The Obstetrician & Gynaecologist 2020
Highly Sensitive Detection of CA 125 Protein with the Use of an n-Type Nanowire Biosensor
KA Malsagova, TO Pleshakova, RA Galiullin, AF Kozlov, ID Shumov, VP Popov, FV Tikhonenko, AV Glukhov, VS Ziborov, OF Petrov, VE Fortov, AI Archakov, YD Ivanov
Biosensors 2020
Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
L Feeney, IJ Harley, WG McCluggage, PB Mullan, JP Beirne
World journal of clinical oncology 2020
Additive prognostic value of carbohydrate antigen‐125 over frailty in patients undergoing transcatheter aortic valve replacement
FJ Romeo, IM Seropian, JG Chiabrando, JV Raleigh, M Smietniansky, M Cal, M Falconi, V Kotowicz, CR Agatiello, DH Berrocal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2020
microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges
V Kumar, S Gupta, K Varma, M Sachan
DNA and Cell Biology 2020
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong, SA Narod, MR Akbari
Cancers 2020
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
B Nemieboka, SK Sharma, TD Rao, KJ Edwards, S Yan, P Wang, A Ragupathi, A Piersigilli, DR Spriggs, JS Lewis
Nuclear Medicine and Biology 2020
E2F8 Induces Cell Proliferation and Invasion through the Epithelial–Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer
KJ Eoh, HJ Kim, JW Lee, LK Kim, SA Park, HS Kim, YT Kim, PJ Koo
International journal of molecular sciences 2020
Association of genetic variants in the 3′‐untranslated region of the mesothelin ( MSLN ) gene with ovarian carcinoma
AM AbouElNaga, SM ElKhair, AZ Mahmoud, M Hamza, RM Elshazli
Journal of Biochemical and Molecular Toxicology 2020
Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment
SY Jeong, BK Park, YY Lee, TJ Kim
Journal of Clinical Medicine 2020
A biosensor for determination of the circulating biomarker CA125/MUC16 by Surface Plasmon Resonance Imaging
B Szymańska, Z Lukaszewski, K Hermanowicz-Szamatowicz, E Gorodkiewicz
Talanta 2020
Biomarker CA125 Feature Engineering and Class Imbalance Learning Improves Ovarian Cancer Prediction
X Yang, M Khushi, K Shaukat
2020
Controversial issues of clinical, laboratory and instrumental diagnostics of ovarian tumors of reproductive women (literature review)
NM Podzolkova, VB Osadchev, KV Babkov, NE Safonova
Gynecology 2020
Diagnostic Utility of Serum CA-125 Levels in Cases of Acute Appendicitis in Male Patients - A Hospital Based Study
MR Lingareddy, M Gajula, AK Vishwanath, SP R
2020
MUC16 affects the biological functions of ovarian cancer cells and induces an antitumor immune response by activating dendritic cells
Y Zhai, Q Lu, T Lou, G Cao, S Wang, Z Zhang
Annals of translational medicine 2020
Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma
Z Li, H Yin, M Ren, Y Shen
Medical science monitor : international medical journal of experimental and clinical research 2020
Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes
B Corradetti, S Pisano, RS Conlan, M Ferrari
The Journal of pharmacology and experimental therapeutics 2019
Untouchable genes in the human genome: Identifying ideal targets for cancer treatment
IP Gorlov, OY Gorlova, CI Amos
Cancer Genetics 2019
Tumour biomarkers—Tracing the molecular function and clinical implication
J Lin, L Ma, D Zhang, J Gao, Y Jin, Z Han, D Lin
Cell Proliferation 2019
Pseudo-pseudo Meigs’ syndrome presenting with a combination of polyserositis, elevated serum CA 125 in systemic lupus erythematosus: A case report
F Gao, YM Xu, GW Yang
Medicine 2019
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
V Dochez, H Caillon, E Vaucel, J Dimet, N Winer, G Ducarme
Journal of Ovarian Research 2019
Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons
J Hua, J Liu, M Hua, R Cai, M Li, J Wang, J Wang
Medicine 2019
Novel Approaches to Ovarian Cancer Screening
DR Nebgen, KH Lu, RC Bast
Current Oncology Reports 2019
Malignant ovarian lesion complicated by a rare entero-ovarian fistula
R Ravikanth, K Kamalasekar
Gynecology and Minimally Invasive Therapy 2019
Compatibility of the frozen section method in histopathological specimens for female pelvic masses with results for pathology and tumor markers
Parisa Mokhles, Amjad Ahmadi, Ramesh Rahehagh, Nasrin Soofizadeh, Ebrahim Ghaderi
Medical journal of the Islamic Republic of Iran 2019
Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels
S Zhou, Z Wang, M Li, L Wu
BioMed Research International 2019
Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management
M Jafari, M Hasanzadeh, E Solhi, S Hassanpour, N Shadjou, A Mokhtarzadeh, A Jouyban, S Mahboob
International Journal of Biological Macromolecules 2019
A protein nanocontainer targeting epithelial cancers: rational engineering, biochemical characterization, drug loading and cell delivery
C Ladurantie, M Coustets, G Czaplicki, P Demange, S Mazères, S Dauvillier, J Teissié, MP Rols, A Milon, V Ecochard, G Gross, L Paquereau
Nanoscale 2019
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†
DP Cook, BC Vanderhyden
Biology of reproduction 2019
American Society of Anesthesiologists physical status score as a predictor of long-term outcome in women with endometrial cancer
AM Kolehmainen, A Pasanen, T Tuomi, R Koivisto-Korander, M Loukovaara, R Butzow
International Journal of Gynecological Cancer 2019
Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy
V Canzonieri, A Giordano
2019
Preventive Oncology for the Gynecologist
S Mehta, A Singla
2019
Biomarkers in Cancer Therapy: Liquid Biopsy Comes of Age
H Shimada
2019
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients
F Plotti, F Guzzo, T Schirò, C Terranova, CD Nardone, R Montera, D Luvero, G Scaletta, S Lopez, S Capriglione, PB Panici, R Angioli
International Journal of Gynecological Cancer 2019
The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study
G Levin, S Herzberg, UP Dior, A Shushan, R Gilad, A Benshushan, A Rottenstreich
European journal of obstetrics, gynecology, and reproductive biology 2019
Ovarian carcinomas express HE4 epitopes independently of each other
I Hellstrom, YY Yip, M Darvas, E Swisher, KE Hellstrom
Cancer Treatment and Research Communications 2019
The Translational Status of Cancer Liquid Biopsies
S Bratulic, F Gatto, J Nielsen
Regenerative Engineering and Translational Medicine 2019
Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer
L Xu, Y Wu, X Che, J Zhao, F Wang, P Wang, X Qu, YP Liu, Z Li
DNA and Cell Biology 2019
Molecularly imprinted polymer SPE sensor for analysis of CA-125 on serum
TS Rebelo, R Costa, AT Brandão, AF Silva, MG Sales, CM Pereira
Analytica Chimica Acta 2019
Paper based immunosensing of ovarian cancer tumor protein CA 125 using novel nano-ink: A new platform for efficient diagnosis of cancer and biomedical analysis using microfluidic paper-based analytical devices (μPAD)
F Bahavarnia, A Saadati, S Hassanpour, M Hasanzadeh, N Shadjou, A Hassanzadeh
International Journal of Biological Macromolecules 2019
The predictive value of serum cancer antigen 125 (CA125) levels on pregnancy outcome in threatened miscarriages
MA Adeku, O Adegbola, GO Ajayi
Journal of Perinatal Medicine 2019
Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease
S Nath, MA Saad, M Pigula, JW Swain, T Hasan
Cancers 2019
Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer
WB Kietzman, GT Graham, V Ory, GM Sharif, MH Kushner, GT Gallanis, B Kallakury, A Wellstein, AT Riegel
Molecular cancer therapeutics 2019
An Investigation of Survival following Ovarian Cancer
JH Karami, K Luo, T Fung, J Carter, Z Ding
2019
Clinical Epigenetics
LB Hesson, AL Pritchard
Clinical Epigenetics 2019
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
AD Barrow, MA Edeling, V Trifonov, J Luo, P Goyal, B Bohl, JK Bando, AH Kim, J Walker, M Andahazy, M Bugatti, L Melocchi, W Vermi, DH Fremont, S Cox, M Cella, C Schmedt, M Colonna
Cell 2018
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
T Hilliard
Cancers 2018
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq
AJ Shih, A Menzin, J Whyte, J Lovecchio, A Liew, H Khalili, T Bhuiya, PK Gregersen, AT Lee, S Orsulic
PloS one 2018
MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion
M Kanwal, XJ Ding, X Song, GB Zhou, Y Cao
Oncotarget 2018
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer
A Aithal, WM Junker, P Kshirsagar, S Das, S Kaur, C Orzechowski, SK Gautam, R Jahan, YM Sheinin, I Lakshmanan, MP Ponnusamy, SK Batra, M Jain, SV Pizzo
PloS one 2018
Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4
Y Shen, Y Wang, X Jiang, L Lu, C Wang, W Luo, Y Zhang, P Li, Z Du, T Dai, C Wu, A Fang, Y Yao, Q Peng, J Yang
Protein Expression and Purification 2018
Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform
V Gedi, CK Song, GB Kim, JO Lee, E Oh, BS Shin, M Jung, J Shim, H Lee, YP Kim
Sensors and actuators. B, Chemical 2018
Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
L Farzin, M Shamsipur
Journal of Pharmaceutical and Biomedical Analysis 2018
MUC16 as a novel target for cancer therapy
A Aithal, S Rauth, P Kshirsagar, A Shah, I Lakshmanan, WM Junker, M Jain, MP Ponnusamy, SK Batra
Expert Opinion on Therapeutic Targets 2018
“Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report”
Y Aso, R Chikazawa, Y Kimura, N Kimura, E Matsubara
BMC neurology 2018
Serum CA125 in combination with ferritin improves diagnostic accuracy for epithelial ovarian cancer
J Zhao, N Guo, L Zhang, L Wang
British journal of biomedical science 2018
Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases
F Falcão, FR de Oliveira, MC da Silva, DC Filho
Biomarkers in Medicine 2018
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
JH Choi, GS Sohn, DB Chay, HB Cho, JH Kim
Obstetrics & Gynecology Science 2018
Elevated CA 125 in a CASE of Leaking Endometrioma
S Rao, S Kapurubandara, A Anpalagan
Case Reports in Obstetrics and Gynecology 2018
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
N Abdalla, R Piorkowski, M Bachanek, P Stanirowski, K Cendrowski, W Sawicki
Disease Markers 2018
Relationship Between Carbohydrate Antigen 125 and Coronary Artery Calcification in Patients without Known Coronary Artery Disease
K Fu, HD Liu, KB MaMuTi, DN Hu, P Hao
Medical science monitor : international medical journal of experimental and clinical research 2018
CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis
CG Glasgow, G Pacheco-Rodriguez, WK Steagall, ME Haughey, PA Julien-Williams, MP Stylianou, BR Gochuico, J Moss
Chest 2018
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
B Singha, SL Harper, AR Goldman, BG Bitler, KM Aird, ME Borowsky, MG Cadungog, Q Liu, R Zhang, S Jean, R Drapkin, DW Speicher
Scientific Reports 2018
Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer
SA Bhat, MU Mir, S Majid, T Hassan, MU Rehman, S Kuchy
Hematology/Oncology and Stem Cell Therapy 2018
Optimisation of Cytoreductive Surgery in Relation to Ca 125 in Epithelial Ovarian Cancer
K Shobha, N Jayashree, UD Bafna
Indian Journal of Gynecologic Oncology 2018
Cell Biology of the Ovary
H Katabuchi, T Ohba, T Motohara
2018
Current advancement on diagnosis of ovarian cancer using biosensing of CA 125 biomarker: Analytical approaches
N Razmi, M Hasanzadeh
Trends in analytical chemistry : TRAC 2018
A case of autoimmune hepatitis diagnosed with elevated value of CA125, ascites, metrorrhagia
W Jomen, R Okutsu, T Masuda
Kanzo 2018
Liquid Crystals: A Novel Approach for Cancer Detection and Treatment
J Vallamkondu, E Corgiat, G Buchaiah, R Kandimalla, P Reddy
Cancers 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
S Grabosch, M Bulatovic, F Zeng, T Ma, L Zhang, M Ross, J Brozick, YS Fang, G Tseng, E Kim, A Gambotto, E Elishaev, RP Edwards, AM Vlad
Oncogene 2018
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
E Papp, D Hallberg, GE Konecny, DC Bruhm, V Adleff, M Noë, I Kagiampakis, D Palsgrove, D Conklin, Y Kinose, JR White, MF Press, R Drapkin, H Easwaran, SB Baylin, D Slamon, VE Velculescu, RB Scharpf
Cell Reports 2018
Ovarian Cancer - From Pathogenesis to Treatment
O Devaja, A Papadopoulos
2018
The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers
VP de Carvalho, ML Grassi, C de Souza Palma, HH Carrara, VM Faça, FJ dos Reis, A Poersch
Translational research : the journal of laboratory and clinical medicine 2018
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)
T Mitamura, S Pradeep, M McGuire, SY Wu, S Ma, H Hatakeyama, YA Lyons, T Hisamatsu, K Noh, A Villar-Prados, X Chen, C Ivan, C Rodriguez-Aguayo, W Hu, G Lopez-Berestein, RL Coleman, AK Sood
Oncogene 2017
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
JP van Putten, K Strijbis
Journal of Innate Immunity 2017
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer
H Nakamura, T Nishimura
Surgery Today 2017
Emerging biomarkers of lymphangioleiomyomatosis
J Nijmeh, S El-Chemaly, EP Henske
Expert Review of Respiratory Medicine 2017
Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients
QL Li, CJ Wang, P Qi, YX Zhang
Clinical and Translational Oncology 2017
A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
F Ueland
Diagnostics 2017
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
CA Borrebaeck
Nature Reviews Cancer 2017
Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
T Namikawa, Y Kawanishi, K Fujisawa, E Munekage, J Iwabu, M Munekage, H Maeda, H Kitagawa, M Kobayashi, K Hanazaki
Surgery Today 2017
A Resident’s Perspective of Ovarian Cancer
C Smith
Diagnostics 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
TD Rao, A Fernández-Tejada, A Axelrod, N Rosales, X Yan, S Thapi, A Wang, KJ Park, B Nemieboka, J Xiang, JS Lewis, N Olvera, DA Levine, SJ Danishefsky, DR Spriggs
ACS chemical biology 2017
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
R Coelho, L Marcos-Silva, S Ricardo, F Ponte, A Costa, JM Lopes, L David
Expert Review of Anticancer Therapy 2017
The role of biomarkers in the management of epithelial ovarian cancer
WL Yang, Z Lu, RC Bast
Expert Review of Molecular Diagnostics 2017
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
J Chovanec, I Selingerova, K Greplova, SL Antonsen, M Nalezinska, C Høgdall, E Høgdall, E Søgaard-Andersen, KM Jochumsen, P Fabian, D Valik, L Zdrazilova-Dubska
Oncotarget 2017
The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
ZN Dolgun, C Kabaca, A Karateke, C İyibozkurt, C İnan, AS Altıntaş, C Karadağ
BALK MED J 2017
Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort
T Tuomi, A Pasanen, A Leminen, R Bützow, M Loukovaara
Gynecologic Oncology 2017
Gastric Cancer Prewarning and Early Diagnosis System
D Cui
2017
Smartphone-based immunosensor for CA125 detection
O Hosu, A Ravalli, GM lo Piccolo, C Cristea, R Sandulescu, G Marrazza
Talanta 2017
Prediction of therapy response in ovarian cancer: Where are we now?
KE Bairi, M Amrani, AH Kandhro, S Afqir
Critical Reviews in Clinical Laboratory Sciences 2017
In Vivo Optical Detection and Spectral Triangulation of Carbon Nanotubes
CW Lin, H Yang, SR Sanchez, W Mao, L Pang, KM Beckingham, RC Bast, RB Weisman
ACS Applied Materials & Interfaces 2017
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer
T May, JM Stewart, MQ Bernardini, SE Ferguson, S Laframboise, H Jiang, B Rosen
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2017
Treatment of peritoneal carcinomatosis with photodynamic therapy: Systematic review of current evidence
MQ Almerie, G Gossedge, KE Wright, DG Jayne
Photodiagnosis and Photodynamic Therapy 2017
Respective and simultaneous detection tumor markers CA125 and STIP1 using aptamer-based fluorescent and RLS sensors
F Chen, Y Liu, C Chen, H Gong, C Cai, X Chen
Sensors and actuators. B, Chemical 2017
Red Snappers and Red Herrings: Pelvic Tuberculosis Causing Elevated CA 125 and Mimicking Advanced Ovarian Cancer. A Case Report and Literature Review
Johnnie Alphonse Yates, Olivia Ann Collis, Thanasak Sueblinvong, Tarquin Kamakana Collis
Hawai'i Journal of Medicine & Public Health 2017
Analysis of CA125 antigen in normal human seminal plasma highlightsthe molecular heterogeneity of underlying glycosylated species
N MITIC, B MILUTINOVIC, M JANKOVIC
TURK J BIOL 2017
Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine
D Zamarin, AA Jazaeri
Gynecologic Oncology 2016
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
JK Chan, MF Brady, RT Penson, H Huang, MJ Birrer, JL Walker, PA DiSilvestro, SC Rubin, LP Martin, SA Davidson, WK Huh, DM OMalley, MP Boente, H Michael, BJ Monk
New England Journal of Medicine 2016
Major milestones in translational oncology
TA Dragani, A Castells, V Kulasingam, EP Diamandis, H Earl, WT Iams, CM Lovly, JP Sedelaar, JA Schalken
BMC Medicine 2016
PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells: PPARγ C ONTROL OF MUC16 E XPRESSION
M Morgado, DD Carson
Journal of Cellular Biochemistry 2016
The human fetoembryonic defense system hypothesis: Twenty years on
PC Pang, SM Haslam, A Dell, GF Clark
Molecular Aspects of Medicine 2016
Prédictibilité préopératoire de la malignité des tumeurs ovariennes à partir du score ADNEX et utilisation en pratique clinique
E Joyeux, T Miras, I Masquin, PE Duglet, K Astruc, S Douvier
Gynécologie Obstétrique & Fertilité 2016
High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
F Morales-Vásquez, E Pedernera, J Reynaga-Obregón, HN López-Basave, MJ Gómora, E Carlón, S Cárdenas, R Silva-Ayala, M Almaraz, C Méndez
Journal of Ovarian Research 2016
Establishment of anti-mesothelioma monoclonal antibodies
N Mizutani, M Abe, S Matsuoka, K Kajino, M Wakiya, N Ohtsuji, R Hatano, C Morimoto, O Hino
BMC Research Notes 2016
Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)
BM Volgger, GH Windbichler, AG Zeimet, AH Graf, G Bogner, L Angleitner-Boubenizek, M Rohde, U Denison, G Sliutz, LC Fuith, D Fuchs, C Marth
Annals of Oncology 2016
Total internal reflection plasmonic scattering-based fluorescence-free nanoimmunosensor probe for ultra-sensitive detection of cancer antigen 125
SK Chakkarapani, P Zhang, S Ahn, SH Kang
Biosensors and Bioelectronics 2016
Elevation of CA19-9-Related Novel Marker, Core 1 Sialyl Lewis A, in Sera of Adenocarcinoma Patients Verified by a SRM-Based Method
M Tanaka-Okamoto, M Yabu, M Mukai, H Takahashi, Y Fujiwara, M Ohue, Y Kamada, E Miyoshi, Y Miyamoto
Journal of Proteome Research 2016
External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer
M Koskas, J Uzan, A Vanderstraeten, I Vergote, F Amant
Gynecologic Oncology 2016
Ocular Surface Membrane-Associated Mucins
AF Ablamowicz, JJ Nichols
The ocular surface 2016
Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer
F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast, G Davis, S Serra, EP Diamandis, V Kulasingam
Cancer epidemiology, biomarkers & prevention 2016
Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients
S Yazawa, R Takahashi, T Yokobori, R Sano, A Mogi, AR Saniabadi, H Kuwano, T Asao, PK Singh
PloS one 2016
Evaluation and Management of Adnexal Masses:
C MacGregor, B Cronin
Topics in Obstetrics & Gynecology 2016
The cost-effectiveness and value of gynecological cancer biomarker screening in financially vulnerable female populations
R Hendricks-Sturrup
Journal of Cancer Policy 2016
Photonics immunotherapy — A novel strategy for cancer treatment
F Zhou, RE Nordquist, WR Chen
Journal of Innovative Optical Health Sciences 2016
Novel Immunogenic Epitopes in the NaPi-IIb Protein: Production of Monospecific Antibodies Using Synthetic Peptides Outlined on Isoform Specific Regions of the Type IIb Sodium-Dependent Phosphate Transporter (NaPi-IIb)
ÂA Megale, JM da Júnior, LB Rangel, MD Diz, MS Mano, PM Hoff, PH Lopes, RJ Arai, WD da Silva
Journal of Cancer Therapy 2016
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer
JF Liu, KN Moore, MJ Birrer, S Berlin, UA Matulonis, JR Infante, B Wolpin, KA Poon, R Firestein, J Xu, R Kahn, Y Wang, K Wood, WC Darbonne, MR Lackner, SK Kelley, X Lu, YJ Choi, D Maslyar, EW Humke, HA Burris
Annals of Oncology 2016
Aptamer and 5-fluorouracil dual-loading Ag2S quantum dots used as a sensitive label-free probe for near-infrared photoluminescence turn-on detection of CA125 antigen
H Jin, R Gui, J Gong, W Huang
Biosensors and Bioelectronics 2016
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
N Arakawa, H Kobayashi, N Yonemoto, Y Masuishi, Y Ino, H Shigetomi, N Furukawa, N Ohtake, Y Miyagi, F Hirahara, H Hirano, E Miyagi, SK Batra
PloS one 2016
Encyclopedia of Signaling Molecules
S Choi
Encyclopedia of Signaling Molecules 2016
Holland-Frei Cancer Medicine
RC Bast, WN Hait, DW Kufe, RR Weichselbaum, JF Holland, CM Croce, M Piccart-Gebart, H Wang, WK Hong, RE Pollock
Holland-Frei Cancer Medicine 2016
NCCN Work Group Report: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies
Alan P. Venook, Maria E. Arcila, Al B. Benson, Donald A. Berry, David Ross Camidge, Robert W. Carlson, Toni K. Choueiri, Valerie Guild, Gregory P. Kalemkerian, Razelle Kurzrock, Christine M. Lovly, Amy E. McKee, Robert J. Morgan, Anthony J. Olszanski, Mary W. Redman, Vered Stearns, Joan McClure, Marian L. Birkeland
Journal of the National Comprehensive Cancer Network : JNCCN 2016
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
CA Parkinson, D Gale, AM Piskorz, H Biggs, C Hodgkin, H Addley, S Freeman, P Moyle, E Sala, K Sayal, K Hosking, I Gounaris, M Jimenez-Linan, HM Earl, W Qian, N Rosenfeld, JD Brenton, ER Mardis
PLoS Medicine 2016
Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women:
CJ Huang, JK Jiang, SC Chang, JK Lin, SH Yang
Medicine 2016
M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop
MJ Carroll, A Kapur, M Felder, MS Patankar, PK Kreeger
Oncotarget 2016
Discovery of biomarkers for endometrial cancer: current status and prospects
TL Rižner
Expert Review of Molecular Diagnostics 2016
Serum concentrations of the biomarkers CA125, CA15-3, PSA and PAPP-A in early pregnancy
M Stemp, P Roberts, A McClements, V Chapple, P Matson
2016
Very rare cause of hemoperitoneum: Ovarian fibroma
M Köse, F Çelik, SK Köse, DT Arıöz, BD Yavas
Journal of Obstetrics & Gynaecology 2016
Protein Glycosylation in Cancer
SR Stowell, T Ju, RD Cummings
Annual review of pathology 2015
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
DL Bourgeois, KA Kabarowski, VL Porubsky, PK Kreeger
Cancer Cell International 2015
The Homeoprotein DLX4 Stimulates NF-κB Activation and CD44-Mediated Tumor–Mesothelial Cell Interactions in Ovarian Cancer
D Haria, BQ Trinh, SY Ko, N Barengo, J Liu, H Naora
The American Journal of Pathology 2015
ROMA, an algorithm for ovarian cancer
AM Chudecka-Głaz
Clinica Chimica Acta 2015
Risk-stratification of endometrial carcinomas revisited: A combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease
T Tuomi, A Pasanen, A Luomaranta, A Leminen, R Bützow, M Loukovaara
Gynecologic Oncology 2015
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
M Koneru, R O’Cearbhaill, S Pendharkar, DR Spriggs, RJ Brentjens
Journal of Translational Medicine 2015
Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
H Zhang, Y Yang, Y Wang, X Gao, W Wang, H Liu, H He, Y Liang, K Pan, H Wu, J Shi, H Xue, L Liang, Z Cai, Y Fan, Y Zhang
Journal of Ovarian Research 2015
Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study
J Wu, H Yin, J Zhu, RJ Buckanovich, JD Thorpe, J Dai, N Urban, DM Lubman, AW Lo
PloS one 2015
Postmenopausal Meigs' Syndrome in Elevated CA-125: A Case Report
JW Park, JW Bae
Journal of Menopausal Medicine 2015
Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments
S Das, PD Majhi, MH Al-Mugotir, S Rachagani, P Sorgen, SK Batra
Scientific Reports 2015
BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer
A Chao, CL Tsai, SM Jung, WC Chuang, C Kao, A Hsu, SH Chen, CY Lin, YC Lee, YS Lee, TH Wang, HS Wang, CH Lai, DW Chan
PloS one 2015
ARID3B Directly Regulates Ovarian Cancer Promoting Genes
A Bobbs, K Gellerman, WM Hallas, S Joseph, C Yang, J Kurkewich, KD Dahl, J Zhang
PloS one 2015
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas
EK Crane, SY Kwan, DI Izaguirre, YT Tsang, LK Mullany, Z Zu, JA Richards, DM Gershenson, KK Wong, AN Cheung
PloS one 2015
Noninvasive Molecular Markers in Gynecologic Cancers
P Peitsidis
Noninvasive Molecular Markers in Gynecologic Cancers 2015
A novel monoclonal antibody to a defined peptide epitope in MUC16
L Marcos-Silva, S Ricardo, K Chen, O Blixt, E Arigi, D Pereira, E Høgdall, U Mandel, EP Bennett, SY Vakhrushev, L David, H Clausen
Glycobiology 2015
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
B Devapatla, A Sharma, S Woo, D Ribatti
PloS one 2015
Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
ML Granados, LG Hudson, SL Samudio-Ruiz, JC States
PloS one 2015
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing
I Lamberti, S Scarano, CL Esposito, A Antoccia, G Antonini, C Tanzarella, VD Franciscis, M Minunni
Methods 2015
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases
TI Oprea, LA Sklar, JO Agola, Y Guo, M Silberberg, J Roxby, A Vestling, E Romero, Z Surviladze, C Murray-Krezan, A Waller, O Ursu, LG Hudson, A Wandinger-Ness, MF Olson
PloS one 2015
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
A Kirwan, M Utratna, ME ODwyer, L Joshi, M Kilcoyne
BioMed Research International 2015
Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
S Das, SK Batra
Cancer research 2015
CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review
G Colloca, A Venturino, I Governato
Clinical and Translational Oncology 2015
Translational Research and Plasma Proteomic in Cancer: P ROTEOMIC IN C ANCER
AC Santini, G Giovane, A Auletta, AD Carlo, A Fiorelli, L Cito, C Astarita, A Giordano, R Alfano, A Feola, MD Domenico
Journal of Cellular Biochemistry 2015
Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review
AC İyibozkurt, M Doğan, E Baştu, H Sözen, D Vatansever, S Topuz, S Berkman
Journal of Turkish Society of Obstetric and Gynecology 2015
CEA in Evaluation of Adnexal Mass: Retrospective Cohort Analysis and Review of the Literature
L Sagi-Dain, O Lavie, R Auslander, S Sagi
The International Journal of Biological Markers 2015
Usefulness of determining CA 125 and HE4 serum concentration in diagnosis of ovarian cancer
I Gumółka
2015
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells
S Das, S Rachagani, MP Torres-Gonzalez, I Lakshmanan, PD Majhi, LM Smith, KU Wagner, SK Batra
Oncotarget 2015
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
T Hu, YM Chung, M Guan, M Ma, J Ma, JS Berek, MC Hu
Scientific Reports 2014
Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy
D Escors
New Journal of Science 2014
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata, J Heintz, R Albrecht, L Fass, J Kaur, K Hu, H Shojaei, RJ Whelan, MS Patankar
Molecular Cancer 2014
Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer
N Povolotskaya, N Das, K Dhar, D Brinkmann, F Gardner, R Woolas
Surgery Research and Practice 2014
Baseline and post prophylactic tubal–ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers
Y Chen, E Bancroft, S Ashley, A Arden-Jones, S Thomas, S Shanley, S Saya, E Wakeling, R Eeles
Familial Cancer 2014
High serum carbohydrate antigen 125 concentration can predict serous effusion but not gastrointestinal malignancy in male patients
X Zhu, W Zhou, Y Chen, J Gao, F Kong, J Liu, Z Li, J Gao, Y Bai
Tumor Biology 2014
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study
AN Fader, J Java, TC Krivak, RE Bristow, AI Tergas, MA Bookman, DK Armstrong, EJ Tanner, DM Gershenson
Gynecologic Oncology 2014
Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer
RA Fuhrman-Luck, ML Silva, Y Dong, H Irving-Rodgers, T Stoll, ML Hastie, D Loessner, JJ Gorman, JA Clements
PROTEOMICS – CLINICAL APPLICATIONS 2014
Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer
N Sandhu, MA Karlsen, C Høgdall, IA Laursen, IJ Christensen, EV Høgdall
Scandinavian Journal of Clinical & Laboratory Investigation 2014
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
A Munshi, V Sharma
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis 2014
Early inflammatory response in epithelial ovarian tumor cyst fluids
B Kristjánsdóttir, K Partheen, ET Fung, C Yip, K Levan, K Sundfeldt
Cancer Medicine 2014
An mDia2/ROCK Signaling Axis Regulates Invasive Egress from Epithelial Ovarian Cancer Spheroids
KM Pettee, KM Dvorak, AL Nestor-Kalinoski, KM Eisenmann, P Aspenstrom
PloS one 2014
Commentary on ‘Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening’
YL Wan, EJ Crosbie
BJOG: An International Journal of Obstetrics & Gynaecology 2014
Cancer antigen 125 after delivery in women with a normal pregnancy: a prospective cohort study
PB Szecsi, MR Andersen, B Bjørngaard, KK Hedengran, S Stender
Acta Obstetricia et Gynecologica Scandinavica 2014
Potential biomarkers for oral squamous cell carcinoma: Proteomics discovery and clinical validation
Y Ni, L Ding, Q Hu, ZC Hua
PROTEOMICS – CLINICAL APPLICATIONS 2014
Immunoassays for the cancer biomarker CA125 based on a large-birefringence nematic liquid-crystal mixture
SH Sun, MJ Lee, YH Lee, W Lee, X Song, CY Chen
Biomedical Optics Express 2014
The chicken model of spontaneous ovarian cancer
AM Hawkridge
PROTEOMICS – CLINICAL APPLICATIONS 2014
Elevated CA-125 in disseminated tuberculosis: a case report
D Kulshreshtha, G Raj, S Singh, PK Maurya, AK Singh, AK Thacker
QJM 2014
In 2014, can we do better than CA125 in the early detection of ovarian cancer?
JG Cohen
World journal of biological chemistry 2014
Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm
C Das
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2014
Characterization of Binding Epitopes of CA125 Monoclonal Antibodies
L Marcos-Silva, Y Narimatsu, A Halim, D Campos, Z Yang, MA Tarp, PJ Pereira, U Mandel, EP Bennett, SY Vakhrushev, SB Levery, L David, H Clausen
Journal of Proteome Research 2014
Development and Characterization of Three Novel Monoclonal Antibodies Against CA-125
T Michurina, M Kerzhner, B Klimovich
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2014
Serum concentrations of the biomarkers CA125, CA15-3, CA72-4, tPSA and PAPP-A in natural and stimulated ovarian cycles
M Stemp, P Roberts, A McClements, V Chapple, J Natalwala, M Black, P Matson
Asian Pacific Journal of Reproduction 2014
A simple resonance Rayleigh scattering method for determination of trace CA125 using immuno-AuRu nanoalloy as probe via ultrasonic irradiation
M Tang, G Wen, Y Luo, A Liang, Z Jiang
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Uncommon Gynecologic Cancers: del Carmen/Uncommon Gynecologic Cancers
LA Garrett, MG Carmen
Uncommon Gynecologic Cancers: del Carmen/Uncommon Gynecologic Cancers 2014
Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics
Sarah A. Engelberth, Nadine Hempel, Magnus Bergkvist
Critical Reviews in Oncogenesis 2014
Role of a Risk of Malignancy Index in Clinical Approaches to Adnexal Masses
HS Simsek, A Tokmak, E Ozgu, M Doganay, N Danisman, S Erkaya, T Gungor
Asian Pacific Journal of Cancer Prevention 2014
Variant Prostate Carcinoma and Elevated Serum CA-125
Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, April Maa, Robert Bast Jr, Louis L. Pisters, Sue-Hwa Lin, Christopher J. Logothetis, Shi-Ming Tu
The Canadian journal of urology 2014
Nanomaterial-Based Electrochemical Immunosensors for Clinically Significant Biomarkers
N Ronkainen, S Okon
Materials 2014
Mutation or Loss of p53 Differentially Modifies TGFβ Action in Ovarian Cancer
EÓ hAinmhire, SM Quartuccio, W Cheng, RA Ahmed, SM King, JE Burdette, S Deb
PloS one 2014
Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line
U Dier, DH Shin, LP Hemachandra, LM Uusitalo, N Hempel, J Zhang
PloS one 2014
Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
S Ricardo, L Marcos-Silva, D Pereira, R Pinto, R Almeida, O Söderberg, U Mandel, H Clausen, A Felix, N Lunet, L David
Molecular Oncology 2014
Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail
P Giannakouros, I Matte, C Rancourt, A Piché
International journal of oncology 2014
MUC16: molecular analysis and its functional implications in benign and malignant conditions
D Haridas, MP Ponnusamy, S Chugh, I Lakshmanan, P Seshacharyulu, SK Batra
The FASEB Journal 2014
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies
Alan P Venook, Maria E Arcila, Al B Benson 3rd, Donald A Berry, David Ross Camidge, Robert W Carlson, Toni K Choueiri, Valerie Guild, Gregory P Kalemkerian, Razelle Kurzrock, Christine M Lovly, Amy E McKee, Robert J Morgan, Anthony J Olszanski, Mary W Redman, Vered Stearns, Joan McClure, Marian L Birkeland
Journal of the National Comprehensive Cancer Network : JNCCN 2014
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance
A Nowicka, FC Marini, TN Solley, PB Elizondo, Y Zhang, HJ Sharp, R Broaddus, M Kolonin, SC Mok, MS Thompson, WA Woodward, K Lu, B Salimian, D Nagrath, AH Klopp
PloS one 2013
Comprehensive Gynecology
RL Coleman, PT Ramirez, DM Gershenson
Comprehensive Gynecology 2013
Multi-peptide nLC-PC-IDMS-SRM-based Assay for the quantification of biomarkers in the chicken ovarian cancer model
GL Kingon, JN Petitte, DC Muddiman, AM Hawkridge
Methods 2013
Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker
Y Ihata, E Miyagi, R Numazaki, T Muramatsu, A Imaizumi, H Yamamoto, M Yamakado, N Okamoto, F Hirahara
International Journal of Clinical Oncology 2013
Error-promoting DNA synthesis in ovarian cancer cells
H Dai, RJ Hickey, J Liu, RM Bigsby, C Lanner, LH Malkas
Gynecologic Oncology 2013
Dual detection of cancer biomarker CA125 using absorbance and electrochemical methods
I Al-Ogaidi, ZP Aguilar, S Suri, H Gou, N Wu
The Analyst 2013
Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: A new model based on demographics, biochemical factors, and tumor histology
A Luomaranta, A Leminen, M Loukovaara
Gynecologic Oncology 2013
The Immunoassay Handbook
RF Ritchie
The Immunoassay Handbook 2013
Cancer antigen 125 detection using the plasmon resonance scattering properties of gold nanorods
K Zhang, X Shen
The Analyst 2013
Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
S Kondalsamy-Chennakesavan, A Hackethal, D Bowtell, A Obermair
Gynecologic Oncology 2013
Screening for gynecological cancers
JK Kalsi, R Manchanda, U Menon
Expert Review of Obstetrics & Gynecology 2013
Dendritic cell immunotherapy in ovarian cancer
PJ Stiff, C Czerlanis, ML Drakes
Expert Review of Anticancer Therapy 2013
The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
J Deng, L Wang, H Chen, L Li, Y Ma, J Ni, Y Li
Cancer and Metastasis Reviews 2013
The Clinico-Pathologic Features and Significance of Preoperative CA 125 in Patients Who Had an Operation for Ovarian Tumors
CR Kim, CH Ku, IS Jeon, DW Son, JS Lee
The Journal of Korean Society of Menopause 2013
Prognostische und prädiktive Marker des Ovarialkarzinoms
I Meinhold-Heerlein, K Bräutigam, U Pecks, N Maass, DO Bauerschlag
Der Gynäkologe 2013
A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro
JM Lee, P Mhawech-Fauceglia, N Lee, LC Parsanian, YG Lin, SA Gayther, K Lawrenson
Laboratory Investigation 2013
Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer
F Leung, N Musrap, EP Diamandis, V Kulasingam
Translational Proteomics 2013
Role of cancer antigen 125 in active pulmonary tuberculosis
AF Said, BI Mohamed, E El-Sharkawy, M Al-Sherif
Egyptian Journal of Chest Diseases and Tuberculosis 2013
Maternal serum CA-125 level is elevated in severe preeclampsia
E Karaman, Y Karaman, İ Alkış, A Han, G Yıldırım, HC Ark
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2013
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis
BMC Medicine 2013
The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited
GF Clark
Molecular Human Reproduction 2013
Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012
B Patsner, GW Yim
Obstetrics & Gynecology Science 2013
Exploring the glycosylation of serum CA125
R Saldova, WB Struwe, K Wynne, G Elia, MJ Duffy, PM Rudd
International journal of molecular sciences 2013
Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
X Xu, Y Wang, F Wang, L Jia, Y Zhou, F Deng, J Qu, B Zhou, A Meng, B Fu, X Chen, Z Qian, J Wang
Journal of Ovarian Research 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium
D Pils, D Tong, G Hager, E Obermayr, S Aust, G Heinze, M Kohl, E Schuster, A Wolf, J Sehouli, I Braicu, I Vergote, TV Gorp, S Mahner, N Concin, P Speiser, R Zeillinger
BMC Cancer 2013
Manifestations of immune tolerance in the human female reproductive tract
GF Clark, DJ Schust
Frontiers in immunology 2013
Glycoprotein disease markers and single protein-omics
K Chandler, R Goldman
Molecular & cellular proteomics : MCP 2013
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
SL Antonsen, E Høgdall, IJ Christensen, M Lydolph, A Tabor, AL Jakobsen, CL Fagö-Olsen, ES Andersen, K Jochumsen, C Høgdall
Acta Obstetricia et Gynecologica Scandinavica 2013
Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer
J Bian, B Li, XJ Kou, TZ Liu, L Ming
Asian Pacific Journal of Cancer Prevention 2013
Pattern of Tissue Expression of CA-125 and HE4 in Primary Epithelial Ovarian Tumours and Correlation with Serum CA-125 Levels
SM Devan, J Pailoor, P Sthaneshwar, V Narayanan
Asian Pacific Journal of Cancer Prevention 2013
The Chinese herbs Scutellaria baicalensis and Fritillaria cirrhosa target NFκB to inhibit proliferation of ovarian and endometrial cancer cells: CHINESE HERBS INDUCED CYTOTOXICITY
L Kavandi, LR Lee, AA Bokhari, JE Pirog, Y Jiang, KA Ahmad, V Syed
Molecular Carcinogenesis 2013
Mucins and Cancer
EO Fourkala, A Gentry-Maharaj, U Menon
Mucins and Cancer 2013
Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion
F Huang, K Zhang, J Chen, Q Cai, X Liu, T Wang, Z Lv, J Wang, H Huang
Clinical Biochemistry 2013
Estradiol 17  and Its Metabolites Stimulate Cell Proliferation and Antagonize Ascorbic Acid-Suppressed Cell Proliferation in Human Ovarian Cancer Cells
HH Li, YJ Zhao, Y Li, CF Dai, SO Jobe, XS Yang, XF Li, MS Patankar, RR Magness, J Zheng
Reproductive sciences (Thousand Oaks, Calif.) 2013
Human Omental-Derived Adipose Stem Cells Increase Ovarian Cancer Proliferation, Migration, and Chemoresistance
A Nowicka, FC Marini, TN Solley, PB Elizondo, Y Zhang, HJ Sharp, R Broaddus, M Kolonin, SC Mok, MS Thompson, WA Woodward, K Lu, B Salimian, D Nagrath, AH Klopp, P Rameshwar
PloS one 2013
An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer
JW Kim, JN Glasgow, M Nakayama, F Ak, H Ugai, DT Curiel, CC Dash
PloS one 2013
Screening for Familial Ovarian Cancer: A Ray of Hope and a Light to Steer by
KC Long, ND Kauff
Journal of Clinical Oncology 2013
Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy
CS Ong, TE Cheah, R Jasmin, F Yahya, S Sockalingam, CT Ng
Lupus 2013
Saliva CA125 and TPS Levels in Patients with Oral Squamous Cell Carcinoma
X Geng, M Du, J Han, M Zhang, X Tang, R Xing
The International Journal of Biological Markers 2013
An Immune AuRu Nanoalloy Probe for Trace CA125 Using Resonance Rayleigh Scattering as Detection Technique
ZL Jiang, ML Tang, AH Liang
Advanced Materials Research 2013
Gynecological Imaging
JN Buy, M Ghossain
2013
Non-coding RNAs and Cancer
M Fabbri
2013
Advances in Diagnosis and Management of Ovarian Cancer
SA Farghaly
2013
Reflection on the Discovery of Carcinoembryonic Antigen, Prostate-Specific Antigen, and Cancer Antigens CA125 and CA19-9
EP Diamandis, RC Bast, P Gold, TM Chu, JL Magnani
Clinical chemistry 2013
CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL
M Kulkarni, A Bhandiwad, S R, S Sumangala
2013
The Mucin MUC16 (CA125) Binds to NK Cells and Monocytes from Peripheral Blood of Women with Healthy Pregnancy and Preeclampsia
C Tyler, A Kapur, M Felder, JA Belisle, C Trautman, JA Gubbels, JP Connor, MS Patankar
American Journal of Reproductive Immunology 2012
TAp73-Mediated the Activation of C-Jun N-Terminal Kinase Enhances Cellular Chemosensitivity to Cisplatin in Ovarian Cancer Cells
P Zhang, SS Liu, HY Ngan
PloS one 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer
L Qamar, E Deitsch, AN Patrick, MD Post, MA Spillman, R Iwanaga, A Thorburn, HL Ford, K Behbakht
Gynecologic Oncology 2012
Protein biomarkers of ovarian cancer: the forest and the trees
BM Nolen, AE Lokshin
Future Oncology 2012
Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
DJ Autelitano, L Raineri, K Knight, K Bannister, GE Rice
Journal of Translational Medicine 2012
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
C Korch, MA Spillman, TA Jackson, BM Jacobsen, SK Murphy, BA Lessey, VC Jordan, AP Bradford
Gynecologic Oncology 2012
Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
SC Koh, CY Huak, D Lutan, J Marpuang, S Ketut, NG Budiana, AZ Saleh, MF Aziz, H Winarto, H Pradjatmo, NK Hoan, PV Thanh, M Choolani
Journal of Gynecologic Oncology 2012
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
MR Kierny, TD Cunningham, BK Kay
Nano Reviews 2012
Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
F Weiland, K Martin, MK Oehler, P Hoffmann
International journal of molecular sciences 2012
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
RA Mosig, M Lobl, E Senturk, H Shah, S Cohen, E Chudin, R Fruscio, S Marchini, M D'Incalci, R Sachidanandam, P Dottino, JA Martignetti
Journal of Ovarian Research 2012
Evaluation and Management of Women Presenting with a Pelvic Mass
S MacLaughlan, B Cronin, RG Moore
Current Obstetrics and Gynecology Reports 2012
Epigenetic biomarkers in epithelial ovarian cancer
BS Gloss, G Samimi
Cancer Letters 2012
Ovarian Cancer Screening :
JO van NAGELL, EJ Pavlik
Clinical Obstetrics & Gynecology 2012
Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic
R George, M Michaelides, MA Brewer, U Utzinger
Lasers in Surgery and Medicine 2012
Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer :
K Akita, S Yoshida, Y Ikehara, S Shirakawa, M Toda, M Inoue, J Kitawaki, H Nakanishi, H Narimatsu, H Nakada
International Journal of Gynecological Cancer 2012
Serum IgG-Like Glycoferroprotein: Identifi cation of Its Final Dissociation Form of Thermostable Protein Coupled with Albumin
PG Prokopenko, VS Poltoranina, VM Shelepova, AA Terent’ev
Bulletin of Experimental Biology and Medicine 2012
Ovarian cancer: role of ultrasound in preoperative diagnosis and population screening
S Campbell
Ultrasound in Obstetrics & Gynecology 2012
Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody–drug conjugate therapeutic
M Carrasco-Triguero, C Mahood, M Milojic-Blair, C Amaya, J Ruppel, K Hong, JH Yi, S Kaur
Bioanalysis 2012
Flow cytometric determination of stem/progenitor content in epithelial tissues: An example from nonsmall lung cancer and normal lung
VS Donnenberg, RJ Landreneau, ME Pfeifer, AD Donnenberg
Cytometry Part A 2012
An Electronic Sensor for Detection of Early-Stage Biomarker/s for Ovarian Cancer
AM Whited, KV Singh, D Evans, R Solanki
BioNanoScience 2012
New label free CA125 detection based on gold nanostructured screen-printed electrode
A Ravalli, GP Santos, M Ferroni, G Faglia, H Yamanaka, G Marrazza
Sensors and Actuators B: Chemical 2012
From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade
F Leung, EP Diamandis, V Kulasingam
Biomarkers in Medicine 2012
Detection and Monitoring of Ovarian Cancer
Z Su, WS Graybill, Y Zhu
Clinica Chimica Acta 2012
Nanocarriers for the targeted treatment of ovarian cancers
J Tomasina, S Lheureux, P Gauduchon, S Rault, A Malzert-Fréon
Biomaterials 2012
NOT THAT RIGID MIDGETS AND NOT SO FLEXIBLE GIANTS: ON THE ABUNDANCE AND ROLES OF INTRINSIC DISORDER IN SHORT AND LONG PROTEINS
M Howell, R Green, A Killeen, L Wedderburn, V Picascio, A Rabionet, Z Peng, M Larina, B Xue, L Kurgan, VN Uversky
Journal of Biological Systems 2012
Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
F Weiland, K Fritz, MK Oehler, P Hoffmann
International journal of molecular sciences 2012
Ovarian Cyst Enlargement in a 14 Year Old Female with Persistent Ascities, Severe Hypothyroidism and Elevated Serum CA-125 Level
F Motamed, K Eftekhari, MA Kiani, A Rabbani
Iranian Red Crescent Medical Journal 2012
The immunomodulating roles of glycoproteins in epithelial ovarian cancer
Manish S. Patankar, Jennifer A.A. Gubbels, Mildred Felder, Joseph P. Connor
Frontiers in bioscience (Elite edition) 2012
Antibody-Drug Conjugates and Immunotoxins
GL Phillips
2012
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Cystic Fibrosis
MD Amaral, K Kunzelmann
Cystic Fibrosis 2011
Prognostic biomarkers in ovarian cancer
J Huang, W Hu, AK Sood
Cancer biomarkers : section A of Disease markers 2011
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
A Chao, CY Lin, YS Lee, CL Tsai, PC Wei, S Hsueh, TI Wu, CN Tsai, CJ Wang, AS Chao, TH Wang, CH Lai
Oncogene 2011
Gynecologic Oncology
A Vasilev, S Vasilev
Gynecologic Oncology 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
M Comamala, M Pinard, C Thériault, I Matte, A Albert, M Boivin, J Beaudin, A Piché, C Rancourt
British Journal of Cancer 2011
The impact of sample storage time on estimates of association in biomarker discovery studies
KG Kugler, WO Hackl, LA Mueller, H Fiegl, A Graber, RM Pfeiffer
Journal of Clinical Bioinformatics 2011
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
F Jacob, M Meier, R Caduff, D Goldstein, T Pochechueva, N Hacker, D Fink, V Heinzelmann-Schwarz
Gynecologic Oncology 2011
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis
RC Bast, DR Spriggs
Gynecologic Oncology 2011
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
RA Budiu, G Mantia-Smaldone, E Elishaev, T Chu, J Thaller, K McCabe, D Lenzner, RP Edwards, AM Vlad
Cancer Immunology, Immunotherapy 2011
Meigs’ syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor
JH Liou, TC Su, JC Hsu
Taiwanese Journal of Obstetrics and Gynecology 2011
Granulin: Biomarker or Interesting Window into Host/tumor Biology?
EM Swisher
Gynecologic Oncology 2011
Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species
H Nguyen, V Syed
Gynecological Endocrinology 2011
Immune Therapy for Ovarian Cancer: Promise and Pitfalls
SR Thibodeaux, TJ Curiel
International Reviews of Immunology 2011
Exploring the immunoproteome for ovarian cancer biomarker discovery
K Martin, C Ricciardelli, P Hoffmann, MK Oehler
International journal of molecular sciences 2011
Ovarian cancer screening and early detection in the general population
JA Rauh-Hain, TC Krivak, MG Carmen, AB Olawaiye
Reviews in obstetrics and gynecology 2011
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
X Xiang, M Feng, M Felder, JP Connor, YG Man, MS Patankar, M Ho
Journal of Cancer 2011
CA125—A Test with a Change of Heart
KA Sikaris
Heart Lung and Circulation 2011
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
N Bolstad, M Øijordsbakken, K Nustad, J Bjerner
Tumor Biology 2011
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
RG Moore, MC Miller, EE Eklund, KH Lu, RC Bast, G Lambert-Messerlian
American Journal of Obstetrics and Gynecology 2011
A családi halmozódású petefészekrák genetikai és onkológiai ellátása
JG Joó, S Ládi, BZ Nagy, Z Langmár
Orvosi Hetilap 2011
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
RG Moore, MC Miller, MM Steinhoff, SJ Skates, KH Lu, G Lambert-Messerlian, RC Bast
American Journal of Obstetrics and Gynecology 2011
Improved blood tests for cancer screening: general or specific?
IA Cree
BMC Cancer 2011
Immunohistology of Lung and Pleural Neoplasms
SP Hammar, S Dacic
Diagnostic Immunohistochemistry 2011
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma :
H Kamachi, H Nishihara, S Homma, H Kanno, K Takahashi, A Sasaki, T Einama, M Tahara, K Okada, S Muraoka
Pancreas 2011
Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application : Mucins in human neoplasms
S Yonezawa, M Higashi, N Yamada, S Yokoyama, S Kitamoto, S Kitajima, M Goto
Pathology International 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
A novel high affinity human monoclonal antibody to mesothelin
M Ho, M Feng, RJ Fisher, C Rader, I Pastan
International Journal of Cancer 2011
Aberrant glycosylation associated with enzymes as cancer biomarkers
DL Meany, DW Chan
Clinical Proteomics 2011
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma
I Hellstrom, KE Hellstrom
Expert Opinion on Medical Diagnostics 2011
Can Ovarian Cancer Screening Save Lives? : The Question Remains Unanswered
&NA;
Obstetrics and gynecology 2011
The Management of Anxiety and Knowledge of Serum CA-125 After an Ovarian Cancer Diagnosis
A Reid, E Ercolano, P Schwartz, R McCorkle
Clinical Journal of Oncology Nursing 2011
Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up
S Pignata, L Cannella, D Leopardo, GS Bruni, G Facchini, C Pisano
Annals of Oncology 2011
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
RA Burger, MF Brady, MA Bookman, GF Fleming, BJ Monk, H Huang, RS Mannel, HD Homesley, J Fowler, BE Greer, M Boente, MJ Birrer, SX Liang
New England Journal of Medicine 2011
Il carcinoma ovarico: nuove acquisizioni sulla patogenesi e nella diagnostica di laboratorio
S Orciari, C Micucci, AD Procopio, R Testa, A Catalano
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 2011
The Past, Present, and Future of Biomarkers: A Need for Molecular Beacons for the Clinical Management of Pancreatic Cancer
JR Brody, AK Witkiewicz, CJ Yeo
Advances in Surgery 2011
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma:
T Einama, H Kamachi, H Nishihara, S Homma, H Kanno, K Takahashi, A Sasaki, M Tahara, K Okada, S Muraoka, T Kamiyama, Y Matsuno, M Ozaki, S Todo
Pancreas 2011
Diagnostic Immunohistochemistry
SP Hammar, S Dacic
Diagnostic Immunohistochemistry 2011
Can Ovarian Cancer Screening Save Lives?: The Question Remains Unanswered
&NA;
Obstetrics & Gynecology 2011
Q: Can I be screened for ovarian cancer?:
HM Felix
Journal of the American Academy of Physician Assistants 2011
An Atlas of Gynecologic Oncology: Investigation and Surgery, Third Edition
R Manchanda, I Jacobs, U Menon
An Atlas of Gynecologic Oncology: Investigation and Surgery, Third Edition 2011
Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer
SM He, F Xing, H Sui, Y Wu, Y Wang, D Wang, G Chen, Z Kong, SF Zhou
Medical science monitor : international medical journal of experimental and clinical research 2011
Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
D Mury, L Woelber, S Jung, C Eulenburg, M Choschzick, I Witzel, J Schwarz, F Jaenicke, S Mahner
Journal of Cancer Research and Clinical Oncology 2011
The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities
EK Breuer, MM Murph
International Journal of Proteomics 2011
Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
D Haridas, S Chakraborty, MP Ponnusamy, I Lakshmanan, S Rachagani, E Cruz, S Kumar, S Das, SM Lele, JM Anderson, UA Wittel, MA Hollingsworth, SK Batra, RK Srivastava
PloS one 2011
125 Jahre Deutsche Gesellschaft für Gynäkologie und Geburtshilfe
R Kreienberg, H Ludwig
2011
Challenges Related to Developing Serum-Based Biomarkers for Early Ovarian Cancer Detection: Table 1
PL Mai, N Wentzensen, MH Greene
Cancer prevention research (Philadelphia, Pa.) 2011
Stress-induced Phosphoprotein 1 as a Secreted Biomarker for Human Ovarian Cancer Promotes Cancer Cell Proliferation*
TH Wang, A Chao, CL Tsai, CL Chang, SH Chen, YS Lee, JK Chen, YJ Lin, PY Chang, CJ Wang, AS Chao, SD Chang, TC Chang, CH Lai, HS Wang
Molecular & cellular proteomics : MCP 2010
Hormonal Regulation and Distinct Functions of Semaphorin-3B and Semaphorin-3F in Ovarian Cancer
D Joseph, SM Ho, V Syed
Molecular cancer therapeutics 2010
Ovarian cancer immunotherapy: opportunities, progresses and challenges
B Liu, J Nash, C Runowicz, H Swede, R Stevens, Z Li
Journal of Hematology & Oncology 2010
Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer
T Bese, M Barbaros, E Baykara, O Guralp, S Cengiz, F Demirkiran, C Sanioglu, M Arvas
Journal of Gynecologic Oncology 2010
Current state of biomarker development for clinical application in epithelial ovarian cancer
RG Moore, S MacLaughlan, RC Bast
Gynecologic Oncology 2010
Ovarian cancer: the duplicity of CA125 measurement
AK Karam, BY Karlan
Nature Reviews Clinical Oncology 2010
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
R Hassan, C Schweizer, KF Lu, B Schuler, AT Remaley, SC Weil, I Pastan
Lung Cancer 2010
Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
ZT Berman, LJ Moore, KE Knudson, RJ Whelan
Tumor Biology 2010
Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma
AM Hawkridge, RB Wysocky, JN Petitte, KE Anderson, PE Mozdziak, OJ Fletcher, JM Horowitz, DC Muddiman
Analytical and Bioanalytical Chemistry 2010
Rational application of tumor marker CA 125 in gynecological oncology
S Djurdjevic, S Stojanovic, M Basta-Nikolic, M Maksimovic
Medicinski pregled 2010
ElevatedMALexpression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer
PS Lee, VS Teaberry, AE Bland, Z Huang, RS Whitaker, T Baba, S Fujii, AA Secord, A Berchuck, SK Murphy
International Journal of Cancer 2010
From the endometrium physiology to a comprehensive strategy for the discovery of ovarian cancer biomarkers
JL Tanyi, N Scholler
Oncology Reviews 2010
Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells
M Saydmohammed, D Joseph, V Syed
Journal of Cellular Biochemistry 2010
Novel targeting strategies using recombinant antibodies for early diagnosis and therapy of ovarian cancer
N Scholler
Therapy 2010
CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: A population-based study
AM van Altena, E Kolwijck, MJ Spanjer, JC Hendriks, LF Massuger, JA de Hullu
Gynecologic Oncology 2010
Current clinical use of biomarkers for epithelial ovarian cancer
RG Moore, S MacLaughlan
Current Opinion in Oncology 2010
Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value
A Gutiérrez, J Martínez-Serra, B Barceló, A Sampol, L Viñas, G González, MD Bea, JC Amat, J Martín, R Ramos, A Bautista, J Forteza-Rey, J Rodríguez, J Besalduch
International Journal of Laboratory Hematology 2010
Cancer antigen 125 level after a bilateral salpingo-oophorectomy
AM van Altena, H Holtsema, JC Hendriks, LF Massuger, JA de Hullu
Menopause 2010
Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas
S Nishimura, H Tsuda, K Ito, M Takano, Y Terai, T Jobo, J Kigawa, T Sugiyama, N Yaegashi, D Aoki
International Journal of Gynecological Cancer 2010
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer
SA Welch, HW Hirte, L Elit, RJ Schilder, L Wang, K MacAlpine, JJ Wright, AM Oza
International Journal of Gynecological Cancer 2010
Production and Characterization of Monoclonal Antibodies against the Extracellular Domain of CA 125
S Shojaeian, A Allameh, AH Zarnani, M Chamankhah, R Ghods, AA Bayat, M Jeddi-Tehrani
Immunological Investigations 2010
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
JA Belisle, S Horibata, GA Jennifer, S Petrie, A Kapur, S André, HJ Gabius, C Rancourt, J Connor, JC Paulson, MS Patankar
Molecular Cancer 2010
Pelvic mass associated with raised CA 125 for benign condition: a case report
V Asher, R Hammond, TJ Duncan
World journal of surgical oncology 2010
Serum tumour markers in gynaecological cancers
P Aggarwal, S Kehoe
Maturitas 2010
Molecular Signatures of Ovarian Cancer: From Detection to Prognosis
CS Walsh, BY Karlan
Molecular diagnosis & therapy 2010
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer
PS Lee, VS Teaberry, AE Bland, Z Huang, RS Whitaker, T Baba, S Fujii, AA Secord, A Berchuck, SK Murphy
International Journal of Cancer 2010
Current clinical use of biomarkers for epithelial ovarian cancer:
RG Moore, S MacLaughlan
Current Opinion in Oncology 2010
Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?
AM van Altena, H Holtsema, JC Hendriks, LF Massuger, JA de Hullu
Menopause 2010
Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas:
S Nishimura, H Tsuda, K Ito, M Takano, Y Terai, T Jobo, J Kigawa, T Sugiyama, N Yaegashi, D Aoki
International Journal of Gynecological Cancer 2010
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium
SA Welch, HW Hirte, L Elit, RJ Schilder, L Wang, K MacAlpine, JJ Wright, AM Oza
International Journal of Gynecological Cancer 2010
The predictive efficacy of maternal serum CA125 in intrauterine early pregnancy with vaginal bleeding
JY Chung, CS Moon
Korean Journal of Obstetrics and Gynecology 2010
Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16:
TD Rao, KJ Park, P Smith-Jones, A Iasonos, I Linkov, RA Soslow, DR Spriggs
Applied Immunohistochemistry & Molecular Morphology 2010
Prognostic Biomarkers in Ovarian Cancer
J Huang, W Hu, AK Sood
Cancer biomarkers : section A of Disease markers 2010
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles
KE Scarberry, EB Dickerson, ZJ Zhang, BB Benigno, JF McDonald
Nanomedicine: Nanotechnology, Biology and Medicine 2010
Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer
M Fu, EL Maresh, RA Soslow, M Alavi, V Mah, Q Zhou, A Iasonos, L Goodglick, LK Gordon, J Braun, M Wadehra
Clinical cancer research 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Mucins in cancer: function, prognosis and therapy
DW Kufe
Nature Reviews Cancer 2009
Genomic and proteomic biomarkers for cancer: A multitude of opportunities
MA Tainsky
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009
General and Applied Toxicology
TC Marrs, S Warren
General and Applied Toxicology 2009
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass
M Montagnana, G Lippi, O Ruzzenente, V Bresciani, E Danese, S Scevarolli, GL Salvagno, S Giudici, M Franchi, GC Guidi
Journal of Clinical Laboratory Analysis 2009
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
S Bellone, S Anfossi, TJ O'Brien, MJ Cannon, DA Silasi, M Azodi, PE Schwartz, TJ Rutherford, S Pecorelli, AD Santin
American Journal of Obstetrics and Gynecology 2009
Beyond CA125: the coming of age of ovarian cancer biomarkers
D Sasaroli, G Coukos, N Scholler
Biomarkers in Medicine 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
O Zivanovic, CS Sima, A Iasonos, KM Bell-McGuinn, PJ Sabbatini, MM Leitao, DA Levine, GJ Gardner, RR Barakat, DS Chi
Gynecologic Oncology 2009
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172
TC Krivak, C Tian, GS Rose, DK Armstrong, GL Maxwell
Gynecologic Oncology 2009
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma
KK Zorn, C Tian, WP McGuire, WJ Hoskins, M Markman, FM Muggia, PG Rose, RF Ozols, D Spriggs, DK Armstrong
Cancer 2009
N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancer
A Seko, F Kataoka, D Aoki, M Sakamoto, T Nakamura, M Hatae, S Yonezawa, K Yamashita
Glycoconjugate Journal 2009
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer
PJ Frederick, JM Straughn, RD Alvarez, DJ Buchsbaum
Gynecologic Oncology 2009
OC-125 immunostaining in endometriotic lesion samples
CP Barbosa, ÂM Souza, B Bianco, DM Christofolini, FA Mafra, GR Lima
Archives of Gynecology and Obstetrics 2009
Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy
VN Harry, FJ Gilbert, DE Parkin
Obstetrical & Gynecological Survey 2009
Meigs' Syndrome with Elevated Serum CA125: Case Report and Review of the Literature
M Benjapibal, S Sangkarat, S Laiwejpithaya, B Viriyapak, P Chaopotong, A Jaishuen
Case reports in oncology 2009
Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes
R Srirajaskanthan, ME Caplin, MG Waugh, J Watkins, T Meyer, JJ Hsuan, NJ Beaumont
Molecular & cellular proteomics : MCP 2009
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
D Gupta, CG Lis
Journal of Ovarian Research 2009
Ovarian cancer pathogenesis: a model in evolution
AM Karst, R Drapkin
Journal of Oncology 2009
HE4 as a biomarker for ovarian and endometrial cancer management
J Li, S Dowdy, T Tipton, K Podratz, WG Lu, X Xie, SW Jiang
Expert Review of Molecular Diagnostics 2009
Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy:
VN Harry, FJ Gilbert, DE Parkin
Obstetrical & Gynecological Survey 2009
Technological challenges of theranostics in oncology
HM Warenius
Expert Opinion on Medical Diagnostics 2009
The Clinical Utility of Tumor Markers
B Handy
Laboratory Medicine 2009
Methods of Cancer Diagnosis, Therapy, and Prognosis
MA Hayat
2009
Single Conducting Polymer Nanowire Chemiresistive Label-Free Immunosensor for Cancer Biomarker
MA Bangar, DJ Shirale, W Chen, NV Myung, A Mulchandani
Analytical Chemistry 2009
Differential methylation profile of ovarian cancer as a possible detection biomarker
Anatoliy A. Melnikov, Denise Scholtens, Andrew K. Godwin, Victor V. Levenson
The Journal of Molecular Diagnostics 2008
Proteomic contributions to personalized cancer care
JM Koomen, EB Haura, G Bepler, R Sutphen, ER Remily-Wood, K Benson, M Hussein, LA Hazlehurst, TJ Yeatman, LT Hildreth, TA Sellers, PB Jacobsen, DA Fenstermacher, WS Dalton
Molecular & cellular proteomics : MCP 2008
Lights and shadows of the tumoral marker CA-125 in ovarian cancer
AS Muñoz, AG Martín, CM Fernández
Clinical and Translational Oncology 2008
Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region
H Kutta, A Willer, P Steven, L Bräuer, M Tsokos, F Paulsen
Journal of Anatomy 2008
Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer
SC Yoo, JH Yoon, MO Lyu, WY Kim, SJ Chang, KH Chang, HS Ryu
Journal of Gynecologic Oncology 2008
Early detection of ovarian cancer
PM Das, RC Bast
Biomarkers in Medicine 2008
Biomarkers in carcinoma of the gallbladder
P Rupesh, P Manoj, SV Kumar
Expert Opinion on Medical Diagnostics 2008
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access®OV Monitor assay on the UniCel®DxI 800 Immunoassay System
S Holdenrieder, R Molina, M Gion, A Gressner, F Troalen, JM Auge, M Zancan, M Wycislo, P Stieber
Clinical Chemistry and Laboratory Medicine 2008
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
V Kulasingam, EP Diamandis
Nature Clinical Practice Oncology 2008
Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen
N Suzuki, Y Tamada, K Shigirahara, A Suzuki, N Susumu, I Ishida, D Aoki
International Journal of Gynecological Cancer 2008
Cancer antigen 125 and prognosis
E Høgdall
Current Opinion in Obstetrics and Gynecology 2008
Characterization of three new serous epithelial ovarian cancer cell lines
V Ouellet, M Zietarska, L Portelance, J Lafontaine, J Madore, ML Puiffe, SL Arcand, Z Shen, J Hébert, PN Tonin, DM Provencher, AM Mes-Masson
BMC Cancer 2008
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
LJ Havrilesky, CM Whitehead, JM Rubatt, RL Cheek, J Groelke, Q He, DP Malinowski, TJ Fischer, A Berchuck
Gynecologic Oncology 2008
Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma
AB Olawaiye, JA Rauh-Hain, M Withiam-Leitch, B Rueda, A Goodman, MG Carmen
Gynecologic Oncology 2008
Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice
B Barceló, O Ayllón, M Belmonte, A Barceló, R Vidal, J Forteza-Rey, A Gutiérrez
Clinical Biochemistry 2008
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access ® OV Monitor assay on the UniCel ® DxI 800 Immunoassay System
S Holdenrieder, R Molina, M Gion, A Gressner, F Troalen, JM Auge, M Zancan, M Wycislo, P Stieber
Clinical Chemistry and Laboratory Medicine 2008
Cancer antigen 125 and prognosis:
E Høgdall
Current Opinion in Obstetrics and Gynecology 2008
Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines
F Paulsen, K Jäger, D Worlitzsch, L Bräuer, U Schulze, G Schäfer, S Sel
Annals of Anatomy - Anatomischer Anzeiger 2008
Abeloff's Clinical Oncology
ER Fearon, GT Bommer
Abeloff's Clinical Oncology 2008
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse
Y Wang, DJ Cheon, Z Lu, SL Cunningham, CM Chen, RZ Luo, D Xing, S Orsulic, RC Bast, RR Behringer
Differentiation 2008
Proteomic Contributions to Personalized Cancer Care
JM Koomen, EB Haura, G Bepler, R Sutphen, ER Remily-Wood, K Benson, M Hussein, LA Hazlehurst, TJ Yeatman, LT Hildreth, TA Sellers, PB Jacobsen, DA Fenstermacher, WS Dalton
Molecular & cellular proteomics : MCP 2008
A Binding Domain on Mesothelin for CA125/MUC16
O Kaneko, L Gong, J Zhang, JK Hansen, R Hassan, B Lee, M Ho
The Journal of biological chemistry 2008
CA-125: A Marker for Diagnosis and Follow-Up of Pleuroperitoneal and Lymph Node Tuberculosis
AM Wani, M Akhtar
Annals of Saudi medicine 2008
CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis
Abdul Majid Wani, Mubeena Akhtar
Annals of Saudi medicine 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brünner, DW Chan, R Babaian, RC Bast, B Dowell, FJ Esteva, C Haglund, N Harbeck, DF Hayes, M Holten-Andersen, GG Klee, R Lamerz, LH Looijenga, R Molina, HJ Nielsen, H Rittenhouse, A Semjonow, IM Shih, P Sibley, G Sölétormos, C Stephan, L Sokoll, BR Hoffman, EP Diamandis
Clinical chemistry 2008
PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival
C Bartholomeusz, D Rosen, C Wei, A Kazansky, F Yamasaki, T Takahashi, H Itamochi, S Kondo, J Liu, NT Ueno
Cancer research 2008
Glycans as a Target in the Detection of Reproductive Tract Cancers
M Janković, M Kosanović, B Milutinović
Journal of Medical Biochemistry 2008
Contemporary progress in ovarian cancer screening
CS Walsh, BY Karlan
Current Oncology Reports 2007
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients
M Yamamoto, H Baba, Y Toh, T Okamura, Y Maehara
Journal of Cancer Research and Clinical Oncology 2007
Tumour markers: An overview
T Malati
Indian Journal of Clinical Biochemistry 2007
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
N Scholler, B Garvik, M Hayden-Ledbetter, T Kline, N Urban
Cancer Letters 2007
MUC16 in the lacrimal apparatus
K Jäger, G Wu, S Sel, F Garreis, L Bräuer, FP Paulsen
Histochemistry and Cell Biology 2007
Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)
JA Belisle, JA Gubbels, CA Raphael, M Migneault, C Rancourt, JP Connor, MS Patankar
Immunology 2007
CA125 in ovarian cancer
N Scholler, N Urban
Biomarkers in Medicine 2007
Analysis of the protein and glycan parts of CA125 antigen from human amniotic fluid
B Milutinovic, M Jankovic
Archives of Biological Sciences 2007
Transient Elevation of Serum Tumor Markers in a Patient with Hypothyroidism
N Takahashi, T Shimada, Y Ishibashi, N Oyake, Y Murakami
The American Journal of the Medical Sciences 2007
Specificity of Serum Tumor Markers (CA125, CEA, AFP, Beta HCG) in Ovarian Malignancies
RM ., KJ .
Trends in Medical Research 2007
Progesterone induces Apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression
V Syed, K Mukherjee, S Godoy-Tundidor, SM Ho
Journal of Cellular Biochemistry 2007
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum
HA Kenny, T Krausz, SD Yamada, E Lengyel
International Journal of Cancer 2007
Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence
B Ye, M Aponte, Y Dai, L Li, MC Ho, A Vitonis, D Edwards, TN Huang, DW Cramer
Cancer Letters 2007
Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: A potential diagnostic pitfall
MR Lewis, ED Euscher, MT Deavers, EG Silva, A Malpica
Gynecologic Oncology 2007
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients
EV Høgdall, L Christensen, SK Kjaer, J Blaakaer, A Kjærbye-Thygesen, S Gayther, IJ Jacobs, CK Høgdall
Gynecologic Oncology 2007
CA125: Megadaltons of novel opportunities
O Dorigo, JS Berek
Gynecologic Oncology 2007
Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab
C Marth, D Egle, D Auer, J Rössler, AG Zeimet, I Vergote, G Daxenbichler
Gynecologic Oncology 2007
Use of high density antibody arrays to validate and discover cancer serum biomarkers
CM Loch, AB Ramirez, Y Liu, CL Sather, JJ Delrow, N Scholler, BM Garvik, ND Urban, MW McIntosh, PD Lampe
Molecular Oncology 2007
Assay of mucins in human tear fluid
S Spurr-Michaud, P Argüeso, I Gipson
Experimental Eye Research 2007
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs
S Nishimura, H Tsuda, K Ito, T Jobo, N Yaegashi, T Inoue, T Sudo, RS Berkowitz, SC Mok
Human Pathology 2007
Current Management Strategies for Ovarian Cancer
GD Aletti, MM Gallenberg, WA Cliby, A Jatoi, LC Hartmann
Mayo Clinic Proceedings 2007
Transient Elevation of Serum Tumor Markers in a Patient with Hypothyroidism:
N Takahashi, T Shimada, Y Ishibashi, N Oyake, Y Murakami
The American Journal of the Medical Sciences 2007
Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma
F Russo, S Lastoria, G Svanera, G Capobianco, A Chiara, R Francia, E Squame, F Martinis, A Pinto
Leukemia & Lymphoma 2007
Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations
TI Goonewardene, MR Hall, GJ Rustin
The Lancet Oncology 2007
Tumor Markers In Biological Fluids Associated With Pregnancy
A Sarandakou, E Protonotariou, D Rizos
Critical Reviews in Clinical Laboratory Sciences 2007
Biochemical recurrent ovarian cancer: CA 125 elevation without symptoms or clinical evidence of disease. What is the optimal management?
E Berry, JA Hurteau
The Women's Oncology Review 2007
Immunologic Approaches to Ovarian Cancer Treatment
P Sabbatini, K Odunsi
Journal of Clinical Oncology 2007
How Do You Distinguish a Malignant Pelvic Mass From a Benign Pelvic Mass? Imaging, Biomarkers, or None of the Above
RG Moore, RC Bast
Journal of Clinical Oncology 2007
Molecular Pathology of Gynecologic Cancer
A Giordano, A Bovicelli, RJ Kurman
2007
Cancer Prevention
HJ Senn, U Kapp
2007
Myxedema Ascites with an Extremely Elevated CA125 Level: A Case Report
H KANEHARA, Y BANDO, M TOMITA, M KONTANI, Y TAKEGOSHI, N TANAKA
Endocrine Journal 2007
Complement-inhibiting effect of ovarian cancer antigen CA-125
WJ Murdoch, EA van Kirk, AM Smedts
Cancer Letters 2006
Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer
AL Petri, E Hogdall, IJ Christensen, SK Kjaer, J Blaakaer, CK Hogdall
APMIS 2006
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)
SC Chauhan, AP Singh, F Ruiz, SL Johansson, M Jain, LM Smith, N Moniaux, SK Batra
Modern Pathology 2006
A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions
A Gustafsson, J Holgersson
Expert Opinion on Drug Discovery 2006
Screening for Ovarian Cancer
AN Rosenthal, U Menon, IJ Jacobs
Clinical Obstetrics and Gynecology 2006
Immunohistochemical characterization of cancer antigen in uterine cancers
S Nur, L Chuang, G Ramaswamy
International Journal of Gynecological Cancer 2006
Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
D Baratti, S Kusamura, A Martinetti, E Seregni, DG Oliva, B Laterza, M Deraco
Annals of Surgical Oncology 2006
A Review and an Update on the Screening of Epithelial Ovarian Cancer
EA Reynolds, KA Moller
Current Problems in Cancer 2006
Molecular predictors of response and outcome in ovarian cancer
S Canevari, M Gariboldi, JF Reid, I Bongarzone, MA Pierotti
Critical Reviews in Oncology/Hematology 2006
Mucins and TFF peptides of the tear film and lacrimal apparatus
FP Paulsen, MS Berry
Progress in Histochemistry and Cytochemistry 2006
Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
L Leggio, L Abenavoli, C D’Angelo, A Ferrulli, L Vonghia, A Mirijello, R Barbarino, TD Michele, C Zuppi, D Gui, GL Rapaccini, G Gasbarrini, G Addolorato
Digestive Diseases and Sciences 2006
Regulation of mucin expression: Mechanistic aspects and implications for cancer and inflammatory diseases
M Andrianifahanana, N Moniaux, SK Batra
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2006
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
JA Gubbels, J Belisle, M Onda, C Rancourt, M Migneault, M Ho, TK Bera, J Connor, BK Sathyanarayana, B Lee, I Pastan, MS Patankar
Molecular Cancer 2006
Bead-based ELISA for validation of ovarian cancer early detection markers
N Scholler, M Crawford, A Sato, CW Drescher, KC O'Briant, N Kiviat, GL Anderson, N Urban
Clinical cancer research 2006
Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16
S Duraisamy, S Ramasamy, S Kharbanda, D Kufe
Gene 2006
Variabilidad de las concentraciones séricas de CA 125 en mujeres sanas en función de la edad, situación hormonal y otras condiciones
B Barceló, A Barceló, M Riesco, G Pérez, B Castanyer, M Vila
Clínica e Investigación en Ginecología y Obstetricia 2006
Testing for ovarian cancer
K Chan, T Selman
Best Practice & Research Clinical Obstetrics & Gynaecology 2006
Screening for ovarian cancer in the general population
CS Chu, SC Rubin
Best Practice & Research Clinical Obstetrics & Gynaecology 2006
Récurrences du cancer épithélial de l'ovaire : valeur du CA125
H Bouanène, S Ferchichi, HB Limem, LB Fatma, SB Ahmed, S Laradi, A Miled
Immuno-analyse & Biologie Spécialisée 2006
The value of ovarian cancer screening
A Sharma, U Menon
BRIT J HOSP MED 2006
Prognostic value of CA125 regression following surgery and chemotherapy in patients with advanced epithelial ovarian carcinoma
M Tanaka, Y IIDA, H Nishimura, K Miyai, Y Terao, D Ogishima, M Yoshida, K Kinoshita
Juntendo Medical Journal 2006
Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
L Leggio, L Abenavoli, C DAngelo, A Ferrulli, L Vonghia, A Mirijello, R Barbarino, TD Michele, C Zuppi, D Gui, GL Rapaccini, G Gasbarrini, G Addolorato
Digestive Diseases and Sciences 2006
Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells
V Syed, X Zhang, KM Lau, R Cheng, K Mukherjee, SM Ho
Oncogene 2005
Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells
K Mukherjee, V Syed, SM Ho
Oncogene 2005
Serum CA 125 levels in patients with chronic lymphocytic leukemia
O Bairey, M Shaklai
Clinical and Laboratory Haematology 2005
CA125: Holy Grail or a Poisoned Chalice
N Topley, D Michael, T Bowen
Nephron Clinical Practice 2005
A sensitive and rapid immunoassay for quantification of CA125 in human sera by capillary electrophoresis with enhanced chemiluminescence detection
J Wang, J Ren
Electrophoresis 2005
Marked ascites and serum carbohydrate antigen (CA) 125 elevation in a patient with anorexia nervosa
T Suwabe, M Taguchi, A Takeshita, Y Ozawa
International Journal of Eating Disorders 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
M Duffy, J Bonfrer, J Kulpa, G Rustin, G Soletormos, G Torre, M Tuxen, M Zwirner
International Journal of Gynecological Cancer 2005
New tumor markers: CA125 and beyond
R Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, K Baggerly, E Atkinson, S Skates, Z Zhang, A Lokshin, U Menon, I Jacobs, K Lu
International Journal of Gynecological Cancer 2005
Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis
P Geomini, G Bremer, R Kruitwagen, BW Mol
Gynecologic Oncology 2005
Greatly Elevated Serum CA-125 Level in a Patient with a Ruptured Endometrioma
MA Rettenmaier, BH Goldstein, JM Stallman, JV Brown, JP Micha
Journal of Gynecologic Surgery 2005
Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens
S Draghici, M Chatterjee, MA Tainsky
Expert Review of Molecular Diagnostics 2005
The role of CA125 in clinical practice
EL Moss, J Hollingworth, TM Reynolds
Journal of clinical pathology 2005
External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity
H Reinauer, WG Wood
German medical science : GMS e-journal 2005
El CA125 citosólico en adenocarcinomas pulmonares. Nuevos aspectos biológicos
A Ruibal, IN Cambre, AS Salmón, MI Nuñez, J Rodríguez
Revista Española de Medicina Nuclear 2005
Pseudo-pseudo Meigs' syndrome
R Schmitt, W Weichert, W Schneider, FC Luft, R Kettritz
The Lancet 2005
Surgery for Ovarian Cancer: Principles and Practice
M Carmen, L Duska
Surgery for Ovarian Cancer: Principles and Practice 2005
Prognostic factors in ovarian cancer: how close are we to a complete picture?
R Agarwal, SB Kaye
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005
Identification of ATF-3, caveolin-1, DLC-1 and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
V Syed, K Mukherjee, J Lyons-Weiler, KM Lau, T Mashima, T Tsuruo, S Ho
Oncogene 2005
Introducing the MUC16 Gene: Implications for Prevention and Early Detection in Epithelial Ovarian Cancer
MR McLemore, B Aouizerat
Biological research for nursing 2005
Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma
D Gisselsson, M Lv, SW Tsao, C Man, C Jin, M H�glund, YL Kwong, Y Jin
Genes, Chromosomes and Cancer 2004
CA 125 Elevation in Breast Cancer: A Case Report and Review of the Literature
GD Leonard, JA Low, AW Berman, SM Swain
The Breast Journal 2004
HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells
N Suzuki, D Aoki, Y Tamada, N Susumu, K Orikawa, K Tsukazaki, M Sakayori, A Suzuki, T Fukuchi, M Mukai, K Kojima-Aikawa, I Ishida, S Nozawa
Gynecologic Oncology 2004
Identification of p53 regulators by genome-wide functional analysis
Q Huang, A Raya, P DeJesus, SH Chao, KC Quon, JS Caldwell, SK Chanda, JC Izpisua-Belmonte, PG Schultz
Proceedings of the National Academy of Sciences 2004
Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare
RC Bast
Transactions of the American Clinical and Climatological Association 2004
Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer
RK Gupta, DL Morton
Clinical and Applied Immunology Reviews 2004
Diagnosis and Management of Ovarian Disorders
AB Copperman, T Mukherjee, NG Kase
Diagnosis and Management of Ovarian Disorders 2004
El CA125 citosólico en carcinomas escamosos de pulmón
A Ruibal, IN Cambre, MI Núñez, J Rodríguez
Revista Española de Medicina Nuclear 2004
Ca 125 elevado en la hepatopatía crónica con ascitis
EC Valadés, MM Corral
Gastroenterología y Hepatología 2004
Solution Structure of the SEA Domain from the Murine Homologue of Ovarian Cancer Antigen CA125 (MUC16)
T Maeda, M Inoue, S Koshiba, T Yabuki, M Aoki, E Nunokawa, E Seki, T Matsuda, Y Motoda, A Kobayashi, F Hiroyasu, M Shirouzu, T Terada, N Hayami, Y Ishizuka, N Shinya, A Tatsuguchi, M Yoshida, H Hirota, Y Matsuo, K Tani, T Arakawa, P Carninci, J Kawai, Y Hayashizaki, T Kigawa, S Yokoyama
The Journal of biological chemistry 2004
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
IJ Jacobs, U Menon
Molecular & cellular proteomics : MCP 2004
Mucins in cancer: protection and control of the cell surface
MA Hollingsworth, BJ Swanson
Nature Reviews Cancer 2004
Cancer Diagnostics
RM Nakamura, WW Grody, JT Wu, RB Nagle
2004
Determination of cancer antigen 125 in ovarian carcinoma
V Thakur, AK Anand, U Mukherjee, D Ghosh
Indian Journal of Clinical Biochemistry 2003
Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma
I But
Wiener klinische Wochenschrift 2003
Clinical indices of in vivo biocompatibility: The role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients
R Mackenzie, CJ Holmes, S Jones, JD Williams, N Topley
Kidney International 2003
Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers
JR Wiener, TC Windham, VC Estrella, NU Parikh, PF Thall, MT Deavers, RC Bast, GB Mills, GE Gallick
Gynecologic Oncology 2003
Current Status of the Molecular Characterization of the Ovarian Cancer Antigen CA125 and Implications for Its Use in Clinical Screening
C Whitehouse, E Solomon
Gynecologic Oncology 2003
CA125 and UQCRFS1 FISH studies of ovarian carcinoma
SJ Kaneko, T Gerasimova, ST Smith, KO Lloyd, K Suzumori, SR Young
Gynecologic Oncology 2003
Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma
O Bairey, D Blickstein, P Stark, M Prokocimer, HM Nativ, I Kirgner, M Shaklai
Leukemia & Lymphoma 2003
Determination of tumor marker CA125 by capillary electrophoretic enzyme immunoassay with electrochemical detection
Z He, N Gao, W Jin
Analytica Chimica Acta 2003
Doppler flow and arterial location in ovarian tumors
T Itakura, F Kikkawa, H Kajiyama, T Mitsui, M Kawai, S Mizutani
International Journal of Gynecology & Obstetrics 2003
The follow-up of ovarian cancer
AP Vaidya, JP Curtin
Seminars in Oncology 2003
Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression
LB Rangel, CA Sherman-Baust, RP Wernyj, DR Schwartz, KR Cho, PJ Morin
Oncogene 2003
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
NK Wong, RL Easton, M Panico, M Sutton-Smith, JC Morrison, FA Lattanzio, HR Morris, GF Clark, A Dell, MS Patankar
The Journal of biological chemistry 2003
Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL
V Syed, SM Ho
Oncogene 2003
Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells
SM Ho, KM Lau, SC Mok, V Syed
Oncogene 2003
Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q
B Stone, M Schummer, PJ Paley, L Thompson, J Stewart, M Ford, M Crawford, N Urban, K O'Briant, BH Nelson
International Journal of Cancer 2003
Ultrasound and Endoscopic Surgery in Obstetrics and Gynaecology
D Timmerman, J Deprest, T Bourne
2003
The cancer antigen CA125 represents a novel counter receptor for galectin-1
C Seelenmeyer, S Wegehingel, J Lechner, W Nickel
Journal of cell science 2003
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
RL Attanoos, R Webb, SD Dojcinov, AR Gibbs
Histopathology 2002
The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma
U Saygili, S Guclu, T Uslu, O Erten, E Dogan
International Journal of Gynecological Cancer 2002
Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?
U Saygili, S Guclu, T Uslu, O Erten, N Demir, A Onvural
Gynecologic Oncology 2002
Preoperative CA-125 Levels in Patients with Hereditary Compared to Sporadic Epithelial Ovarian Carcinoma
M Leitao, J Boyd
Gynecologic Oncology 2002
The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma
ID Zacharos, SP Efstathiou, E Petreli, G Georgiou, DI Tsioulos, SE Mastorantonakis, I Christakopoulou, PP Roussou
European Journal of Haematology 2002
Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland
K Okamura
Oral Oncology 2002
Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis
H Satoh, H Ishikawa, YT Yamashita, M Ohtsuka, K Sekizawa
Thorax 2002
Cancer Antigen 125 in Patients With Chronic Liver Disease
H Devarbhavi, D Kaese, AW Williams, J Rakela, GG Klee, PS Kamath
Mayo Clinic Proceedings 2002
Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients
E Sapi, NI Okpokwasili, T Rutherford
Cancer Detection and Prevention 2002
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan, F Podo
British Journal of Cancer 2002
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan, F Podo
British Journal of Cancer 2002
High concentrations of CA 125 in uterine flushings: influence of cause of infertility and menstrual cycle day
JA Hamilton, RK Iles, LK Gunn, CM Wilson, AM Lower, JG Grudzinskas
Gynecological Endocrinology 2002
Lung tumour markers in oncology practice: a study of TPA and CA125
G Buccheri, D Ferrigno
British Journal of Cancer 2002
Ovarian cancer antigen CA125 is encoded by theMUC16 mucin gene
BW Yin, A Dnistrian, KO Lloyd
International Journal of Cancer 2002
CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?
AE Guppy, GJ Rustin
The oncologist 2002
Application of tumor markers in ovarian malignancies
T Malati, GR Kumari, B Yadagiri
Indian Journal of Clinical Biochemistry 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker
Cancer 2001
A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene
H Lin, PJ Morin
Cancer Letters 2001
Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations
LJ Havrilesky, AA Alvarez, RS Whitaker, JR Marks, A Berchuck
Gynecologic Oncology 2001
Whole cell ELISA for detection of tumor antigen expression in tumor samples
LF Erdile, D Smith, D Berd
Journal of Immunological Methods 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker
Cancer 2001
CA 125
O Gaillard
Immuno-analyse & Biologie Spécialisée 2001
Microarray analysis of gene expression mirrors the biology of an ovarian cancer model
PN Tonin, TJ Hudson, F Rodier, M Bossolasco, PD Lee, J Novak, EN Manderson, D Provencher, AM Mes-Masson
Oncogene 2001
Molecular Cloning of the CA125 Ovarian Cancer Antigen: IDENTIFICATION AS A NEW MUCIN, MUC16
BW Yin, KO Lloyd
The Journal of biological chemistry 2001
Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopy
EH Ng, OS Tang, PC Ho
Human Reproduction 2001
Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones
LJ Havrilesky, CP McMahon, EK Lobenhofer, R Whitaker, JR Marks, A Berchuck
Journal of the Society for Gynecologic Investigation 2001
ELEVATION OF CA-125 LEVEL IS DUE TO ABDOMINAL DISTENSION IN LIVER TRANSPLANTATION CANDIDATES:
M Deschnes, RP Michel, E Alpert, JS Barkun, P Metrakos, J Tchervenkov
Transplantation 2001
Dialysate Cancer Antigen 125 Concentration as Marker of Peritoneal Membrane Status in Patients Treated with Chronic Peritoneal Dialysis
RT Krediet
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2001
Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI-MS) Analyses
Y Xiao, Y Chen, AW Kennedy, J Belinson, Y Xu
Annals of the New York Academy of Sciences 2000
Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement
A Camera, MR Villa, S Rocco, TD Novellis, S Costantini, L Pezzullo, A Lucania, A Mariano, V Macchia, B Rotoli
Cancer 2000
Tumour markers and ovarian cancer screening
B Kumar, J Davies-Humphreys
The Obstetrician & Gynaecologist 2000
Rare Activation of the TCF/β-Catenin Pathway in Ovarian Cancer
MT Furlong, PJ Morin
Gynecologic Oncology 2000
Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
MN Hosono, M Hosono, AK Mishra, A Faivre-Chauvet, E Gautherot, J Barbet, FF Knapp, JF Chatal
Annals of Nuclear Medicine 2000
Recent Advances in the Management of Gynecologic Cancers
SJ Kim
Journal of Obstetrics and Gynaecology Research 2000
Uterine Leiomyoma Causing Massive Ascites and Left Pleural Effusion with Elevated CA 125: A Case Report
F Migishima, T Jobo, H Hata, R Sato, Y Ikeda, M Arai, H Kuramoto
Journal of Obstetrics and Gynaecology Research 2000
Intraperitoneal Photoimmunotherapy of Ovarian Carcinoma Xenografts in Nude Mice Using Charged Photoimmunoconjugates
KL Molpus, MR Hamblin, I Rizvi, T Hasan
Gynecologic Oncology 2000
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma
LA Hefler, AC Rosen, AH Graf, M Lahousen, M Klein, S Leodolter, A Reinthaller, C Kainz, CB Tempfer
Cancer 2000
Role of tumour markers in monitoring epithelial ovarian cancer
T Meyer, GJ Rustin
British Journal of Cancer 2000
CHARACTERIZATION OF FOUR NOVEL EPITHELIAL OVARIAN CANCER CELL LINES
DM Provencher, H Lounis, L Champoux, M Tétrault, EN Manderson, JC Wang, P Eydoux, R Savoie, PN Tonin, AM Mes-Masson
In Vitro Cellular & Developmental Biology - Animal 2000
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: A multicenter study
LA Hefler, AC Rosen, AH Graf, M Lahousen, M Klein, S Leodolter, A Reinthaller, C Kainz, CB Tempfer
Cancer 2000
Preoperative CA 125 in endometrial cancer: Is it useful?
DJ Dotters
American Journal of Obstetrics and Gynecology 2000
The Prognostic Significance of Expression of CA125 and Proliferation Markers and Architectural Type in Ovarian Clear Cell Adenocarcinoma
T OKUDA, H SAITO, A SEKIZAWA, T AKAMATSU, A SUZUKI, A SHIMIZU, M KUSHIMA, H OTA, T YANAIHARA
The Showa University Journal of Medical Sciences 2000
Handbook of Oxidants and Antioxidants in Exercise
RR Jenkins, J Beard
Handbook of Oxidants and Antioxidants in Exercise 2000
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer
MK Tuxen, GJ Rustin, P Dombernowsky, G Sölétormos, AE Nelstrop
Scandinavian Journal of Clinical & Laboratory Investigation 2000
CA125 production by the peritoneum: in-vitro and in-vivo studies
M Epiney, C Bertossa, A Weil, A Campana, P Bischof
Human Reproduction 2000
Lessons to be learned: a case study approach: Ascites and elevated serum CA 125 due to a pancreatic carcinoma. A diagnostic dilemma
AS Ahmed, M Long, D Donaldson
The Journal of the Royal Society for the Promotion of Health 2000
CHARACTERIZATION OF FOUR NOVEL EPITHELIAL OVARIAN CANCER CELL LINES
DM Provencher, H Lounis, L Champoux, M Tétrault, EN Manderson, JC Wang, P Eydoux, R Savoie, PN Tonin, AM Mes-Masson
In vitro cellular & developmental biology. Animal 2000
Screening for ovarian cancer: a pilot randomised controlled trial
IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, R Woolas, AR Jeyarajah, K Sibley, DG Lowe, DH Oram
The Lancet 1999
Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis
E Zuckerman, A Lanir, E Sabo, T Rosenvald-Zuckerman, I Matter, D Yeshurun, S Eldar
The American Journal of Gastroenterology 1999
Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer
MK Tuxen, G Sölétormos, PH Petersen, V Schiøler, P Dombernowsky
Gynecologic Oncology 1999
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach
JH Lagendijk, H Mullink, PJ van Diest, GA Meijer, CJ Meijer
Journal of clinical pathology 1999
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment
DA Fishman, A Kearns, S Larsh, JJ Enghild, MS Stack
Biochemical Journal 1999
Technical and clinical comparison of two fully automated methods for the immunoassay of CA 125 in serum
G Yan, H Ju, Z Liang, T Zhang
Journal of Immunological Methods 1999
Is there a place for screening in ovarian cancer?
ND MacDonald, IJ Jacobs
European Journal of Obstetrics & Gynecology and Reproductive Biology 1999
Radioimmunoscintigraphy in Patients with Ovarian Cancer
HH Constantino
Acta Oncologica 1999
Developments in Serologic Detection of Human Pancreatic Adenocarcinoma
ME Haglund
Scandinavian Journal of Gastroenterology 1999
Ovarian Cancer Antigen CA 125 Enhances the Invasiveness of the Endometriotic Cell Line EEC 145
R Gaetje, DW Winnekendonk, A Scharl, M Kaufmann
Journal of the Society for Gynecologic Investigation 1999
Tissue Quantification of CA 125 in Epithelial Ovarian Cancer
RD Cuesta, ML Maestro, J Solana, JA Vidart, M Escudero, E Iglesias, R Valor
The International Journal of Biological Markers 1999
Nuclear Oncology
C Aktolun, WN Tauxe
Nuclear Oncology 1999
Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
JM Bidart, F Thuillier, C Augereau, J Chalas, A Daver, N Jacob, F Labrousse, H Voitot
Clinical chemistry 1999
Comparison of Glycoprotein Expression Between Ovarian and Colon Adenocarcinomas
HA Multhaupt, CP Arenas-Elliott, MJ Warhol
Archives of pathology & laboratory medicine 1999
Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer
G Fleckenstein, R Osmers, J Puchta
Medical Oncology 1998
Immunoscreening protocols for the identification of clinically useful antibodies and antigens
S Mukerjee, ME McKnight, MC Glassy
Expert Opinion on Investigational Drugs 1998
Elevated Ovarian Cancer Marker(CA-125) in Cirrhotic Patients With Intractable Ascites
D Zamir, J Jarchovsky, C Singer, P Weiner
Journal of Clinical Gastroenterology 1998
Determination of a Normal Level of Serum CA125 in Postmenopausal Women as a Tool for Preoperative Evaluation and Postoperative Surveillance of Endometrial Carcinoma
T Kurihara, H Mizunuma, M Obara, K Andoh, Y Ibuki, T Nishimura
Gynecologic Oncology 1998
Immunohistochemical and Molecular Studies on Malignant Transformation in Mature Cystic Teratoma of the Ovary
T Yoshioka, T Tanaka
Journal of Obstetrics and Gynaecology Research 1998
Establishment and characterization of a novel cancer cell line (SMOV-1), derived from the ascitic fluid of a woman with ovarian cancer who had never responded to chemotherapeutic drugs
T Iida, K Yonamine, H Takeuchi, K Hayashi, T Meguro, T Shinagawa, A Amemiya
International Journal of Clinical Oncology 1998
Human tetranectin: Methodological and clinical studies
CK Høgdall
APMIS 1998
Elevated Ovarian Cancer Marker(CA-125) in Cirrhotic Patients With Intractable Ascites:
D Zamir, J Jarchovsky, C Singer, P Weiner
Journal of Clinical Gastroenterology 1998
Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
JH Lagendijk, H Mullink, PJ van Diest, GA Meijer, CJ Meijer
Human Pathology 1998
Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv
PS Chowdhury, G Vasmatzis, R Beers, B Lee, I Pastan
Journal of Molecular Biology 1998
Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma
J Hoffmann, A Munz, M Krimmel, G Alfter
Journal of Oral and Maxillofacial Surgery 1998
CA-125 concentrations in the serum and pregnancy outcome in IVF cycles
AW Brandenberger, NA Bersinger, PR Huber, E Berger, P Glanzmann, MH Birkhaeuser
Journal of Assisted Reproduction and Genetics 1998
Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma
B Nakata, KH Chung, Y Kato, Y Yamashita, K Maeda, N Onoda, T Sawada, M Sowa
Cancer 1998
CA 125: The past and the Future
RC Bast, FJ Xu, YH Yu, S Barnhill, Z Zhang, GB Mills
The International Journal of Biological Markers 1998
CA 125 - Epitopes and Molecular Size
K Nustad, M Onsrud, B Jansson, D Warren
The International Journal of Biological Markers 1998
CA 125 Production and Release by Ovarian Cancer Cells In Vitro
EP Beck, A Moldenhauer, E Merkle, F Kiesewetter, W Jäger, L Wildt, N Lang
The International Journal of Biological Markers 1998
CA 125 in Benign Gynecological Conditions
H Meden, A Fattahi-Meibodi
The International Journal of Biological Markers 1998
Immunohistochemistry of CA 125: Unusual expression in normal tissues, distribution in the human fetus and questions around its application in diagnostic pathology
M Nap
The International Journal of Biological Markers 1998
CA 125 in Ovarian Cancer: Advances and Controversy
HA Fritsche, RC Bast
Clinical chemistry 1998
Interferences with Two-site Immunoassays by Human Anti-mouse Antibodies Formed by Patients Treated with Monoclonal Antibodies: Comparison of Different Blocking Reagents
J Reinsberg
Clinical chemistry 1998
Comparison of seven immunoassays for the quantification of CA 125 antigen in serum
EM Davelaar, GJ van Kamp, RA Verstraeten, P Kenemans
Clinical chemistry 1998
Serum CA 125 levels and survival in advanced ovarian cancer
K Münstedt, M Krisch, S Sachsse, H Vahrson
Archives of Gynecology and Obstetrics 1997
Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer
T Ind, R Iles, J Shepherd, T Chard
BJOG: An International Journal of Obstetrics and Gynaecology 1997
The ratio between carcinoma antigen-125 levels in the seminal plasma and serum may be a marker for fertilization in intracytoplasmic sperm injection
E Geva, J Arava, L Lerner-Geva, M Hareuveni, JB Lessing, S Ballas, A Amit
Fertility and Sterility 1997
What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
T Bese, F Demirkiran, M Arvas, AU oz, D Kosebay, E Erkun
International Journal of Gynecological Cancer 1997
Serum CA 125 concentrations in women of different ages, hormonal statuses, orclinical conditions
NP Koper, CM Thomas, LF Massuger, MJ van der Mooren, LA Kiemeney, AL Verbeek
International Journal of Gynecological Cancer 1997
Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule
KO Lloyd, BW Yin, V Kudryashov
International Journal of Cancer 1997
Utility of tumour markers in the diagnosis of neoplastic pleural effusion
ME Jose, D Alvarez, L Valdes, A Sarandeses, JM Valle, P Penela
Clinica Chimica Acta 1997
Establishment and Characterization of Human Ovarian Carcinoma Cell Lines
Y Yuan, WH Kim, HS Han, JH Lee, HS Park, JK Chung, SB Kang, JG Park
Gynecologic Oncology 1997
Preevacuation Serum CA 125 in Complete Hydatidiform Mole
S Tangtrakul, S Srisupandit, LO Chailurkit, R Rajatanavin
Gynecologic Oncology 1997
In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines
YJ Lidor, WE Lee, JH Nilson, H Maxwell, LJ Su, E Brand, LM Glode
American Journal of Obstetrics and Gynecology 1997
Immunological Responses to the Tumor-Associated Antigen CA15 in Patients with Advanced Ovarian Cancer Induced by the Murine Monoclonal Anti-idiotype Vaccine ACA125
U Wagner, H Schlebusch, S Köhler, J Schmolling, U Grünn, D Krebs
Hybridoma 1997
Anti-TAG-72 Antibody B72.3—Immunological and Clinical Effects in Ovarian Carcinoma
J Schmolling, J Reinsberg, U Wagner, D Krebs
Hybridoma 1997
Are Human Anti-Idiotypic Anti-OC125 Antibodies Formed after Immunization with the Anti-CA125 Antibody B43.13?
J Reinsberg, D Krebs
Hybridoma 1997
Ascites with a raised CA 125
DJ D'Souza, EJ Walker
Journal of the Royal Society of Medicine 1997
Idiotypes in Medicine: Autoimmunity, Infection and Cancer
TJ Kunicki, DJ Nugent
Idiotypes in Medicine: Autoimmunity, Infection and Cancer 1997
Clinical Significance of Preoperative Serum Levels of CA 125 and TAG-72 in Ovarian Carcinoma
A Gonzalez, F Vizoso, J Vázquez, A Ruibal, JL Balibrea
The International Journal of Biological Markers 1997
How to Overcome the Disturbing Effects of Human Anti-Mouse Antibodies (Hama) on in Vitro Assays
JB Oltrogge, RP Baum, KN Lema, B Donnerstag, G Hör
The International Journal of Biological Markers 1997
Ovca (CA125) Second Generation: Technical Aspects and Serum Levels in Controls, Patients with Liver Disease, Pregnant Women and Patients with Ovarian Disease
M Cioffi, M Fratta, P Gazzerro, BD Finizio, A Tucci, AM Molinari
TUMORI 1997
Radiation Oncology of Gynecological Cancers
HW Vahrson
1997
Ovarian Vein vs Peripheral Blood CA125 Serum Levels: A Comparative Study
YD Podnos, G Gamboa, T Kurosaki, R Buller, JL Walker, A Manetta
Gynecologic Oncology 1997
The Role of CA‐125 in the Management of Ovarian Cancer
M Markman
The oncologist 1997
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value
JM Bonfrer, CM Korse, RA Verstraeten, GJ van Kamp, GA Hart, P Kenemans
Clinical chemistry 1997
Tumor Markers in Ovarian Malignancies
K Eagle, JA Ledermann
The oncologist 1997
Sensitivity of Breast and Ovarian Cancer Cells for Interferons (IFNs) and Retinoids
G Daxenbichler, M Widschwendter, C Marth
Annals of the New York Academy of Sciences 1996
Transforming growth factor-α promotes tumor markers secretion from human ovarian cancers in vitro
H Kurachi, H Adachi, K Morishige, K Adachi, T Takeda, H Homma, T Yamamoto, A Miyake
Cancer 1996
Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors
C Sperti, C Pasquali, P Guolo, R Polverosi, G Liessi, S Pedrazzoli
Cancer 1996
Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer
BW Yin, CL Finstad, K Kitamura, MG Federici, M Welshinger, V Kudryashov, WJ Hoskins, S Welt, KO Lloyd
International Journal of Cancer 1996
Immunohistochemical Study of Colorectal Polyps with Antibodies against CEA, CA19-9, CA125, CA15-3 (DF3), PCNA and p53
K SAITO, A OGAWA, I OHKI
Digestive Endoscopy 1996
Use of Immunocytochemistry in the Diagnosis of Metastatic Carcinoma
P Matthews, IO Ellis
Annals of Medicine 1996
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer
F Kraeber-Bodéré, A Mishra, P Thédrez, A Faivre-Chauvet, M Bardiès, S Imai, J Boterff, JF Chatal
European Journal of Nuclear Medicine 1996
Use of Tetranectin, CA-125 and Casa to Predict Residual Tumor and Survival at Second- and Third-Look Operations for Ovarian Cancer
CK Høgdall, EV Høgdall, U Hørding, K Toftager-Larsen, J Arends, B Nørgaard-Pedersen, I Clemmensen
Acta Oncologica 1996
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study
IJ Jacobs, S Skates, AP Davies, RP Woolas, A Jeyerajah, P Weidemann, K Sibley, DH Oram
BMJ (Clinical research ed.) 1996
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model
BA Goff, J Blake, MP Bamberg, T Hasan
British Journal of Cancer 1996
Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma
RA Audisio, P Veronesi, P Maisonneuve, A Chiappa, B Andreoni, E Bombardieri, JG Geraghty
Surgical Oncology 1996
Maternal serum CA 125 is of prognostic value in patients with uterine bleeding in the detection of small-for-gestational-age neonates
M Mazor, A Bashiri, F Ghezzi, E Maymon, O Kuperman, G Kopernik, JR Leiberman
European Journal of Obstetrics & Gynecology and Reproductive Biology 1996
Evaluation des dosages du CA 19-9, du CA 125II et du CA 15 3 sur l'automate RIA-MAT 280TM
L Nonnenmacher, Y Fulla
Immuno-analyse & Biologie Spécialisée 1996
Magnetic resonance imaging, OC125 immunoscintigraphy and serum CA125 levels in the management of patients with suspected primary or recurrent ovarian carcinoma
Q Davies, IM Symonds, AC Perkins, RW Kerslake, ML Wastie, BS Worthington, EM Symonds
Journal of Obstetrics & Gynaecology 1996
Immunologic Characterization of Tumor Markers in Human Ovarian Cancer Cell Lines
WH Kutteh, DS Miller, JM Mathis
Journal of the Society for Gynecologic Investigation 1996
Neurocutaneous Melanosis With Dandy-Walker Malformation Complicated by Primary Spinal Leptomeningeal Melanoma
RD Craver, SE Golladay, RP Warrier, AJ Gates, JS Nelson
Journal of child neurology 1996
Generation of Human Monoclonal Anti-idiotypic Antibodies with Specificity to the Murine Monoclonal Anti-CA 125 Antibody B43.13
JB Oltrogge, B Donnerstag, RP Baum, AA Noujaim, L Träger
The International Journal of Biological Markers 1996
An antibody-lectin sandwich assay for the determination of CA125 antigen in ovarian cancer patients
R Madiyalakan, M Kuzma, AA Noujaim, MR Suresh
Glycoconjugate Journal 1996
Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma
H Hareyama, N Sakuragi, S Makinoda, S Fujimoto
Journal of clinical pathology 1996
The Clinical Value of Tumour Markers in the Management of Ovarian Cancer
GJ Rustin
Annals of Clinical Biochemistry 1996
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer
F Kraeber-Bodéré, A Mishra, P Thédrez, A Faivre-Chauvet, M Bardiès, S Imai, JL Boterff, JF Chatal
European Journal of Nuclear Medicine 1996
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies
AM Paoletti, GG Serra, V Mais, S Ajossa, S Guerriero, M Orrú, GB Melis
Journal of Assisted Reproduction and Genetics 1995
Superiority of CA 125 over CA 19-9 and CEA for epithelial ovarian malignancies
A Saraswathi, T Malati
Indian Journal of Clinical Biochemistry 1995
High serum level of CA125 in malignant peritoneal mesothelioma
H Simsek
European Journal of Cancer 1995
Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation
WE Corver, CJ Cornelisse, J Hermans, GJ Fleuren
Cytometry 1995
Clinical validation of the new ELSA-CA 125 II assay: Report of a european multicentre evaluation
M Clement, P Bischof, C Gruffat, G Ricolleau, E Auvray, V Quilien, C Pacheco, M Torres, M Ferdeghini
International Journal of Cancer 1995
Serum CA 125 levels and spontaneous abortion
MD Hornstein, JH Check, JA Hill
American Journal of Obstetrics and Gynecology 1995
The Second Generation CA125 Assays
P Kenemans, AA Verstraeten, GJ van Kamp, S Mensdorff-Pouilly
Annals of Medicine 1995
A Monoclonal Antiidiotypic Antibody ACA 125 Mimicking the Tumor-Associated Antigen CA 125 for Immunotherapy of Ovarian Cancer
H Schlebusch, U Wagner, U Grünn, B Schultes
Hybridoma 1995
Antiidiotypic Antibodies in Ovarian Cancer Patients Treated with the Monoclonal Antibody B72.3
J Schmolling, J Reinsberg, U Wagner, D Krebs
Hybridoma 1995
Radioimmunotherapy of Ovarian Cancer
K Syrigos, A Epenetos
Hybridoma 1995
Is Ca 125 Actually a Tumor Marker for Ovarian Cancer?
J Collazos
Acta Oncologica 1995
Cancer Therapy With Radiolabeled Antibodies An Overview
S Bruland
Acta Oncologica 1995
Tumor markers in the management of patients with ovarian cancer
MK Tuxen, G Sölétormos, P Dombernowsky
Cancer Treatment Reviews 1995
Can you screen for ovarian cancer?
ML Hicks, G Parham
Journal of the National Medical Association 1995
Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers
G Griffon, C Marchal, JL Merlin, S Marchal, RM Parache, P Bey
European Journal of Cancer 1995
Evaluation of second generation CA 125 assays
EV Cosmi, G Atlante, C Donadio, L Mariani, A Barbati
European Journal of Obstetrics & Gynecology and Reproductive Biology 1995
Serum CA 125 and first trimester abortion
F Scarpellini, M Mastrone, M Sbracia, L Scarpellini
International Journal of Gynecology & Obstetrics 1995
Predictive value of combined assays of urinary gonadotropin fragment (UGF) and CA 125 for ovarian carcinoma in patients with pelvic masses
NC Gleeson, MS Hoffman, JV Fiorica, WS Roberts, D Cavanagh
Journal of Obstetrics & Gynaecology 1995
Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art
M Plebani, D Basso, MP Panozzo, P Fogar, GD Favero, R Naccarato
The International Journal of Biological Markers 1995
CA125 Serum levels in tubercolosis patients
JF Quirós, M Telenti, PS Leiva, BF Llana, MT Allende, AR Morell
The International Journal of Biological Markers 1995
False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose
J Reinsberg, U Wagner, D Krebs
Archives of Gynecology and Obstetrics 1994
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells
AL Veatch, LF Carson, S Ramakrishnan
International Journal of Cancer 1994
Prognostic significance of serum ca 125 antigen assay in patients with non-small cell lung cancer
M Diez, J Granell, A Torres, A Gomez, JL Balibrea, M Pollán, D Ortega, ML Maestro
Cancer 1994
Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer
D Parker, C Bradley, SM Bogle, J Lay, M Masood, AK Hancock, B Naylor, JJ Price
BJOG: An International Journal of Obstetrics and Gynaecology 1994
Molecular cloning and expression of a cDNA encoding a protein detected by the ki antibody from an ovarian carcinoma (OVCAR-3) cell line
K Chang, I Pastan
International Journal of Cancer 1994
Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination
BM Imbert-Marcille, P Thëdrez, C Saï-Maurel, C Francois, JL Auget, J Benard, Y Jacques, S Imai, JF Chatal
International Journal of Cancer 1994
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
TL Moser, TN Young, GC Rodriguez, SV Pizzo, RC Bast, MS Stack
International Journal of Cancer 1994
Distribution of VRA09, an ovarian tumor-associated antigen, distinguishing borderline serous tumors
T Voeltzel, P Duvillard, P Ghillani, J Bénard, C Bohuon, D Bellet, JM Bidart
International Journal of Cancer 1994
Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors
CY Chou, CH Chang, BL Yao, HC Kuo
Journal of Clinical Ultrasound 1994
Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours
J Leake, R Woolas, J Daniel, D Oram, C Brown
Histopathology 1994
CA125-producing adenocarcinoma of the seminal vesicle
T Ohmori, K Okada, R Tabei, K Sugiura, S Nabeshima, H Ohoka, M Okamoto
Pathology International 1994
Construction and Expression of Chimeric Antibodies by a Simple Replacement of Heavy and Light Chain V Genes into a Single Cassette Vector
H Kanda, K Mori, H Koga, K Taniguchi, H Kobayashi, H Sakahara, J Konishi, K Endo, T Watanabe
Hybridoma 1994
Serum Tumor Markers for Detection of Bone Metastasis in Breast Cancer Patients
A Aydiner, E Topuz, R Discli, V Yasasever, M Dincer, K Dincol, N Bilge
Acta Oncologica 1994
A Comparison of Ovarian Cyst Aspirate Cytology and Histology. The Case Against Aspiration of Cystic Pelvic Masses
JL Nicklin, M Eijkeren, P Athanasatos, GV Wain, NF Hacker
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1994
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer
SM Scholl, CH Bascou, V Mosseri, R Olivares, H Magdelenat, T Dorval, T Palangié, P Validire, P Pouillart, ER Stanley
British Journal of Cancer 1994
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model
BA Goff, U Hermanto, J Rumbaugh, J Blake, M Bamberg, T Hasan
British Journal of Cancer 1994
Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium
E Chatzaki, CJ Gallagher, RK Iles, TE Ind, AM Nouri, CM Bax, JG Grudzinskas
British Journal of Cancer 1994
Decreased kidney uptake of technetium-99m-labelled Fab′ fragments in ovarian carcinoma bearing nude mice using a cleavable chelator
JG Tibben, LF Massuger, OC Boerman, RA Claessens, GF Borm, KY Pak, EB Koenders, FH Corstens
Nuclear Medicine and Biology 1994
A comparison study of IFN-γ, ADA, and CA125 as the diagnostic parameters in tuberculous pleuritis
Y Aoki, O Katoh, Y Nakanishi, S Kuroki, H Yamada
Respiratory Medicine 1994
Biological markers and ovarian carcinomas: Galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase
F Sichel, V Salaün, E Bara, P Gauduchon, JP Malas, J Goussard, JY Talaër
Clinica Chimica Acta 1994
Performances analytiques d'un nouvel automate d'immunoanalyse : le LIA-mat S300
C Bogard, G Glikmanas, M Bogard, F Thuillier, Y Gourmelin
Immuno-analyse & Biologie Spécialisée 1994
Antibody-directed enzyme prodrug therapy (ADEPT): A three-phase study in ovarian tumor xenografts
SK Sharma, JA Boden, CJ Springer, PJ Burke, KD Bagshawe
Cell Biochemistry and Biophysics 1994
In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines
E Beck, M Hofmann, G Bernhardt, W Jäger, L Wildt, N Lang
Cell Biochemistry and Biophysics 1994
Atlas of Human Tumor Cell Lines
YC Hung, PG Satyaswaroop, S Tabibzadeh
Atlas of Human Tumor Cell Lines 1994
CA-125 levels in cervical mucus during the menstrual cycle*
AR Martinez, CM Thomas, MF Segers, J Schoemaker, TK Eskes
Fertility and Sterility 1994
Epidermal Growth Factor Enhances Secretion of the Ovarian Tumor-Associated Cancer Antigen CAI25 From the Human Amnion WISH Cell Line
I Konishi, JL Fendrick, TH Parmley, JG Quirk, TJ O'Brien
Journal of the Society for Gynecologic Investigation 1994
Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels
R Molina, C Agusti, JM Mañe, X Filella, J Jo, J Joseph, N Giménez, J Estapé, AM Ballesta
The International Journal of Biological Markers 1994
Expression of the Tumor-Associated Glycoproteins Mca, Ca 125 and Bw 495/36-P in Epithelial Tumors of the Kidney and the Urinary Bladder
A Ammon, MH Weber, I Wallner, N Marschner, M Droese, HJ Gröne, W Hiddemann
The International Journal of Biological Markers 1994
Relation between Ovarian Carcinoma-Associated Antigens in Tumor Tissue and Detached Cyst Fluid Cells of Patients with Ovarian Neoplasms
JK Bar, A Harłtozińska, E Sobańska, M Cislo
TUMORI 1994
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
GM McGeehan, JD Becherer, RC Bast, CM Boyer, B Champion, KM Connolly, JG Conway, P Furdon, S Karp, S Kidao, AB McElroy, J Nichols, KM Pryzwansky, F Schoenen, L Sekut, A Truesdale, M Verghese, J Warner, JP Ways
Nature 1994
Immunohistochemical characterization of undifferentiated carcinomas of the ovary
Y Kuwashima, T Uehara, K Kishi, K Shiromizu, M Matsuzawa, S Takayama
Journal of Cancer Research and Clinical Oncology 1994
Cancer Treatment An Update
P Banzet, JF Holland, D Khayat, M Weil
1994
Blaustein’s Pathology of the Female Genital Tract
RJ Kurman
1994
CA 125 secretion by peritoneal mesothelial cells
AM Zeillemaker, HA Verbrugh, AA van Papendrecht, P Leguit
Journal of clinical pathology 1994
Atlas of Exocrine Pancreatic Tumors
PM Pour, Y Konishi, G Klöppel, DS Longnecker
1994
Adenocarcinoma of the submandibular gland with positive serum and tissue immunohistochemical staining for both CEA and CA 125: report of a case
Y Kasuga, A Nakai, Y Matsunaga, M Toi, H Goto, Y Nimura, R Kurasawa, S Moriyama
The Journal of Laryngology & Otology 1994
TUMOR MARKERS IN EPITHELIAL OVARIAN CANCER
RE Hempling
Obstetrics and Gynecology Clinics of North America 1994
Cancer Antigen 1251S Locally Produced in the Peritoneal Cavity during Continuous Ambulatory Peritoneal Dialysis
GC Koomen, MG Betjes, O Zemel, RT Krediet, FJ Hoek
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1994
Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action
YJ Lidor, KC O'Briant, FJ Xu, TC Hamilton, RF Ozols, RC Bast
Journal of Clinical Investigation 1993
Quantitative and qualitative assessment of CA-125 production by human endometrial epithelial cells: Comparison of eutopic and heterotopic epithelial cells
H Kobayashi, W Ida, T Terao, Y Kawashima
International Journal of Cancer 1993
Immunohistochemical markers of uterine receptivity in the human endometrium
AO Ilesanmi, DA Hawkins, BA Lessey
Microscopy Research and Technique 1993
Elevated serum ca 125 secondary to tuberculous peritonitis
SA Candocia, GY Locker
Cancer 1993
Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
PH Hand, PF Robbins, ML Salgaller, DJ Poole, J Schlom
Cancer Immunology Immunotherapy 1993
mAb-Labeled Liposomes in Breast Cancer Cell Targeting
G Rombi, F Cossu, G Melis
Annals of the New York Academy of Sciences 1993
Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer
RE Hempling, MS Piver, N Natarajan, TR Baker, JM Thompson, ML Hicks, CJ Mettlin
Journal of Surgical Oncology 1993
Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies
M Mottolese, I Venturo, M Salzano, M Benevolo, A Bigotti, PG Natali
Journal of Clinical Laboratory Analysis 1993
Falsely Low Results in CA 125 Determination Due to Anti-Idiotypic Antibodies Induced by Infusion of [131I]F(ab′)2 Fragments of the OC125 Antibody
J Reinsberg, W Nocke
Clinical Chemistry and Laboratory Medicine 1993
Cancer in the elderly
A Byrne, DN Carney
Current Problems in Cancer 1993
Ovarian cancer screening
JR van Nagell, PD Depriest, HH Gallion, EJ Pavlik
Cancer 1993
Monoclonal antibodies in the management of ovarian cancer: A clinical perspective
SC Rubin
Cancer 1993
Idiotypic Cascades After MAb OC 125 Application
J Reinsberg
Hybridoma 1993
In vitro cytotoxic activity of taxol' and taxotere on primary cultures and established cell lines of human ovarian cancer
R Silvestrini, N Zaffaroni, L Orlandi, S Oriana
Stem Cells 1993
Limitations of CA125 in the Preoperative Evaluation of a Pelvic Mass: Struma Ovarii and Ascites
YC Leung, IG Hammond
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1993
Women with a Pelvic Mass - When to Perform an Ultrasound
JR Dowd, MA Quinn, R Rome, H Koh
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1993
Origin of CA125 and SCC Antigen in Human Amniotic Fluid*
N Takeshima, Y Suminami, O Takeda, H Abe, H Kato
Asia-Oceania Journal of Obstetrics and Gynaecology 1993
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125
J Fisken, JE Roulston, C Sturgeon, RA Badley, I Jönrup, L Aspinall, RC Leonard
British Journal of Cancer 1993
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein
P Garin-Chesa, I Campbell, PE Saigo, JL Lewis, LJ Old, WJ Rettig
The American Journal of Pathology 1993
Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers
H Kobayashi, H Ohi, T Fujii, T Terao
British Journal of Cancer 1993
Changes in expression of differentiation markers between normal ovarian cells and derived tumors
CC van Niekerk, FC Ramaekers, AG Hanselaar, J Aldeweireldt, LG Poels
The American Journal of Pathology 1993
Cancer of the Ovary
SA Cannistra
New England Journal of Medicine 1993
Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: Comparison with CA125
H Kobayashi, M Tamura, T Satoh, T Terao
Clinical Biochemistry 1993
Characterization of CA 125 antigen identified by monoclonal antibodies that recognize different epitopes
H Kobayashi, H Ohi, N Moniwa, H Shinohara, T Terao
Clinical Biochemistry 1993
mAb-Labeled Liposomes in Breast Cancer Cell Targeting.: Therapeutics and Diagnostic Use of Polyspecific Artificial Carriers
G Rombi, F Cossu, G Melis
Annals of the New York Academy of Sciences 1993
Falsely Low Results in CA 125 Determination Due to Anti-Idiotypic Antibodies Induced by Infusion of [ 131 I]F(ab′)2 Fragments of the OC125 Antibody
J Reinsberg, W Nocke
Clinical Chemistry and Laboratory Medicine 1993
What do we know about the origin of CA 125?
P Bischof
European Journal of Obstetrics & Gynecology and Reproductive Biology 1993
Discordant serum CA 125 values in commercial immunoassays
GJ Kamp, AA Verstraeten, P Kenemans
European Journal of Obstetrics & Gynecology and Reproductive Biology 1993
Que peut attendre le clinicien aujourd'hui du dosage du CA125 ?
PF Vallino
Immuno-analyse & Biologie Spécialisée 1993
4 Markers for endometriosis
JL Evers, GA Dunselman, PJ der Linden
Baillière's Clinical Obstetrics and Gynaecology 1993
Molecular characteristics of the CA 125 antigen produced by human endometrial epithelial cells: Comparison between eutopic and heterotopic epithelial cells
H Kobayashi, W Ida, T Terao, Y Kawashima
American Journal of Obstetrics and Gynecology 1993
Determinación de marcadores tumorales séricos (CEA, SCC y CA 125) en pacientes con cáncer de pulmón. I. Análisis pretratamiento
M Díez, A Torres, MD Ortega, ML Maestro, A Gómez, A Cidoncha, F Hernando, J Granell, JL Balibrea
Archivos de Bronconeumología 1993
In vitro CA-125 secretion by endometrium from women with advanced endometriosis
JH McBean, JR Brumsted
Fertility and Sterility 1993
Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle
AG Zeimet, E Müller-Holzner, C Marth, G Daxenbichler, O Dapunt
Fertility and Sterility 1993
Serum and Tissue Levels of CEA, TPA, CA 125 and CA 15.3 in Patients with Lung Cancer
V Macchia, D Paduano, AD Carlo, A Mariano, C Cecere, G Ferrante
The International Journal of Biological Markers 1993
Production and Characterization of a Tumor-Specific Monoclonal Antibody Act19 Recognizing an Epitope Distinctive from Sialosyl-Tn on the TAG72 Antigen
J Xiang, T Moyana, Z Chen, W Han, T Ping, E Li
TUMORI 1993
Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor
K Nishida, R Ueda, K Sakakibara, Y Minoura, M Ohta, Y Ariyoshi, T Takahashi
Japanese journal of cancer research : Gann 1993
A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer
H Kobavashi, H Sakahara, T Saga, M Hosono, M Shirato, H Kanda, K Ishibashi, T Watanabe, K Endo, I Ishiwata, J Konishi
Cancer Immunology, Immunotherapy 1993
Office Gynecology
JV Knaus, JH Isaacs
1993
Serum CA 125 levels in patients with non-malignant liver diseases without ascites
J Collazos, J Genolla, MT Allende, A Ruibal
The Clinical Investigator 1993
Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
PH Hand, PF Robbins, ML Salgaller, DJ Poole, J Schlom
Cancer Immunology, Immunotherapy 1993
Characterization of OM‐B Monoclonal Antibody‐defined Antigen Associated with Mucinous Type Human Ovarian Tumor
Nishida K, Ueda R, Sakakibara K, Minoura Y, Ohta M, Ariyoshi Y, Takahashi T
Japanese journal of cancer research : Gann 1993
Tumour markers in oncology: past, present and future
H Magdelénat
Journal of Immunological Methods 1992
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters
CK Høgdall, EV Høgdall, J Arends, B Nørgaard-Pedersen, S Smidt-Jensen, SO Larsen
Prenatal Diagnosis 1992
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: Uptake, retention kinetics and dosimetric evaluation
M Bardiès, P Thedrez, JF Gestin, BM Marcille, D Guerreau, A Faivre-Chauvet, M Mahe, C Sai-Maurel, JF Chatal
International Journal of Cancer 1992
Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer
G Olt, A Berchuck, AP Soisson, CM Boyer, RC Bast
Cancer 1992
Different antigenic nature in apparently healthy women with high serum CA 125 levels compared with typical patients with ovarian cancer
MN Hosono, K Endo, H Sakahara, Y Watanabe, T Saga, T Nakai, M Hosono, T Nakajima, Y Onoyama, J Konishi
Cancer 1992
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases
T Shinozaki, M Chigira, K Kato
Cancer 1992
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody
CY Lee, KW Chen, FS Sheu, A Tsang, KC Chao, HT Ng
Cancer Immunology Immunotherapy 1992
In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma
M Apiranthitou-Drogari, C Paganin, S Bernasconi, G Losa, A Maneo, N Colombo, A Mantovani, P Allavena
Cancer Immunology Immunotherapy 1992
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cells
G Ferrandina, G Scambia, PB Panici, G Bonanno, RD Vincenzo, C Rumi, S Bussa, M Genuardi, VS Romano, S Mancuso
Molecular and Cellular Endocrinology 1992
Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture
M Mottolese, A Cianciulli, I Venturo, RP Donnorso, M Salzano, M Benevolo, G Bigotti, PG Natali
Diagnostic Cytopathology 1992
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium
K Chang, I Pastan, MC Willingham
International Journal of Cancer 1992
Second-trimester cancer antigen 125 and Down's syndrome
MV Blerk, J Smitz, LD Catte, C Kumps, JV der Elst, AC van Steirteghem
Prenatal Diagnosis 1992
Monoclonal antibody-based ELISA to detect glycoprotein tumor-associated-antigen-specific immune complexes in cancer patients
RK Gupta, DL Morton
Journal of Clinical Laboratory Analysis 1992
An immunoenzymometric assay for a CA 125-like antigen, CA602
H Mochizuki, I Sato, K Nagoya, S Furusako, T Yamauchi, H Masuko, H Sato, H Morishita, M Yajima, H Sasaki, Y Udagawa, S Nozawa
Journal of Clinical Laboratory Analysis 1992
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
A Gadducci, M Ferdeghini, C Prontera, L Moretti, G Mariani, R Bianchi, P Fioretti
Gynecologic Oncology 1992
CA125 in peritoneal fluid of ovarian cancer patients
IB Vergote, M Onsrud, OP Børmer, BM Sert, M Moen
Gynecologic Oncology 1992
Characterization and clinical evaluation of tumor-associated antigen CA54/61 identified by monoclonal antibodies MA54 and MA61 in epithelial ovarian cancer
H Kobayashi, H Ohi, M Sugimura, H Shinohara, T Terao
Gynecologic Oncology 1992
Seven tumor markers in benign and malignant germ cell tumors of the ovary
M Kawai, T Kano, F Kikkawa, Y Morikawa, H Oguchi, N Nakashima, T Ishizuka, K Kuzuya, M Ohta, Y Arii, Y Tomoda
Gynecologic Oncology 1992
Histopathologic Diagnostic and Histogenetic Problems in Malignant Soft Tissue Tumors
S Ushigome, T Shimoda, T Nikaido, S Takasaki
Pathology International 1992
Significance of the Serum CA125 Level in Recurrent Ovarian Cancer
H Nishimura, M Tashiro, K Hamaguchi, Y Kiyozuka, H Ide, N Tateno, T Miyoshi, M Yakushiji
Asia-Oceania Journal of Obstetrics and Gynaecology 1992
CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory study
J Collazos, J Genolla, A Ruibal
Scandinavian Journal of Clinical & Laboratory Investigation 1992
The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer
HH Gallion, JE Hunter, JR Nagell, HE Averette, JM Cain, LJ Copeland, RV Higgins, N Husseinzadeh, WA Nahhas, EE Partridge, SH Pursell
Gynecologic Oncology 1992
Heterophile Antigens in Serous Cystadenocarcinoma of the Human Ovary
M Kamada, T Mori, Y Sakamoto, T Daitoh, H Furumoto, M Irahara, T Aono, T Mori
Asia-Oceania Journal of Obstetrics and Gynaecology 1992
Effect of Menstruation on Serum CA125 Levels
YY Kan, SH Yeh, HT Ng, CM Lou
Asia-Oceania Journal of Obstetrics and Gynaecology 1992
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9
O Nilsson, C Johansson, B Glimelius, B Persson, B Nørgaard-Pedersen, A Andrén-Sandberg, L Lindholm
British Journal of Cancer 1992
Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer
CF Molthoff, HM Pinedo, HM Schlüper, HW Nijman, E Boven
British Journal of Cancer 1992
An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer
DJ Cruickshank, J Paul, CR Lewis, EJ McAllister, SB Kaye
British Journal of Cancer 1992
Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-alpha
P Giacomini, M Mottolese, R Fraioli, M Benevolo, I Venturo, PG Natali
British Journal of Cancer 1992
Management of patients with ovarian cancer using monoclonal antibodies
S Lastoria, N Panza, G Esposito, E Vergara, L Castelli, C Caraco, C Battista, G Pacilio, M Salvatore
Biomedicine & Pharmacotherapy 1992
Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells
C Marth, AG Zeimet, G Böck, G Daxenbichler
European Journal of Cancer 1992
Metastatic ovarian or colonic cancer: A clinical challenge
BG Taal, FC Jager, PC Hageman, JF Delemarre, JM Bonfrèr
European Journal of Cancer 1992
The prognostic significance of maternal serum CA125 measurement in threatened abortion
F Öçer, T Beşe, E Saridoǧan, K Aydinli, T Atasü
European Journal of Obstetrics & Gynecology and Reproductive Biology 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α
S Wu, K Rodabaugh, O Martinez-Maza, JM Watson, DS Silberstein, CM Boyer, WP Peters, JB Weinberg, JS Berek, RC Bast
American Journal of Obstetrics and Gynecology 1992
Menstrual cyclicity of CA-125 in patients with endometriosis**Presented in part at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, October 19 to 24, 1991.††Supported in part by a grant from Centocor, Inc., Malvern, Pennsylvania, and by General Clinical Research Center grant 5-Mol-RR-02635, Brigham and Women’s Hospital, Boston, Massachusetts.‡‡Data organization and analysis assisted by the Computerized Data Base Management and Analysis System
MD Hornstein, PP Thomas, RE Gleason, RL Barbieri
Fertility and Sterility 1992
CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients
N Mordel, SO Anteby, G Zajicek, I Roisman, A Treves, V Barak
Fertility and Sterility 1992
CA-125 levels in human uterine fluid**Presented in part at the 46th Annual Meeting of The American Fertility Society, Washington, D.C., October 13 to 18, 1990
M Abaé, M Gibson, J Chapitis, DH Riddick, JR Brumsted
Fertility and Sterility 1992
Characterization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture**Supported by the Wellcome Trust, London, United Kingdom, and the University of Newcastle upon Tyne Research Committee, Newcastle upon Tyne, United Kingdom
CJ Matthews, CP Redfern, BH Hirst, EJ Thomas
Fertility and Sterility 1992
Unsettled questions regarding ovarian cancer
C Tropé, A Makar
Acta Obstetricia et Gynecologica Scandinavica 1992
What do CA 125 and other antigens tell us about ovarian cancer biology?
CE Welander
Acta Obstetricia et Gynecologica Scandinavica 1992
Biologic and Immunologic Therapy of Ovarian Cancer
MA Bookman, JS Berek
Hematology/Oncology Clinics of North America 1992
Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma
T Hada, Y Kinoshita, Y Ichimori, H Imanishi, K Umeyama, Y Amuro, A Toyosaka, E Okamoto, K Higashino
Japanese journal of cancer research : Gann 1992
Serological Cancer Markers
S Sell
1992
Tumormarker und Immunszintigraphie in der gynäkologischen Onkologie
D Elling, V Pink
1992
Chirurgische Therapie von Kopf-Hals-Karzinomen
K Vinzenz, HW Waclawiczek
1992
TUMOR MARKERS
MJ Seleznick
Primary care 1992
SCREENING FOR GYNECOLOGIC CANCER
KL Hall, MA Dewar, J Perchalski
Primary care 1992
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody
CY Lee, KW Chen, FS Sheu, A Tsang, KC Chao, HT Ng
Cancer Immunology, Immunotherapy 1992
In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma
M Apiranthitou-Drogari, C Paganin, S Bernasconi, G Losa, A Maneo, N Colombo, A Mantovani, P Allavena
Cancer Immunology, Immunotherapy 1992
Establishment of an Enzyme Immunoassay Using Monoclonal Antibody (HG1‐219) and Its Application for the Diagnosis of Hepatocellular Carcinoma
Hada T, Kinoshita Y, Ichimori Y, Imanishi H, Umeyama K, Amuro Y, Toyosaka A, Okamoto E, Higashino K
Japanese journal of cancer research : Gann 1992
Clinical use of tumor markers in oncology
EL Jacobs, CM Haskell
Current Problems in Cancer 1991
Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas
G Gitsch, P Kohlberger, E Hanzal, H Kölbl, G Breitenecker
Archives of Gynecology and Obstetrics 1991
Carcinoma-associated mucin serum markers CA M26 and CA M29: Efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix
KA Yedema, P Kenemans, T Wobbes, GJ van Kamp, HW de Bruijn, CM Thomas, LF Massuger, CP Schuf, GG Bon, JB Vermorken, F Voorhorst, J Hilgers
International Journal of Cancer 1991
Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expression
CF Molthoff, JJ Calame, HM Pinedo, E Boven
International Journal of Cancer 1991
Drug effects on CA125 antigen expression and antibody binding to cancer cells
T Nakai, K Endo, M Hosono, T Saga, Y Watanabe, H Sakahara, K Imai, A Yachi, Y Kivozuka, I Ishiwata, J Konishi
International Journal of Cancer 1991
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer
YJ Lidor, EJ Shpall, WP Peters, RC Bast
International Journal of Cancer 1991
Evaluation of serum ca 125 as a tumor marker in non-small cell lung cancer
M Diez, FJ Cerdàn, MD Ortega, A Torres, A Picardo, JL Balibrea
Cancer 1991
Monitoring patients with ovarian carcinoma: the relationship of serum CA125 levels to CT scanning
E Moskovic, E Wiltshaw, P Blake, C Parsons
International Journal of Gynecological Cancer 1991
Elevated tissue concentrations of sialyl lex-i in cancerous tissues compared with those in noncancerous tissues of various organs
K Nishida, H Yamamoto, T Ohtsuki, M Matsuba, S Mukai, Y Naito, T Yoshikawa, M Kondo
Cancer 1991
CA125 parameters in survivors and non-survivors with epithelial ovarian cancer
D Cruickshank
International Journal of Gynecological Cancer 1991
Histochemical distribution of CA-125 as a prognostic indicator in patients with serous ovarian cancer
P Bichel, A Jakobsen, T Ørntoft
International Journal of Gynecological Cancer 1991
Presence of epidermal growth factor (EGF) receptor and proliferative response to EGF in six human ovarian carcinoma cell lines
G Scambia, PB Panici, F Battaglia, G Ferrandina, C Gaggini, S Mancuso
International Journal of Gynecological Cancer 1991
Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
P Sevelda, A Rosen, U Denison, M Barrada, J Spona, H Salzer
Gynecologic Oncology 1991
Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary
T Yamada, M Ueda, Y Otsuki, M Ueki, O Sugimoto
Gynecologic Oncology 1991
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
SE Brooks, J Timmerman, CC Lau, SW Tsao, RC Knapp, EE Sheets
Gynecologic Oncology 1991
Two Cases of Peritoneal Serous Papillary Adenocarcinoma
T Tsujimura, M Takeda, N Terada, H Uramoto
Pathology International 1991
S-100 Protein in Ovarian Tumors
M Lin, J Hanai, A Wada, M Ozaki, K Nasu, S Okamoto, K Matsumoto
Pathology International 1991
Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer
A Gadducci, M Ferdeghini, G Rispoli, C Prontera, R Bianchi, P Fioretti
Scandinavian Journal of Clinical & Laboratory Investigation 1991
Tumour marker CA 125 in patients with digestive tract malignancies
C Haglund, P Kuusela, P Roberts, H Jalanko
Scandinavian Journal of Clinical & Laboratory Investigation 1991
Serial Changes of Serum CA125 Levels during Menstrual Cycles
H Nonogaki, S Fujii, I Konishi, Y Nanbu, F Kobayashi, T Mori
Asia-Oceania Journal of Obstetrics and Gynaecology 1991
Antigenic Studies on an Enzymatically Sialylated Carbohydrate: NeuAc(α2-3)Gal(β1-3)[GlcNAc(131-6)]GalNAc
DJ Handley, KL Matta, MS Piver, KR Diakun
Immunological Investigations 1991
Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters
H Egami, T Tomioka, M Tempero, D Kay, PM Pour
The American Journal of Pathology 1991
Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas
CC van Niekerk, OC Boerman, FC Ramaekers, LG Poels
The American Journal of Pathology 1991
Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program
PE Schwartz, JT Chambers, KJ Taylor, J Pellerito, L Hammers, LA Cole, TL Yang-Feng, P Smith, ST Mayne, R Makuch
The Yale journal of biology and medicine 1991
Monoclonal antibodies against CA125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers
S Imai, H Maeda, Y Kiyozuka, J Morimoto, S Haga, T Noda, S Hiroishi, J Hilgers
Molecular and Cellular Probes 1991
Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary
NG Davidson, S Khanna, PH Kirwan, D Bircumshaw
Clinical Oncology 1991
Malignant ileal carcinoid with metastasis to adenocarcinoma of the ovary
WG Finn, MS Rao
Human Pathology 1991
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies
LF Massuger, P Kenemans, RA Claessens, RH Verheijen, FH Corstens
European Journal of Obstetrics & Gynecology and Reproductive Biology 1991
Immunocytochemical markerprofile of endometriotic epithelial, endometrial epithelial, and mesothelial cells: a comparative study
RF Kruitwagen, LG Poels, WN Willemsen, PH Jap, IJ de Ronde, TG Hanselaar, R Rolland
European Journal of Obstetrics & Gynecology and Reproductive Biology 1991
Identification of an ectopic developmental antigen that appears in malignant ascitic fluid
M Nakai, M Ishikawa, H Kawauchi
European Journal of Obstetrics & Gynecology and Reproductive Biology 1991
Primary diagnosis and follow-up of ovarian cancer: Radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and “second look”
G Barzen, J Hierholzer, M Cordes, W Friedmann, R Felix
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1991
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
FJ Xu, S Ramakrishnan, L Daly, JT Soper, A Berchuck, D Clarke-Pearson, RC Bast
American Journal of Obstetrics and Gynecology 1991
Secondary müllerian system and endometriosis
S Fujii
American Journal of Obstetrics and Gynecology 1991
New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope
TJ O'Brien, LM Raymond, GA Bannon, DH Ford, H Hardardottir, FC Miller, JG Quirk
American Journal of Obstetrics and Gynecology 1991
Tumour Markers in Gynaecologic Oncology
M Onsrud
Scandinavian Journal of Clinical & Laboratory Investigation 1991
High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay
RF Kruitwagen, C Thomas, LG Poels, AM Koster, WN Willemsen, R Rolland
Fertility and Sterility 1991
Clinical chemistry
DJ Anderson, FV Lente, FS Apple, SC Kazmierczak, JA Lott, MK Gupta, N McBride, WE Katzin, RE Scott, al.
Analytical Chemistry 1991
The Potential Value of CA125 as a Tumour Marker in Small Volume, Non-Evaluable Epithelial Ovarian Cancer
DJ Cruickshank, PB Terry, WT Fullerton
The International Journal of Biological Markers 1991
A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)
S Nozawa, M Yajima, H Sasaki, K Tsukazaki, D Aoki, M Sakayori, Y Udagawa, T Kobayashi, I Sato, S Furusako
Japanese journal of cancer research : Gann 1991
Gynäkologie und Geburtshilfe 1990
EJ Hickl, D Berg
1991
OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma
RV Skov, P Bichel
Virchows Archiv A Pathological Anatomy and Histopathology 1991
A New CA125‐like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG‐II)
Nozawa S, Yajima M, Sasaki H, Tsukazaki K, Aoki D, Sakayori M, Udagawa Y, Kobayashi T, Sato I, Furusako S, Mochizuki H
Japanese journal of cancer research : Gann 1991
Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125
S Kol, D Gal, M Friedman, E Paldi
Gynecologic Oncology 1990
A Simple Procedure for Isolation of Tumor-Associated Antigens by Affinity Chromatography Using Fucose-SpecificAleuria aurantiaLectin
S Yazawa, N Kochibe, T Asao
Immunological Investigations 1990
Imaging of ovarian cancer with radiolabelled monoclonal antibodies
DL Kranenburg, MJ Kroonenburgh, JB Trimbos, GJ Fleuren, EK Pauwels
Archives of Gynecology and Obstetrics 1990
Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas
L Mettler, HJ Radzun, A Salmassi, W Köchling, MR Parwaresch
Cancer 1990
Cancer antigen 125, carcinoembryonic antigen, and carbohydrate determinant 19-9 in ovarian tumors
T Motoyama, H Watanabe, S Takeuchi, T Watanabe, S Gotoh, E Okazaki
Cancer 1990
Ovarian carcinoma.Advances in diagnosis, staging, and treatment
HE Averette, DM Donato
Cancer 1990
Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen
Y Matsuoka, K Endo, Y Kawamura, T Yoshida, T Saga, Y Watanabe, M Koizumi, T Nakashima, J Konishi, N Yamaguchi, R Yatani
Cancer 1990
Adrenal Steroids and Tumor Antigens in Plasma and Cyst Fluid of Women with Gross Cystic Breast Disease
P Inaudi, V Leo, S Baldini, N D'Antona
Annals of the New York Academy of Sciences 1990
Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy
R Marana, L Muzh, P Muscatello, A Lanzone, A Caruso, S Dell'acqua, S Mancuso
BJOG: An International Journal of Obstetrics and Gynaecology 1990
Antigenic heterogeneity in human ovarian cancer
WR Welch, JM Niloff, D Anderson, A Battaile, S Emery, RC Knapp, RC Bast
Gynecologic Oncology 1990
Gynecologic tumor markers
GJ Olt, A Berchuck, RC Bast
Seminars in Surgical Oncology 1990
Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours
M Ghazizadeh, Y Sasaki, T Oguro, K Aihara, H Tenjin, T Araki
Histopathology 1990
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: Relevance for differential diagnosis
B Tholander, A Taube, A Lindgren, O Sjöberg, U Stendahl, A Kiviranta, K Hallman, L Holm, E Weiner, L Tamsen
Gynecologic Oncology 1990
Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma
WS Wong, YF Wong, YT Ng, PD Huang, EC Chew, TH Ho, MZ Chang
Gynecologic Oncology 1990
Immunoscintigraphy of endometriosis
SH Kennedy, OA Mojiminiyi, ND Soper, BJ Shepstone, DH Barlow
BJOG: An International Journal of Obstetrics and Gynaecology 1990
Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube
T Tokunaga, K Miyazaki, S Matsuyama, H Okamura
Gynecologic Oncology 1990
Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer
M Suzuki, M Ohwada, T Tamada
Gynecologic Oncology 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer
VJ Hunter, JB Weinberg, AF Haney, JT Soper, P Lavin, L Metsch, RC Knapp, RC Bast
Gynecologic Oncology 1990
CA 19-9 and CA 125 Determination by Immunoluminometric Assay
M Plebani, D Faggian, M Masiero, A Giacomini, A Burlina
Clinical Chemistry and Laboratory Medicine 1990
α-Fetoprotein in malignant germ cell tumors of the ovary
M Kawai, Y Furuhashi, T Kano, T Misawa, N Nakashima, S Hattori, Y Okamoto, I Kobayashi, M Ohta, Y Arii, Y Tomoda
Gynecologic Oncology 1990
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer
O Mogensen, B Mogensen, A Jakobsen
Gynecologic Oncology 1990
Immunohistochemical Localization of CA130 in Fetal Tissues, and in Normal and Neoplastic Tissues of the Female Genital Tract
Y Nanbu, S Fujii, I Konishi, H Nonogaki, N Sagawa, F Kobayashi, T Mori, T Saga, K Endo
Asia-Oceania Journal of Obstetrics and Gynaecology 1990
Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: An immunofluorescence study
B Dezsö, I Török, LO Rosik, F Sweet
Gynecologic Oncology 1990
Construction of An Immunoradiometric Ay for Ovarian Cancer Associated Antigen Ca125 Recognizing Different Antigenic Determinant
T Saga, K Endo, T Nakashima, T Awaji, M Koizumi, Y Kawamura, Y Watanabe, J Konishi, H Nonogaki, Y Nanbu, S Fujii, T Mori
Acta Obstetricia et Gynecologica Scandinavica 1990
Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters
Y Takiyama, H Egami, PM Pour
The American Journal of Pathology 1990
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours
O Mogensen, B Mogensen, A Jakobsen
British Journal of Cancer 1990
Serum CA125 level is a good prognostic indicator in lung cancer
Y Kimura, T Fujii, K Hamamoto, N Miyagawa, M Kataoka, A Iio
British Journal of Cancer 1990
Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue
G Ronay, W Jäger, K Weiss, H Feistel, F Wolf, AH Tulusan, N Lang
The British journal of cancer. Supplement 1990
Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma
M Mottolese, I Venturo, G Digiesi, RP Donnorso, A Bigotti, R Muraro, A Aluffi, PG Natali
British Journal of Cancer 1990
OC125 immunoscintigraphy in ovarian carcinoma: A comparison with alternative methods of assessment
TS Maughan, B Haylock, M Hayward, P Facey, WD Evans, MD Shelley, RG Fish, M Adams
Clinical Oncology 1990
Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies — with special reference to the combination of PLAP and CA54/61 assay
S Nozawa, Y Udagawa, H Ohkura, Y Negishi, K Akiya, N Inaba, H Takamizawa, E Kimura, Y Terashima
Clinica Chimica Acta 1990
A Simple Procedure for Isolation of Tumor-Associated Antigens by Affinity Chromatography Using Fucose-Specific Aleuria aurantia Lectin
S Yazawa, N Kochibe, T Asao
Immunological Investigations 1990
Comparative study of RIS with the 131I-OC 125 F(ab′)2 Mab and CT scan prior to second look operation for ovarian cancer
V Papazefkos, S Michalas, V Papantoniou, J Datseris, P Athanasiadis, T Akrivos, A Leonti, A Xygakis, D Aravantinos
European Journal of Obstetrics & Gynecology and Reproductive Biology 1990
Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer
D Aravantinos, S Michalas, V Papazefkos, M Christoforaki, A Stypsaneli, G Vlachos, P Athanasiadis
European Journal of Obstetrics & Gynecology and Reproductive Biology 1990
Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours
OC Boerman, WK Makkink, CM Thomas, AG Hanselaar, CA Yedema, P Kenemans, LG Poels
European Journal of Cancer and Clinical Oncology 1990
Separation and biochemical characterization of blood group N antigen precursor glycoproteins with thomsen-friedenreich (T) activity, T-active glycoproteins and N antigen precursor glycoproteins from ascites of primary ovarian cancer patients
H Shigemi, O Kunio, Y Khomei, Y Toshio, W Hajime, H Shun, O Seiichi
International Journal of Biochemistry 1990
Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm
H Hardardottir, TH Parmley, JG Quirk, MM Sanders, FC Miller, TJ O'Brien
American Journal of Obstetrics and Gynecology 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancer
A Berchuck, GJ Olt, AP Soisson, A Kamel, JT Soper, CM Boyer, DL Clarke-Pearson, DS Leslie, RC Bast
American Journal of Obstetrics and Gynecology 1990
CA 125 is released by human amnion cells in culture
A Barbati, MM Anceschi, L Broccucci, EV Cosmi
American Journal of Obstetrics and Gynecology 1990
Correlation between peripheral CA-125 levels and ovarian activity**Supported in part by the Abbott Diagnostics Division, Ottignies, Belgium
A Zweers, JD Boever, R Serreyn, D Vandekerckhove
Fertility and Sterility 1990
Reactivity of Polyclonal and Two Monoclonal Antibodies with Cell Subsets Isolated from Cystic Fluids of Ovarian Serous Neoplasms
A Hartozińska, JK Bar, J Rabczyński, RC Bast, R Richter, M Cisto
TUMORI 1990
Clinical Value of Radioimmunoscintigraphy in the follow-up of Ovarian Carcinoma: A Prospective Study
F Crippa, M Presti, A Marini, B D'Onofrio, G Bolis, GL Buraggi
The International Journal of Biological Markers 1990
MCA in Patients with Breast Cancer: Correlation with CEA and CA15-3
R Molina, X Filella, P Mengual, M Prats, G Zanon, M Daniels, AM Ballesta
The International Journal of Biological Markers 1990
An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies
T Saga, I Ishiwata, K Endo, H Sakahara, M Koizumi, Y Watanabe, T Nakai, M Hosono, H Ishikawa, M Sawada
Japanese journal of cancer research : Gann 1990
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas
M Chigira, T Shinozaki
Archives of Orthopaedic and Trauma Surgery 1990
Endometrial Carcinoma
S Li, E Wang
1990
From Clone to Clinic
DJ Crommelin, H Schellekens
1990
Diagnostic significance of the tumour markers CEA, CA 15–3 and CA 125 in malignant effusions in breast cancer
K Kandylis, M Vassilomanolakis, N Baziotis, A Papadimitriou, S Tsoussis, A Ferderigou, AP Efremidis
Annals of Oncology 1990
Screening for Gynecologic Cancer
MJ Campion, R Reid
Obstetrics and Gynecology Clinics of North America 1990
Imaging of ovarian cancer with radiolabelled monoclonal antibodies
DL van Kranenburg, MJ van Kroonenburgh, JB Trimbos, GJ Fleuren, EK Pauwels
Archives of Gynecology and Obstetrics 1990
An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
Saga T, Ishiwata I, Endo K, Sakahara H, Koizumi M, Watanabe Y, Nakai T, Hosono M, Ishikawa H, Sawada M, Konishi J
Japanese journal of cancer research : Gann 1990
Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines
S Ramakrishnan, FJ Xu, SJ Brandt, JE Niedel, RC Bast, EL Brown
Journal of Clinical Investigation 1989
Present status of serum markers
JP Minton, A Chevinsky
Seminars in Surgical Oncology 1989
CA 125 as a tumour marker in epithelial ovarian cancer
JD Sheehan, MJ Duffy, MA Allen, JJ Fennelly
Irish Journal of Medical Science 1989
The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer
M Teeling, P McGing, DN Carney
Irish Journal of Medical Science 1989
Alpha1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125
O Mogensen, B Mogensen, A Jakobsen
Cancer 1989
Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsy
M Mottolese, I Venturo, M Rinaldi, N Campioni, A Aluffi, CG Curcio, RP Donnorso, PG Natali
Cancer 1989
Die Bedeutung des Markers CA 125 für die Nachsorge des Ovarialkarzinoms
K Engel, T Piotrowski, H Schmid, W Kühn, M Kaufmann
Archives of Gynecology and Obstetrics 1989
Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells
V Band, BY Karlan, VR Zurawski, BA Littlefield
Journal of Cellular Physiology 1989
Serum CA 125 in acute pelvic inflammatory disease
J Paavonen, A Miettinen, PK Heinonen, RK Aaran, K Teisala, R Aine, R Punnonen, S Laine, OP Kallioniemi, M Lehtinen
BJOG: An International Journal of Obstetrics and Gynaecology 1989
Marker profile of mesothelial cellsversus ovarian carcinoma cells
CC van Niekerk, PH Jap, CM Thomas, DF Smeets, FC Ramaekers, LG Poels
International Journal of Cancer 1989
ETN-1: A new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice
RF Kruitwagen, LG Poels, WN Willemsen, HJ Croes, DF Smeets, JL Beck, AG Hanselaar, FC Ramaekers, R Rolland, PH Jap
International Journal of Cancer 1989
CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma
W Neunteufel, G Breitenecker
Cancer Letters 1989
A longitudinal study of antigen expression in epithelial ovarian cancer
SC Rubin, CL Finstad, WJ Hoskins, MG Federici, KO Lloyd, JL Lewis
Gynecologic Oncology 1989
Value of serum 125Ca levels: Does the result preclude second look?
ME Potter, M Moradi, AC To, KD Hatch, HM Shingleton
Gynecologic Oncology 1989
Characterization of two monoclonal antibodies that recognize high molecular weight colon antigens
JP Moosic, AM Mosley, K Huang, CW Taylor, LC Yeoman
Cancer Letters 1989
Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA125 and copper-to-zinc ratio
D Gal, S Lischinsky, M Friedman, O Zinder
Gynecologic Oncology 1989
A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors
L Xinguo, C Dixia, PE Schwartz, Y Zhan
Gynecologic Oncology 1989
Therapeutic effect of a radiolabeled monoclonal antibody on human ovarian cancer xenograft in nude mice
A Manetta, PG Satyaswaroop, T Hamilton, R Ozols, R Mortel
Gynecologic Oncology 1989
Characterization of the CA125 Antigen Secreted from a Newly Established Human Ovarian Cancer Cell Line (SHIN-3)
S Imai, H Maeda, Y Kiyozuka, T Noda, I Moriyama, M Ichijo
Pathology International 1989
Establishment and Characterization of CA 125 Producing Cell Line (OMC-2) Originating from a Human Endometrial Adenocarcinoma
T Yamada, M Ueda, T Maeda, Y Okamoto, Y Miyawaki, Y Otsuki, M Ueki, O Sugimoto
Asia-Oceania Journal of Obstetrics and Gynaecology 1989
Use of CA 125 to monitor patients with ovarian epithelial carcinomas
E Podczaski, C Whitney, A Manetta, JE Larson, J Kirk, CW Stevens, J Lyter, R Mortel
Gynecologic Oncology 1989
Characterization of a hormone-producing ovarian carcinoma cell line
LG Poels, PH Jap, FF Ramaekers, JM Scheres, CM Thomas, PG Vooijs, HJ Croes, G Mungyer
Gynecologic Oncology 1989
Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells
F Sweet, LO Rosik, GM Sommers, JL Collins
Gynecologic Oncology 1989
Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: A comparison with CA 19-9 and CEA
W Neunteufel, G Breitenecker
Gynecologic Oncology 1989
Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer
S Kudlacek, K Schieder, H Kölbl, W Neunteufel, C Nowotny, G Breitenecker, G Biegelmayer, M Vetterlein, B Fürlinger, M Micksche
Gynecologic Oncology 1989
Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma
W Meier, P Stieber, W Eiermann, A Schneider, A Fateh-Moghadam, H Hepp
Gynecologic Oncology 1989
Tumor Markers in Human Biopsy Material
VP Lehto, J Pontén
Acta Oncologica 1989
The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma
RE Hawkins, K Roberts, E Wiltshaw, J Mundy, VR McCready
British Journal of Cancer 1989
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes
CA Hills, LR Kelland, G Abel, J Siracky, AP Wilson, KR Harrap
British Journal of Cancer 1989
Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511
K Ohkawa, Y Tsukada, M Murae, E Kimura, K Takada, T Abe, Y Terashima, K Mitani
British Journal of Cancer 1989
Partial purification and characterization of CA19-9 antigen from the ascitic fluid of a patient with pancreatic cancer
Y Haga, S Horiuchi, Y Morino, M Akagi
Clinical Biochemistry 1989
Clinical significance of mucin-like high molecular weight glycoprotein originated from lung cancer as tumor marker
M Imokawa, H Okabe, Y Ochi, Y Kajita
Clinica Chimica Acta 1989
A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium
M Miyagiwa, T Ichida, T Tokiwa, J Sato, H Sasaki
In Vitro Cellular & Developmental Biology 1989
Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung
G Berthiot, F Marechal, A Cattan, G Deltour
Biomedicine & Pharmacotherapy 1989
The use of tumour markers in clinical practice
T Cooke, CA Makin
Bailliere's Clinical Gastroenterology 1989
CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists
P Acien, RW Shaw, L Irvine, G Burford, R Gardner
European Journal of Obstetrics & Gynecology and Reproductive Biology 1989
Locoregional immunotherapy of human ovarian cancer: Preliminary results
P Riva, M Marangolo, S Lazzari, M Agostini, G Sarti, G Moscatelli, G Franceschi, A Spinelli, G Vecchietti
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1989
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab′)2 fragment in a xenograft model with circulating antigen
MR Zalutsky, RC Bast, RC Knapp
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1989
Labeling proteins using aryl iodide acylation agents: Influence of meta vs para substitution on in vivo stability
PK Garg, SK Slade, CL Harrison, MR Zalutsky
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1989
Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women
F Kobayashi, N Sagawa, K Nakamura, M Nonogaki, C Ban, S Fujii, T Mori
American Journal of Obstetrics and Gynecology 1989
Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes
A Barbati, MM Anceschi, P Alberti, G Pomili, GC Renzo, EV Cosmi
American Journal of Obstetrics and Gynecology 1989
Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125
MG Muto, EM Lepisto, AD van Abbeele, RC Knapp, AI Kassis
American Journal of Obstetrics and Gynecology 1989
CA 125 in the epithelium closely related to the embryonic ectoderm: The periderm and the amnion
Y Nanbu, S Fujii, I Konishi, H Nonogaki, T Mori
American Journal of Obstetrics and Gynecology 1989
Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications
AD Thor, SM Edgerton
Seminars in Nuclear Medicine 1989
Immunohistochemical Reactivity of a Monoclonal Antibody Prepared against Human Ovarian Carcinoma on Normal and Pathological Female Genital Tissues
R Veggian, S Fasolato, S Ménard, D Minucci, P Pizzetti, M Regazzoni, E Tagliabue, MI Colnaghi
TUMORI 1989
A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes
Y Okada, G Yahata, S Takeuchi, T Seidoh, K Tanaka
Japanese journal of cancer research : Gann 1989
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors
BS Coller, JD Folts, SR Smith, LE Scudder, R Jordan
Circulation 1989
Immunoreactive determinants of CA 125 in women with endometriosis
OA Mojiminiyi, ME Bramwell, SH Kennedy, BJ Shepstone, SM Humm, DH Barlow
Journal of clinical pathology 1989
New Cancer Markers
MJ Duffy
Annals of Clinical Biochemistry 1989
Gynäkologie und Geburtshilfe 1988
H Ludwig, D Krebs
1989
Breast Cancer Immunodiagnosis and Immunotherapy
RL Ceriani
1989
CA-125 in Women with Endometriosis
DE Pittaway
Obstetrics and Gynecology Clinics of North America 1989
Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments
G Barzen, AC Mayr, M Langer, R Becker, M Cordes, C Zwicker, K Koppenhagen, R Felix
European Journal of Nuclear Medicine 1989
A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium
M Miyagiwa, T Ichida, T Tokiwa, J Sato, H Sasaki
In Vitro Cellular & Developmental Biology – Animal 1989
A Correlation between the Expression of CD 8 Antigen and Specific Cytotoxicity of Tumor‐infiltrating Lymphocytes
Okada Y, Yahata G, Takeuchi S, Seidoh T, Tanaka K
Japanese journal of cancer research : Gann 1989
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs
T Yasuda, HK Gold, JT Fallon, RC Leinbach, JL Guerrero, LE Scudder, M Kanke, D Shealy, MJ Ross, D Collen
Journal of Clinical Investigation 1988
Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells
M Kunimatsu, K Endo, T Nakashima, T Awaji, T Saga, Y Watanabe, Y Kawamura, H Ohta, M Koizumi, H Sakahara, J Konishi, S Fujii, T Mori, K Torizuka, Y Matsuoka, T Nakagawa, N Yamaguchi
Annals of Nuclear Medicine 1988
Serum levels of six tumor markers in patients with benign and malignant gynecological disease
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, T Sato, H Takamizawa, B Wiklund
Archives of Gynecology and Obstetrics 1988
Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery
K Itahashi, N Inaba, I Fukazawa, H Takamizawa
Archives of Gynecology and Obstetrics 1988
MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
I Jacobs, J Bridges, C Reynolds, I Stabile, P Kemsley, J Grudzinskas, D Oram
The Lancet 1988
Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma
N Panza, G Pacilio, L Campanella, G Peluso, C Battista, A Amoriello, W Utech, C Vacca, G Lombardi
Cancer 1988
The distribution of CA 125 in the reproductive tract of pregnant and non-pregnant women
IJ Jacobs, TN Fay, I Stabile, JE Bridges, DH Oram, JG Grudzinskas
BJOG: An International Journal of Obstetrics and Gynaecology 1988
Immunoscintigraphy of ovarian endometriosis. A preliminary study
SH Kennedy, DH Barlow, ND Soper, OA Mojiminiyi, BJ Shepstone
BJOG: An International Journal of Obstetrics and Gynaecology 1988
Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin
M Mottolese, I Venturo, RP Donnorso, CG Curcio, M Rinaldi, PG Natali
European Journal of Cancer and Clinical Oncology 1988
Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays
C Yedema, L Massuger, J Hilgers, J Servaas, L Poels, C Thomas, P Kenemans
International Journal of Cancer 1988
CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma
M Quaranta, V Lorusso, M Coviello, G Micelli, A Casamassima
International Journal of Cancer 1988
Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma
CC van Niekerk, LG Poels, PH Jap, DF Smeets, CM Thomas, FC Ramaekers, GP Vooijs
International Journal of Cancer 1988
Localization of radiolabelled F(ab′)2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts
KR Moseley, A Battaile, RC Knapp, HJ Haisma
International Journal of Cancer 1988
Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components
D Mezzanzanica, S Canevari, S Ménard, SM Pupa, E Tagliabue, A Lanzavecchia, MI Colnaghi
International Journal of Cancer 1988
Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: Report of a case with immunocytochemical features
TK Kobayashi, S Teraoka, T Tsujioka, Y Yoshida
Diagnostic Cytopathology 1988
Serum levels of cancer-associated antigen 195, a circulating marker for colon cancer, and its relationship to carcinoembryonic antigen
KR Bray, PK Gaur
Journal of Clinical Laboratory Analysis 1988
Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro
BY Karlan, W Amin, V Band, VR Zurawski, BA Littlefield
Gynecologic Oncology 1988
Human ovarian tumors in primary culture: Growth, characterization and initial evaluation of the response to cis platinum treatmentin vitro
G Balconi, M Brogcini, E Erba, M D'Incalci, N Colombo, C Mangioni, F Bertolero
International Journal of Cancer 1988
Reactivity of the Monoclonal Antibody B72.3 with Fetal Antigen: Correlation with Expression of TAG-72 in Human Carcinomas
D Stanick, A Schuss, Y Mishriki, S Chao, A Thor, J Lundy
Cancer Investigation 1988
Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer
H Yabushita, T Masuda, A Ogawa, M Noguchi, M Ishihara
Gynecologic Oncology 1988
The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas
MM Altaras, GL Goldberg, W Levin, B Bloch, L Darge, JA Smith
Gynecologic Oncology 1988
Tumour marker immunoreactivity in adenocarcinoma
IO Ellis, A Hitchcock
Journal of clinical pathology 1988
The use of monoclonal antibody B72.3 in the management of gynecologic malignancies
J Simpson, J Schlom
The Yale journal of biology and medicine 1988
An assay for the detection of human anti-murine immunoglubulins in the presence of CA125 antigen
KR Moseley, RC Knapp, HJ Haisma
Journal of Immunological Methods 1988
Human ovarian tumors in primary culture: Growth, characterization and initial evaluation of the response to cis platinum treatment in vitro
G Balconi, M Brogcini, E Erba, M D'Incalci, N Colombo, C Mangioni, F Bertolero
International Journal of Cancer 1988
Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens
P Kenemans, CA Yedema, JH Hilgers, LF Massuger, RH Verheijen, CM Thomas, LG Poels
European Journal of Obstetrics & Gynecology and Reproductive Biology 1988
Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody
MR Zalutsky, RC Knapp, RC Bast
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1988
Tumor markers in non-malignant diseases
Y Touitou, A Bogdan
European Journal of Cancer and Clinical Oncology 1988
The ovarian cancer associated antigen CA 125 in patients with pleural effusions
J Lindgren, P Kuusela, PE Hellström, T Pettersson, M Klockars
European Journal of Cancer and Clinical Oncology 1988
Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid
GS Rao, P Hanjani
American Journal of Obstetrics and Gynecology 1988
CA 125 in tissues and amniotic fluid during pregnancy
JG Quirk, GL Brunson, CA Long, GA Bannon, MM Sanders, TJ O'Brien
American Journal of Obstetrics and Gynecology 1988
Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease
S Knauf
American Journal of Obstetrics and Gynecology 1988
Serum and peritoneal lavage fluid CA-125 levels in endometriosis
RW Moretuzzo, S DiLauro, E Jenison, SL Chen, RH Reindollar, PG McDonough
Fertility and Sterility 1988
An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome
M Friedlander, J Leary, P Russell
Pathology 1988
Tumor Antigen Nb/70K and Ca 125 Levels in the Blood of Preoperative Ovarian Cancer Patients and Controls: A Preliminary Report of the use of the Nb12123 and Ca 125 Radioimmunoassays Alone and in Combination
S Knauf, RC Bast
The International Journal of Biological Markers 1988
Radioimmunoscintigraphy Using Monoclonal Antibodies to CEA, CA 19-9 and CA 125
RP Baum, M Lorenz, C Hottenrott, M Albrecht, R Senekowitsch, J Happ, A Hertel, J Spitz, G Hör
The International Journal of Biological Markers 1988
Co-expression of human cancer-associated epitopes on mucin molecules
MS Lan, RS Metzgar, RC Bast, MI Colnaghi, RC Knapp, D Colcher, J Schlom
International Journal of Cancer 1987
Manipulation of the intratumor infiltrate by anti-tumor antibody conjugates
R Obrist
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1987
Lewis and related tumor-associated determinants on ovarian carcinoma
NG Ordonez, RS Freedman, M Herlyn
Gynecologic Oncology 1987
Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity
S Miotti, S Canevari, S Ménard, D Mezzanzanica, G Porro, SM Pupa, M Regazzoni, E Tagliabue, MI Colnaghi
International Journal of Cancer 1987
Serum CA 125 and survival of mice inoculated with ovarian carcinoma and treated with antiestrogen, estrogen, or progestin
JA Holt, SE Waggoner, EY Lee, MM Hubby, TC Hamilton
Gynecologic Oncology 1987
Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors
GJ Fleuren, M Nap, JG Aalders, JB Trimbos, HW de Bruijn
Cancer 1987
Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas
R Moll, S Robine, B Dudouet, D Louvard
Virchows Archiv B Cell Pathology Including Molecular Pathology 1987
Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigen
MM Pinto, LH Bernstein, DA Brogan, E Criscuolo
Cancer 1987
The detection of human pancreatic cancer-associated antigen in the serum of cancer patients
YS Chung, JJ Ho, YS Kim, H Tanaka, B Nakata, A Hiura, H Motoyoshi, K Satake, K Umeyama
Cancer 1987
Elevation of CA 125 in patients with benign and malignant ascites
JF Bergmann, JM Bidart, M George, M Beaugrand, VG Levy, C Bohuon
Cancer 1987
Hepatoid carcinoma of the ovary. A newly described tumor
H Ishikura, RE Scully
Cancer 1987
The clinical significance of pre-operative serum CA 125 in ovarian cancer
D Cruickshank, WT Fullerton, A Klopper
BJOG: An International Journal of Obstetrics and Gynaecology 1987
Serum CA 125 in epithelial ovarian cancer. A longitudinal study
PA Brioschi, O Irion, P Bischof, M Bader, M Forni, F Krauer
BJOG: An International Journal of Obstetrics and Gynaecology 1987
Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence
MS Schtlthuis, JG Aalders, J Bouma, HW Bruijn, H Kooi, PH Willemse, GJ Fleuren
BJOG: An International Journal of Obstetrics and Gynaecology 1987
Immunochemical characterization and radioimmunometric petection of molecules shed by human ovarian cancer
F Leoni, RC Bast, S Canevari, S Menard, JT Soper, MI Colnaghi
International Journal of Cancer 1987
Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer
HJ Haisma, A Battaile, EW Stradtman, RC Knapp, VR Zurawski
International Journal of Cancer 1987
Radioimaging of human ovarian carcinoma xenograft in nude mice
A Manetta, PG Satyaswaroop, T Hamilton, R Ozols, R Mortel
Gynecologic Oncology 1987
Establishment of a murine monoclonal antibody against human clear cell carcinoma and analysis of the corresponding antigen
S Nakagawa, Y Tsuji, N Masuda, H Nishiura, S Isojima
Gynecologic Oncology 1987
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma
P Fioretti, A Gadducci, M Ferdeghini, T Bartolini, R Bianchi, V Facchini
Gynecologic Oncology 1987
COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA ARISING IN A CIRRHOTIC LIVER: Report of an Autopsy Case
H Sonobe, K Hayashi, K Takahashi, Y Ohtsuki, K Matsumoto, S Onishi, K Jinno
Pathology International 1987
Characterization of newly established human ovarian carcinoma cell line—Special reference of the effects of cis-platinum on cellular proliferation and release of CA125
I Ishiwata, C Ishiwata, M Soma, S Nozawa, H Ishikawa
Gynecologic Oncology 1987
Cytological Properties of Human Ovarian Carcinoma Cell Lines
I Ishiwata, C Ishiwata, S Nozawa, H Ishikawa
Asia-Oceania Journal of Obstetrics and Gynaecology 1987
Clinical Significance of CA125 and Its Assessement with an Enzyme Immunoassay
QY Shi, T Sakawaki, T Kasamatsu, H Ohkura
Asia-Oceania Journal of Obstetrics and Gynaecology 1987
CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian Tumours
RM Rome, H Koh, D Fortune, M Cauchi
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1987
Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study
EJ Nouwen, PG Hendrix, S Dauwe, MW Eerdekens, ME de Broe
The American Journal of Pathology 1987
cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment
AP Wilson, CH Ford, CE Newman, A Howell
British Journal of Cancer 1987
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA
H Halila, ML Huhtala, C Haglund, S Nordling, UH Stenman
British Journal of Cancer 1987
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker
G Moldenhauer, F Momburg, P Möller, R Schwartz, GJ Hämmerling
British Journal of Cancer 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovary
TC Hamilton, RF Ozols, DL Longo
Cancer 1987
Surgical staging of gynecologic malignancies
HE Averette, DM Donato, JL Lovecchio, BU Sevin
Cancer 1987
Pros and cons of gynecologic tumor markers
RC Bast, V Hunter, RC Knapp
Cancer 1987
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione
RF Ozols, KG Louie, J Plowman, BC Behrens, RL Fine, D Dykes, TC Hamilton
Biochemical Pharmacology 1987
Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy
SK Khoo, T Hurst, MJ Webb, GJ Dickie, JH Kearsley, EV Mackay
European Journal of Cancer and Clinical Oncology 1987
CA-125 in gynecological malignancies
W Meier, P Stieber, A Fateh-Moghadam, W Eiermann, H Hepp
European Journal of Cancer and Clinical Oncology 1987
The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy
RG Fish, MD Shelley, T Maughan, I Rocker, M Adams
European Journal of Cancer and Clinical Oncology 1987
Relation of fibrin and tumour-associated antigens to the spread of ovarian cancer
M Röbl, K Jürgensmeyer, R Hafter, R Schröck, O Wilhelm, R Babic, H Graeff
Fibrinolysis 1987
Therapeutic and diagnostic uses of modified monoclonal antibodies
LW Brady, DV Woo, ND Heindel, AM Markoe, H Koprowski
International journal of radiation oncology, biology, physics 1987
Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome
W Jäger, K Diedrich, L Wildt
Fertility and Sterility 1987
A combined serological and immunohistological investigation of CA 125 antigen and malignant ovarian epithelial tumours
A Hitchcock, IO Ellis, C Selby, DT Liu, RE Cotton
Journal of Obstetrics & Gynaecology 1987
Present Status of Serum Tumor Markers in Diagnosis, Prognosis, and Evaluation of Therapy
SL Cohn, ST Lincoln, ST Rosen
Cancer Investigation 1986
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy
H Halila, UH Stenman, M Seppälä
Cancer 1986
Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker
H Kaesemann, H Caffier, FJ Hoffmann, G Crombach, H Würz, R Kreienberg, V Möbus, P Schmidt-Rhode, G Sturm
Klinische Wochenschrift 1986
Biochemical characterization of the monoclonal antibody-defined ovarian carcinoma-associated antigen SGA
TA de Kretser, HJ Thorne, D Picone, DG Jose
International Journal of Cancer 1986
Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component)
I Ishiwata, C Ishiwata, M Soma, H Ishikawa
Gynecologic Oncology 1986
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary
MM Altaras, GL Goldberg, W Levin, L Darge, B Bloch, JA Smith
Gynecologic Oncology 1986
CA125 Production by Gynecologic Tumors in Vitro and its Modulation Induced by Dibutyl Cyclic Adenosine Monophosphate
I Ishiwata, C Ishiwata, S Nozawa, H Ishikawa
Asia-Oceania Journal of Obstetrics and Gynaecology 1986
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA
C Haglund
British Journal of Cancer 1986
Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker: Eine kooperative Studie der Gynäkologischen Tumormarkergruppe (GTMG)
H Kaesemann, H Caffier, FJ Hoffmann, G Crombach, H Würz, R Kreienberg, V Möbus, P Schmidt-Rhode, G Sturm
Klinische Wochenschrift 1986
A serum test for cystic fibrosis using monoclonal antibody 19-9
DD Roberts, DL Monsein, RC Frates, MS Chernick, V Ginsburg
Archives of Biochemistry and Biophysics 1986
CA 125 in gynecologic practice
GD Malkasian, KC Podratz, CR Stanhope, RE Ritts, VR Zurawski
American Journal of Obstetrics and Gynecology 1986
CA 125 surveillance and second-look laparotomy in ovarian carcinoma
DB Atack, JA Nisker, HH Allen, ER Tustanoff, L Levin
American Journal of Obstetrics and Gynecology 1986
CA 125 antigen in human amniotic fluid and fetal membranes
TJ O'Brien, JW Hardin, GA Bannon, JS Norris, G Quirk
American Journal of Obstetrics and Gynecology 1986
The tumor marker CA 125 is a common constituent of normal cervical mucus
HW de Bruijn, TB Calkoen-Carpay, S Jager, JM Duk, JG Aalders, GJ Fleuren
American Journal of Obstetrics and Gynecology 1986
Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant Women
Y Haga, K Sakamoto, H Egami, R Yoshimura, M Akagi
The American Journal of the Medical Sciences 1986
Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System
Y Haga, K Sakamoto, H Egami, R Yoshimura, K Mori, M Akagi
The American Journal of the Medical Sciences 1986
CA-125 in patients with endometriosis
RL Barbieri
Fertility and Sterility 1986
Tumour Markers in Pancreatic Cancer
C Haglund, PJ Roberts, P Kuusela, H Jalanko
Scandinavian Journal of Gastroenterology 1986
CA-125 levels in endometriosis
PE Patton, CS Field, RW Harms, CB Coulam
Fertility and Sterility 1986
Elevated serum concentrations of CA-125 in patients with advanced endometriosis
RL Barbieri, JM Niloff, RC Bast, E Schaetzl, RW Kistner, RC Knapp
Fertility and Sterility 1986
Monoclonal Antibodies: Their Chemistry, Functions, and Possible Uses
FR Seiler, P Gronski, R Kurrle, G L�ben, HP Harthus, W Ax, K Bosslet, HG Schwick
Angewandte Chemie (International ed. in English) 1985
Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk
FG HANISCH, G UHLENBRUCK, C DIENST, M STOTTROP, E HIPPAUF
European Journal of Biochemistry 1985
The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
J Dodd, JP Tyler, AJ Crandon, NJ Blumenthal, RA Fay, PJ Baird, LJ Hicks, CN Hudson
BJOG: An International Journal of Obstetrics and Gynaecology 1985
Tumour-associated antigen CA 125 in patients with ovarian cancer
PK Heinonen, K Tontti, T Koivula, P Pystynen
BJOG: An International Journal of Obstetrics and Gynaecology 1985
Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma
M Bhattacharya, SK Chatterjee, A Gangopadhyay, JJ Barlow
Journal of Surgical Oncology 1985
Monoklonale Antikörper: Chemie, Funktion und Anwendungsmöglichkeiten
FR Seiler, P Gronski, R Kurrle, G Lüben, HP Harthus, W Ax, K Bosslet, HG Schwick
Angewandte Chemie 1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
RC Bast, FP Siegal, C Runowicz, TL Klug, VR Zurawski, D Schonholz, CJ Cohen, RC Knapp
Gynecologic Oncology 1985
The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells
TA de Kretser, HJ Thorne, DJ Jacobs, DG Jose
European Journal of Cancer and Clinical Oncology 1985
Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer
JO Davies, ER Davies, K Howe, P Jackson, E Pitcher, B Randle, C Sadowski, GM Stirrat, CA Sunderland
Journal of the Royal Society of Medicine 1985
Characterization of the Specificity by Immunohistology of a Monoclonal Antibody to a Novel Epithelial Antigen of Ovarian Carcinomas
R Mariani-Costantini, R Agresti, MI Colnaghi, S Ménard, S Andreola, F Rilke
Pathology - Research and Practice 1985
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma
RC Bast, RC Knapp
European Journal of Obstetrics & Gynecology and Reproductive Biology 1985
Prospects and applications of monoclonal antibodies in gynecological oncology
P Kenemans, RH Verheijen, AM Leloux, LG Poels
European Journal of Obstetrics & Gynecology and Reproductive Biology 1985
Reply to Davies et al
JM Niloff, RC Knapp, RC Bast
American Journal of Obstetrics and Gynecology 1985
Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: A Gynecologic Oncology Group study
G Abdulhay, PJ DiSaia, JA Blessing, WT Creasman
American Journal of Obstetrics and Gynecology 1985
Are CA125 and placental alkaline phosphatase the same antigen?
JO Davies, GM Stirrat, CA Sunderland
American Journal of Obstetrics and Gynecology 1985
Practical Applications of a Monoclonal Antibody (NDOG 2 ) against Placental Alkaline Phosphatase in Ovarian Cancer
JO Davies, P Jackson, C Sadowski, ER Davies, E Pitcher, GM Stirrat, K Howe, B Randle, CA Sunderland
Journal of the Royal Society of Medicine 1985
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours
NC Armitage, AC Perkins, MV Pimm, PA Farrands, RW Baldwin, JD Hardcastle
British Journal of Surgery 1984
Immunoelectronmicroscopic Demonstration of Surface Tumor Antigen Ca 125
A Blaustein
Ultrastructural Pathology 1984
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies
MJ Mattes, C Cordon-Cardo, JL Lewis, LJ Old, KO Lloyd
Proceedings of the National Academy of Sciences 1984
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
PA Canney, M Moore, PM Wilkinson, RD James
British Journal of Cancer 1984
Biotechnology in medicine
AM Green
Canadian Medical Association journal 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
RC Bast, TL Klug, E Schaetzl, P Lavin, JM Niloff, TF Greber, VR Zurawski, RC Knapp
American Journal of Obstetrics and Gynecology 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
JM Niloff, TL Klug, E Schaetzl, VR Zurawski, RC Knapp, RC Bast
American Journal of Obstetrics and Gynecology 1984
Clinical Biochemistry
E Cooper, M Bowen
Clinical Biochemistry 1984
Environmental factors in the etiology of carcinoma of the human ovary: A review
CH Lingeman
American Journal of Industrial Medicine 1983
Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma
R Obrist, R Reilly, T Leavitt, RC Knapp, RC Bast
International Journal of Immunopharmacology 1983
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
RC Bast, TL Klug, ES John, E Jenison, JM Niloff, H Lazarus, RS Berkowitz, T Leavitt, CT Griffiths, L Parker, VR Zurawski, RC Knapp
New England Journal of Medicine 1983
Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line
R Berkowitz, S Kabawat, H Lazarus, R Colvin, R Knapp, RC Bast
American Journal of Obstetrics and Gynecology 1983
Lymphocyte hybridomas
CS Foster
Cancer Treatment Reviews 1982
In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts
MV Pimm, MJ Embleton, AC Perkins, MR Price, RA Robins, GR Robinson, RW Baldwin
International Journal of Cancer 1982
Recent progress in the treatment of epithelial ovarian malignancy
JS Berek, NF Hacker, LD Lagasse
The Western journal of medicine 1982
Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors
I Damjanov, N Fox, BB Knowles, D Solter, PH Lange, EE Fraley
The American Journal of Pathology 1982
Protides of the Biological Fluids
PA Small, RH Waldman
Protides of the Biological Fluids 1969
Ultrahigh sensitivity in liquid-crystal-based immunodetection by surface modification of the alignment layer
IC Khoo, MJ Lee, HW Su, SH Sun, W Lee
Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen
MM Jankovic, BS Tapuskovic
Human Reproduction 2005
Human Cell Culture
MR Koller, BO Palsson, JR Masters
2002
Peritoneal Carcinomatosis: Principles of Management
PH Sugarbaker
1996
Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report
L Wasserman, A Neri, B Kaplan, Y Manor, M Galli, B Hardy
Journal of Cancer Research and Clinical Oncology 1995
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography
I Jacobs, AP Davies, J Bridges, I Stabile, T Fay, A Lower, JG Grudzinskas, D Oram
BMJ : British Medical Journal 1993
Neue Entwicklungen in der Dermatologie
OP Hornstein, M Hundeiker, J Schönfeld
1990
GnRH Analogues in Cancer and Human Reproduction
BH Vickery, B Lunenfeld
1990
A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinoma
AC Perkins, MC Powell, ML Wastie, IV Scott, A Hitchcock, BS Worthington, EM Symonds
European Journal of Nuclear Medicine 1990
Preoperative and Longitudinal Serum Levels of CA 125 and CA 15.3 in Patients with Breast Cancer
YT Omar, AE Behbehani, N Al-Naqeeb, MM Motawy, MO Foudeh, AH Awwad, MY Nasralla, JJ Szymendera
The International Journal of Biological Markers 1989
Distribution of CA 125 in Placental Tissues
LC Fuith, E Müller-Holzner, C Marth, E Perkmann, A Zeimet, G Daxenbichler
The International Journal of Biological Markers 1989
CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube: I. Immunohistochemical detection
A Scharl, G Crombach, M Vierbuchen, H Msch, A Bolte
Archives of Gynecology and Obstetrics 1989
In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines
MJ Xu, DS Alberts, R Liu, A Leibovitz, Y Liu
Cancer Chemotherapy and Pharmacology 1989
Radiolabeled Monoclonal Antibodies for Imaging and Therapy
SC Srivastava
1988
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, S Sekiya, H Takamizawa, N Suzuki, H Tokita
Archives of Gynecology and Obstetrics 1988
CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading
W Neunteufel, C Bieglmayer, G Breitenecker
Archives of Gynecology and Obstetrics 1988
Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, T Sato, H Takamizawa, B Wiklund
Archives of Gynecology and Obstetrics 1988
Immunohistochemical study of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in the human and cynomolgus monkey placenta, umbilical cord and decidua
K Itahashi, N Inaba, I Fukazawa, H Takamizawa
Archives of Gynecology and Obstetrics 1988
Immunochemical identification of ?2-globulin in metastases of ovarian tumors
PG Prokopenko, SA Borisenko, YS Tatarinov
Bulletin of Experimental Biology and Medicine 1988
Tumour associated antigens in diagnosis of serous effusions
J Mezger, W Permanetter, AL Gerbes, W Wilmanns, R Lamerz
Journal of clinical pathology 1988
Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas
SC Henzen-Logmans, NW Schipper, LG Poels, K Stolk, P Kenemans, CJ Meyer
Journal of clinical pathology 1988
New Frontiers in Cytology
K Goerttler, GE Feichter, S Witte
1988
Radiobiology in Radiotherapy
NM Bleehen
1988
The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage
RL Wahl, J Barrett, O Geatti, M Liebert, BS Wilson, S Fisher, JG Wagner
Cancer Immunology, Immunotherapy 1988
CA 125 in the serum and tissue of patients with gynecological disease
LC Fuith, G Daxenbichler, O Dapunt
Archives of Gynecology and Obstetrics 1987
Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system
K Sakamoto, Y Haga, R Yoshimura, H Egami, Y Yokoyama, M Akagi
Gut 1987
Application of Monoclonal Antibodies in Tumor Pathology
DJ Ruiter, GJ Fleuren, SO Warnaar
1987
Sarcoma-like mural nodules in cystic serous ovarian tumours
TJ Clarke
Journal of clinical pathology 1987
Cellular Biology and Pharmacology of the Placenta
RK Miller, HA Thiede
1987
Morphological Tumor Markers
G Seifer
1987
Immunological Approaches to the Diagnosis and Therapy of Breast Cancer
RL Ceriani
1987
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model
M Ripamonti, S Canevari, S Mnard, D Mezzanzanica, S Miotti, R Orlandi, F Rilke, E Tagliabue, MI Colnaghi
Cancer Immunology, Immunotherapy 1987
Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas
G J Fleuren, E G Coerkamp, M Nap, L J vd Broek, S O Warnaar
Virchows Archiv A Pathological Anatomy and Histopathology 1987
Immunobiology of complete molar pregnancy and gestational trophoblastic tumor
RS Berkowitz, SA Umpierre, S Taylor-Emery, DP Goldstein, DJ Anderson
Cancer and Metastasis Reviews 1986
Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera
M Dietel, H Arps, R Klapdor, S Mller-Hagen, M Sieck, L Hoffmann
Journal of Cancer Research and Clinical Oncology 1986
Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma: A Phase I study
MS Huberman, JJ Lokich, T Hill, A Kaldany, A Kassis, T Price, C Moore, S Davis, P Kasulis, AP Monaco, DE Haagensen
Cancer Immunology, Immunotherapy 1986
Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum
MD Shelley, RG Fish
Annals of Clinical Biochemistry 1986
Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: Preparation and use in a radioimmunoassay for measuring NB/70K in serum
S Knauf, J Kalwas, BF Helmkamp, LW Harwell, J Beecham, EdithM.
Cancer Immunology, Immunotherapy 1986
Ovarian Cancer
DS Alberts, EA Surwit
1985
Spezielle Gynäkologie und Geburtshilfe
E Burghardt
1985
Microenvironments in the Lymphoid System
GG Klaus
1985
Immune Complexes and Human Cancer
FA Salinas, MG Hanna
1985
Monoclonal Antibodies in Cancer
S Sell, RA Reisfeld
1985
Monoclonal Antibodies and Functional Cell Lines
RH Kennett, KB Bechtol, TJ McKearn
1984
Somatic Activation of rasK Gene in a Human Ovarian Carcinoma
LA Feig, RC Bast, RC Knapp, GM Cooper
Science 1984
Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder: I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence
H Koho, S Paulie, H Ben-Aissa, I Jnsdttir, Y Hansson, ML Lundblad, P Perlmann
Cancer Immunology, Immunotherapy 1984
Basic and Clinical Tumor Immunology
RB Herberman
1983
A Review of Intraperitoneal Therapy of Human Ovarian Carcinoma
RC Knapp, RC Knapp, ES John, RC Bast
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1983
Human tumor-associated antigens identified by monoclonal antibodies
KE Hellstrm, I Hellstrm, JP Brown
Springer Seminars in Immunopathology 1982

← Previous 1 2 3 4 5 6 … 48 49 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 37 patents
Referenced in 5 Wikipedia pages
Referenced in 2 clinical guideline sources
351 readers on Mendeley
See more details